AAN Annual Meeting Education Program by American Academy of Neurology

ANNUAL MEETING EDUCATION PROGRAM

Seattle: April 2 –7 Virtual Experience: April 24–26

LEC

New Learner Engagement Centers Redefining Conference Education We’re taking education to an entirely new level with the introduction of Learner Engagement Centers. We’re creating dedicated spaces for informal and formal learning where you can casually gather with colleagues, as well as share knowledge in a unique environment.

Academic Exchange Offering career development, coaching, small group dialogue sessions, and networking opportunities across career stages for academic neurology professionals.

Leadership University Expanding neurology leadership development training through education, exposure, and engagement.

Research Connections

Practice and Policy Engagement Center Providing inclusive tools in practice management, quality improvement, and advocacy to support high-quality care, improve efficiency, and increase revenue.

Offering researcher resources, inspiration for future research, and connection with other researchers.

The Neuro Trainee and Educator Junction Sharing information and resources and connecting trainees and educators.

What ’s

INSIDE Introduction What’s New. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 Registration. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 Hotel & Travel Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Program Glossary. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10

Annual Meeting Schedules Meeting-at-a-Glance Annual Meeting in Seattle. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Annual Meeting Virtual Experience. . . . . . . . . . . . . . . . . . . . . . . Daily Schedule: Annual Meeting in Seattle Saturday, April 2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Sunday, April 3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Monday, April 4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tuesday, April 5 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Wednesday, April 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Thursday, April 7. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

11 15 16 18 20 22 24 26

Programs by Topic: Annual Meeting in Seattle. . . . . . . . . . . . . . . . . . . . . 27

Conference Guidelines Accreditation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Select Meeting Policies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . COVID-19 Policies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cancellation Policies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

71 71 72 72

Annual Meeting in Seattle April 2-7, 2022

Early Registration Deadline February 17, 2022

Annual Meeting Virtual Experience April 24-26, 2022

Receive the best rates and no-risk cancellation policies for registration packages that include the Annual Meeting in Seattle. AAN.com/AM

“

We’re excited to welcome everyone to the Great Neuro Reunion in Seattle where we look forward to coming back together in a safe environment in one of the country’s most gorgeous cities! For those who can’t join us in person, we’re offering an exciting three-day virtual option, as well. The in-person meeting will offer a unique chance to celebrate your neurology community while fulfilling all your education needs. You’ll find hundreds of offerings taught by the world’s best neurologists presented in ways that only the AAN can deliver. For this year we’ve taken the whole idea of customized learning to the next level with the new Learner Engagement Centers—high-energy learning environments designed specifically to foster collaboration and spark engaging conversations. Our distinct virtual option will take place April 24-26 and offers a completely different experience where you’ll find plenary sessions ending in fireside chats that will allow you to engage directly with speakers, education tracks designed for a variety of career stages and specialties, edutainment, and more!

”

2022 AAN Annual Meeting

Joseph I. Sirven, MD, FAAN Chair, AAN Education Committee

We can’t wait to see you in Seattle! Catch up and collaborate on the latest neuroscience research and advances

Come together at alumni reunions

Engage in learning opportunities in small group settings

It’s been two long years and we’re making up for it with the best Annual Meeting yet. Let’s get back to the unforgettable moments, the friendships and camaraderie, the knowledge sharing, and the opportunities for success and growth we create when we’re together.

The Great Neuro Reunion Party Sunday, April 3, at 7 p.m. PT

Space Needle

Chihuly Garden and Glass

Museum of Pop Culture

Registration for the Annual Meeting in Seattle includes one complimentary ticket to the Great Neuro Reunion Party at these three locations.

SEATTLE: BY THE NUMBERS

Welcome Back

MEMORABLE PARTY

to the Annual Meeting in Seattle! The AAN’s first in-person meeting since 2019! Join us at the Washington State Convention Center in Seattle April 2-7, 2022.

Reconnect with friends and colleagues at the Space Needle, Chihuly Garden and Glass, and Museum of Pop Culture.

No-risk registration for Seattle through the early registration deadline, February 17, 2022. Register early to secure your spot.

LEC

Learner Engagement Centers

Experiential Learning Areas

Education for All Your CME Needs

160+

23 4

2022 AAN Annual Meeting

of in-person networking opportunities

2,400 Abstract presentations

and unique courses and sessions in Seattle

TOPICS

DAYS

Cutting-edge Science UP TO

LIVE

LOCATIONS

40 7

Scientific Sessions + Poster Hall

Plenary Sessions

VIRTUAL EXPERIENCE: BY THE NUMBERS Annual Meeting Virtual Experience

The convenience of the virtual meeting is returning April 24-26, 2022! More information on specific programming will be available soon on AAN.com/AM.

DAYS

of networking opportunities through chat channels and more

The AAN’s

VIRTUAL ANNUAL MEETING

40+

PROGRAM TRACKS

What a Past Attendee Says

VIRTUAL and unique courses and sessions with live Q&A

Plenary Sessions

“

The AAN Annual Meeting is such an exciting event for me each year. I know I’ll get the best clinical and science updates. More importantly, it gives me a sense of professional community that I get nowhere else. It will be refreshing to see everyone back in person. -Carol M. Ulloa, MD, FAES, FAAN

AAN.com/AM

REGISTRATION Registration packages allow you to customize your Annual Meeting experience based on your unique needs with three exceptionally valued registration packages.

PLATINUM REGISTRATION = Annual Meeting in Seattle Gold + Annual Meeting Virtual Experience Gold Attend both meetings with extended access to recordings through March 1, 2023! Save 25% when you go Platinum!

Annual Meeting in Seattle Registration Registration includes: • 160+ education programs offering CME credits for the entire year • Up to 2,400 scientific abstracts presented in multiple formats • 7 plenary sessions featuring leaders in neurology • HeadTalks and Live Well Experiential Learning Areas • New! Learner Engagement Centers (see inside front cover for more information) • Networking opportunities throughout the week, including one complimentary ticket to the Great Neuro Reunion party on Sunday, April 3, and closing party on April 7

• Access to program slides and syllabi • Breakfast and lunch included • Exhibit Hall and Industry Therapeutic Updates • Access to most recordings through May 14, 2022 • Upgrade to Gold: Extend access to most recordings through March 1, 2023, with Annual Meeting On Demand Seattle

REGISTER NOW RISK-FREE! No cancellation fees for Annual Meeting in Seattle registration through February 17, 2022. See page 72 for complete cancellation policies. VACCINATION REQUIRED

All Annual Meeting attendees in Seattle must be “fully vaccinated” (as defined by the CDC at the time of the meeting) and must provide verification of full COVID-19 vaccination status. Unvaccinated individuals may register for the Annual Meeting Virtual Experience. See AAN.com/AMCOVID19 for more information.

Annual Meeting Virtual Experience Registration Registration includes: • 40+ unique education courses offering CME credits that were not available at the Annual Meeting in Seattle • Access to program slides and syllabi • Networking opportunities • Interaction with industry

2022 AAN Annual Meeting

• Access to most recordings through May 14, 2022

• Upgrade to Gold: Extend access to most recordings through

March 1, 2023, with Annual Meeting On Demand Virtual Experience • And more to be announced!

Platinum

Annual Meeting Seattle

Annual Meeting Virtual Experience

Proof of vaccination required to attend One ticket to the Great Neuro Reunion and closing parties in Seattle Attendance in Seattle April 2-7 Seattle recordings through May 14, 2022 Extended access to Seattle recordings through March 1, 2023 Virtual attendance April 24-26 Virtual Experience recordings through May 14, 2022 Extended access to Annual Meeting Virtual Experience recordings through March 1, 2023

(with Gold Upgrade)

Online AAN.com/AM

Phone (800) 676-4226 (US/Canada) (415) 979-2283 (International)

Deadline February 17, 2022

Prices Increase Starting February 18, 2022 Member Type

Platinum

Student Member, Senior, or Honorary Member Intern or Junior Member

$200 $570

Non-physician Member**

$995

Neurologist or Physician Affiliate Member Nonmember

$1,525 $2,575

Annual Meeting Seattle $0 $150 Gold $295 $445 Gold $495 $745 Gold $795 $1,195 Gold $1,320 $2,060 Gold

Annual Meeting Virtual Experience $0 $110 Gold $210 $320 Gold $375 $575 Gold $525 $825 Gold $875 $1,385 Gold

*Note: All pricing is in US dollars. **Non-physician member includes Business Administrator, Researcher, and Advanced Practice Provider member types.

Don’t get scammed. Look for this logo and only register or secure housing through Convention Management Resources (CMR), the AAN’s official partner.

Become an AAN member today for registration discounts. Visit AAN.com/Membership.

BOOK YOUR HOTEL Online AAN.com/AM

Phone (800) 676-4226 (US/Canada) (415) 979-2283 (International)

Why Book a Hotel Through the AAN? • All hotels within walking distance of the Washington State Convention Center • Discounted rates and easy-to-modify reservations • Greater networking opportunities • High-quality venues and amenities • Friendly booking terms: No change fees or full prepayment upon booking • Housing representatives are available in advance and on-site for assistance with official hotels

Look out for scammers. Protect yourself from fraudulent booking companies. Convention Management Resources (CMR) is the official and only registration and housing partner of the AAN and is accessible via AAN.com/AM.

Look Out for Hotel Scammers Follow these important tips when booking housing: 1. CMR is the only official housing provider for the 2022 AAN Annual Meeting. 2. Scammers and poachers generally request full payment for your hotel stay. CMR will only request a credit card guarantee for one-night room and tax deposit. 3. If it seems too good to be true, it probably is. 4. If you have not booked through the official block, the AAN is unable to help you resolve any issues with the hotel. 5. The best way to book your hotel is to navigate to the housing site on AAN.com/AM.

TRAVEL DISCOUNTS The AAN has negotiated discounted pricing for certain airlines and rental car companies. Use these promotional codes when booking directly with each company to receive the discount.

2022 AAN Annual Meeting

Official Annual Meeting Hotel Block All hotels booked through the AAN include complimentary internet access and are within walking distance (1-mile) of the Washington State Convention Center. No daily shuttle service to the convention center will be provided.

Lowest Available Rate*

# Hotel Name

Lowest Available Rate*

# Hotel Name

1 Sheraton Grand Seattle (Co-HQ)

$289

9 Hyatt at Olive 8

$285

2 Hyatt Regency Seattle (Co-HQ)

$279

3 Crowne Plaza Seattle Downtown

$185

10 Motif Seattle, a Destination by Hyatt Hotel

$229

4 The Fairmont Olympic Hotel Seattle

$269

11 Renaissance Seattle Hotel

$245

5 Grand Hyatt Seattle

$289

$219

6 Hilton Garden Inn Seattle Downtown

12 Residence Inn by Marriott Seattle Downtown/Convention Center

$209

7 Hilton Seattle

13 The Westin Seattle

$229

$279

8 Homewood Suites by Hilton Seattle of Convention CenterMuseum Pike Street

14 W Seattle

$269

$225

Pop Culture

Travel Tips

*All hotel rates are in US dollars. Availability may be limited; other room categories may be available

a higher rate. Rates include a $8 per night assessment fee to offset the expense of the meeting. ChihulyatGarden Rates do not include hotel tax or a $2 nightly Seattle Tourism Assessment Fee. For deposit and other and Glass Space Needle information, visit AAN.com/AM.

Visit AAN.com/AMFAQ for travel tips, including: • Travel documents/passport and entry requirements • COVID-19 protocols in Seattle • Letter of Announcement request

John St

• And more! ry

tte

ar ew

we ll

Pik

6th

11 5

e Av

ve dA 2n

1st

e Av

4th

3rd

s me

6th

5th

e Av

5th

e Av

3rd

t dS

e Av

ve dA 2n

1st

rry

e Ch

ri Sp

is ad

St St

ri Ma

ia mb

rry

e Ch

e am

J rry

e Av

t aS

4th

n pri

S son

St Ma neSct a c 3 ity Serion 14nivers Ma 14ia St U 11 5 Columb St St rry

n pri

e Av

rin

e Av ren Bo e Av ry Ter

ity

ers

iv Un

e Av

ern

ity

ers

ion

e Av

st We

io Un

iv Un

ty S

si ver

ry Ter

5P 1

e Pik

io Un

e Av

ini

Pine St

Washington State Convention t Center eS

ay eW

liv

Pik

n nio

5 1

Pik

8th

e Pin

Oli

9th

Vi rg

Av e2

Av e

t Av e

ve 13 A

4th

e Av

Hertz Car Rentals 1170024

St no ra Le t dS ar ch

dA ve

rn ste We

Alamo Car Rentals LEADERS

Washington State Convention Center

ay eW

8th

United Airlines ZKH7674291

ar ch t

4th

dA ve

7th

13 6 A

Pine St

ren Bo

tA ve

6th

5th

Av e

ll S

Bl an

St ry te Ba t ll S Be

dA ve

3r 1s

9th

Delta Airlines NGNL6

6 12

ll S

Vi ne

Av e

dA ve

tA ve

8th

tA v ka e nW ay

dA ve

Vi St rg ew ini ar aS dS

iot

dA ve

Av e

Ell as

tA ve

4th

1s W es

Vi ne

St ay Cl

W all

rS t da

Av e

Denny7Way th Ya Av le e 6 Te tBhor W rry e AnvA ay Av 9th eve Av 5 e e th

John St

tA Al v as ka e nW ay Al

Denny Way

W es iot

dA ve

tA ve

Av e

2n 1s

Ell

W all

t rS Ce

4th

d A Needle Space

Chihuly Garden and Glass

Denny Way Ya Annual Meeting in Seattle registration le Te Bo W re includes one ticket to the Great Neuro Reunion rry ay n Av 9th Av Party on Sunday, April 3, at 7:00 p.m. PT. ThreeA e e ve locations, one great night! 8th Av e St

Museum of Pop Culture

Denny Way

PROGRAM GLOSSARY The Annual Meeting offers programming for neurologists and neurology professionals at every career stage and allows you to customize your learning pathway. Use this glossary to get information at-a-glance to help you quickly find items of interest to you.

Programs

Many programs are indicated by one of the letter codes below, followed by sequential numbers, to help you spot a specific program quickly. All Annual Meeting programs are color-coded.

C = Course

An education program using one or more teaching methods, including didactic, interactive, and case-based.

N = Neuroscience in A two-hour session featuring a mix of scientists and clinicians actively engaged in lively case discussion to integrate scientific research with clinical application. the Clinic Session Scientists will provide background on a case and clinicians will apply the case to a patient. Sessions will feature abstract presentations related to the topic and end with a panel discussion. IS = Invited Science

An AAN scientific session featuring encore presentations of top abstracts presented at previous subspecialty meetings.

P = Poster Session

A series of thematic abstract presentations in an electronic format.

S = Scientific Session A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes for question and answer with the author. = Experiential Learning Area

= Learner Engagement Center LEC

An interactive way of learning that will engage you intellectually, emotionally, and socially and offer you fresh ideas to help you personally and professionally. Centers designed to foster collaborative learning, share unique education delivery methods, and spark engaging conversations among attendees.

Plenary Session

A premier session highlighting the latest advances in neuroscience presented by some of the most cutting-edge and well-known thought leaders in the field of neurology.

Skills Workshop

A four-hour interactive, hands-on program to learn and practice new skills. Skills Workshops require a separate fee and registration.

Networking & Entertainment

A must-see entertainment or social event to complement the meeting’s science and education programming. Interact and network with colleagues from around the world!

2022 AAN Annual Meeting

MEETING-AT-A-GLANCE

The following pages provide a high-level look at when various types of programming will be available during the Annual Meeting in Seattle.

Annual Meeting in Seattle SAT April 2

SUN April 3 7:00 a.m. PT

7:00 a.m.–4:45 p.m. PT

7:00 a.m.–5:00 p.m. PT

8:00 a.m.–4:45 p.m. PT

9:15 a.m.–11:15 a.m. PT

8:00 a.m.–4:45 p.m. PT

Controversies in Neurology Plenary Session

7:00 a.m.–9:00 a.m. PT

Poster Sessions

LEC

Time frames for specific Poster Sessions to be announced!

Trainee and Educator Area 7:00 a.m.–5:30 p.m. PT

Presidential Plenary Session 9:15 a.m.–12:00 p.m. PT

8:00 a.m. PT

Poster Sessions

LEC

8:00 a.m.–5:30 p.m. PT

Trainee and Educator Area

Courses C33-C40

8:00 a.m.–5:30 p.m. PT

Courses C1-C27

Time frames for specific Poster Sessions to be announced!

9:00 a.m. PT

10:00 a.m. PT

11:00 a.m. PT

Exhibit Hall

12:00 p.m. PT

11:30 a.m.–4:00 p.m. PT

Neuroscience in the Clinic Session 12:15 p.m.–2:15 p.m. PT

Exhibit Hall Opening Luncheon 11:30 a.m.–1:00 p.m. PT

Courses C41-C59

Invited Science 1:00 p.m.–3:00 p.m. PT

1:00 p.m.–5:30 p.m. PT

1:00 p.m. PT

Scientific Sessions S1-S4

2:00 p.m. PT

1:00 p.m.–3:00 p.m. PT 3:00 p.m. PT

Neuroscience in the Clinic Session

AAN Business Meeting 4:00 p.m.–4:45 p.m. PT

3:30 p.m.–5:30 p.m. PT

Scientific Sessions S5-S8

4:00 p.m. PT

3:30 p.m.–5:30 p.m. PT

5:00 p.m. PT

Hot Topics Plenary Session Reception

5:00 p.m.–6:00 p.m. PT 6:00 p.m. PT

5:30 p.m.–6:30 p.m. PT

Case Studies C28-C32

7:00 p.m. PT

6:15 p.m.–8:15 p.m. PT

Industry Therapeutic Updates

The Great Neuro Reunion Party

7:00 p.m.–10:00 p.m. PT

8:00 p.m. PT

9:00 p.m. PT

10:00 p.m. PT

Information is accurate as of November 29, 2021, and is subject to change.

AAN.com/AM

MEETING-AT-A-GLANCE TUE April 5

Run/Walk for Brain Research

7:00 a.m. PT

Courses C60-C68 7:00 a.m.–9:00 a.m. PT

7:00 a.m.–5:00 p.m. PT

11:00 a.m. PT

8:00 a.m.–5:30 p.m. PT

9:15 a.m.–11:30 a.m. PT

8:00 a.m.–5:30 p.m. PT

9:00 a.m. PT

10:00 a.m. PT

3:00 p.m. PT

7:00 a.m.–9:00 a.m. PT

Exhibit Hall Networking Reception 4 p.m.–6 p.m. PT

Invited Science 1:00 p.m.–3:00 p.m. PT

Trainee and Educator Area 7:00 a.m.–5:30 p.m. PT

Poster Sessions

LEC

Clinical Trials Plenary Session 9:15 a.m.–12:00 p.m. PT

11:30 a.m.–6:00 p.m.

1:00 p.m. PT

2:00 p.m. PT

Time frames for specific Poster Sessions to be announced!

Exhibit Hall

12:00 p.m. PT

Courses C69-C85 & Health Care Equity Symposium

6:30 a.m.–8:00 a.m. PT

Poster Sessions

LEC

Contemporary Clinical Issues Plenary Session

Courses C86-C93

8:00 a.m.–5:30 p.m. PT

8:00 a.m. PT

Trainee and Educator Area

Emerging Science Session

8:00 a.m.–5:30 p.m. PT

MON April 4

Annual Meeting in Seattle

Time frames for specific Poster Sessions to be announced!

Exhibit Hall 11:30 a.m.–4:00 p.m. PT

11:45 a.m.–12:45 p.m. PT

Scientific Sessions S9-S12

Neuroscience in the Clinic Session

1:00 p.m.–3:00 p.m. PT

Invited Science 1:00 p.m.–3:00 p.m. PT

Scientific Sessions S17-S20 1:00 p.m.–3:00 p.m. PT

1:00 p.m.–5:30 p.m. PT

4:00 p.m. PT

5:00 p.m. PT

Neuroscience in the Clinic Session

Scientific Sessions S13-S16

3:30 p.m.–5:30 p.m. PT

Courses C94-C113 1:00 p.m.–5:30 p.m. PT

Scientific Sessions S21-S24 3:30 p.m.–5:30 p.m. PT

6:00 p.m. PT

Faculty & Trainee Reception

7:00 p.m. PT

6:00 p.m.–8:00 p.m. PT 8:00 p.m. PT

Industry Therapeutic Updates 7:00 p.m.–10:00 p.m. PT

9:00 p.m. PT

10:00 p.m. PT

2022 AAN Annual Meeting

Industry Therapeutic Updates 7:00 p.m.–10:00 p.m. PT

WED April 6

THUR April 7 7:00 a.m. PT

Trainee and Educator Area 7:00 a.m.–5:30 p.m. PT

8:00 a.m.–5:30 p.m. PT

9:15 a.m.–11:30 a.m. PT

8:00 a.m.–5:30 p.m. PT

Frontiers in Neuroscience Plenary Session

7:00 a.m.–9:00 a.m. PT

Poster Sessions

LEC

Trainee and Educator Area 7:00 a.m.–5:30 p.m. PT

Time frames for specific Poster Sessions to be announced!

Neurology Year in Review Plenary Session 9:15 a.m.–12:00 p.m. PT

8:00 a.m. PT

Poster Sessions

LEC

8:00 a.m.–5:30 p.m. PT

7:00 a.m.–9:00 a.m. PT

Courses C143-C151

8:00 a.m.–5:30 p.m. PT

Courses C114-C122

9:00 a.m. PT

Time frames for specific Poster Sessions to be announced!

10:00 a.m. PT

11:00 a.m. PT

Exhibit Hall

12:00 p.m. PT

11:30 a.m.–4:00 p.m. PT

1:00 p.m. PT

Courses C123-C142

Invited Science 1:00 p.m.–3:00 p.m. PT

1:00 p.m.–5:30 p.m. PT

Scientific Sessions S25-S28

Courses C152-C166

Invited Science 1:00 p.m.–3:00 p.m. PT

1:00 p.m.–5:30 p.m. PT

1:00 p.m.–3:00 p.m. PT

Scientific Sessions S33-S36

2:00 p.m. PT

1:00 p.m.–3:00 p.m. PT 3:00 p.m. PT

Neuroscience in the Clinic Session

Scientific Sessions S29-S32

Neuroscience in the Clinic Session

Scientific Sessions S37-S40

3:30 p.m.–5:30 p.m. PT

4:00 p.m. PT

Closing Party

6:00 p.m. PT

5:30 p.m.–7:00 p.m. PT

Commitment to Cures

7:00 p.m. PT

6:00 p.m.–10:00 p.m. PT *Purchase of ticket is required

5:00 p.m. PT

Industry Therapeutic Updates

8:00 p.m. PT

7:00 p.m.–10:00 p.m. PT 9:00 p.m. PT

10:00 p.m. PT

Information is accurate as of November 29, 2021, and is subject to change.

AAN.com/AM

GO PLATINUM TO GET IT ALL AND LOCK IN 25% SAVINGS

Platinum Registration Get Annual Meeting Seattle Gold

PLUS

Annual Meeting Virtual Experience Gold, which include extended access to recordings through March 1, 2023.

Register by February 17, 2022 for No-risk & Zero Cancellation Fees for Seattle AAN.com/AM See page 6 for a complete listing of what is included with Platinum registration!

MEETING-AT-A-GLANCE SUN April 24 Quick Learning Sessions 9:00 a.m.–9:30 a.m. ET

MON April 25

VIRTUAL EXPERIENCE

TUE April 26

Start off each morning of your virtual experience with a brief session presenting takeaways for the day ahead or the top learning opportunities from earlier in the conference.

Presidential Plenary Session

Clinical Plenary Session

10:00 a.m.–12:00 p.m. ET

Featuring the Robert Wartenberg Lecture, George C. Cotzias Lecture, and Sidney Carter Award in Child Neurology, this encore session from the Annual Meeting in Seattle will be followed by a brand new fireside chat featuring the three speakers with live audience Q&A.

Featuring select trials from the Annual Meeting in Seattle, this plenary session will be followed by a brand new fireside chat where a panel of speakers will discuss these clinical trials with live audience Q&A.

9:00 a.m. ET

AVAILABLE THROUGHOUT THE MEETING

10:00 a.m. ET

Frontiers in Neuroscience Plenary Session 10:00 a.m.–12:00 p.m. ET

Featuring a selection of speakers from the Annual Meeting in Seattle, this session will be followed by a brand new fireside chat where a panel of speakers will review the basic and translational research discussed with live audience Q&A.

11:00 a.m. ET

Daily programming between 2:30 p.m. and 5 p.m. ET will focus on specific tracks that are to be developed.

12:00 p.m. ET

1:00 p.m. ET

Edutainment 1:00 p.m.–2:00 p.m. ET

Refresh and energize your mind each day of the virtual Annual Meeting with outside-of-the-box mid-day talks.

A Poster Hall will be available where you can see the latest research and science.

2:00 p.m. ET

Programming 2:30 p.m.–5:00 p.m. ET

3:00 p.m. ET

Daily programming is still under development and will include specific tracks to help you maximize your learning. Programming may include scientific sessions featuring abstracts of distinction, Neuroscience in the Clinic sessions, Neurology Case Conference presentations, neurology updates, education tracks focused on clinical practice, leadership, and more!

Chat functionality to help you engage and connect with your fellow attendees.

4:00 p.m. ET

5:00 p.m. ET

Controversies in Neurology Plenary Session 5:30 p.m.–6:30 p.m. ET

6:00 p.m. ET

Each day, we’ll tackle a new current and controversial issue in neuroscience as an encore presentation from the Annual Meeting in Seattle. Tune in for a scholarly debate between two expert speakers, each advocating for one side of a single topic, followed by a rebuttal. Each session will end with live Q&A with speakers.

7:00 p.m. ET

Information is accurate as of November 29, 2021, and is subject to change.

AAN.com/AM

DAILY SCHEDULE SAT April 2 7:00 a.m.-12:15 p.m. PT C1

Clerkship and Program Directors Conference . . . . . . . . . . . 67

7:00 a.m.-4:00 p.m. PT C2

CME

7.5

Neurology Continuing Certification Prep Course . . . . . . . . 37

Neurology Update . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37

7:00 a.m.-9:00 a.m. PT

CME

Non-motor Parkinson’s Disease Symptoms . . . . . . . . . . . . 52

Treatment of Pediatric MS In the Current Era . . . . . . . . . . . 55

SATURDAY, APRIL 2

CME

Lewy Body Dementia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27

Low and High Pressure Headache: Clinical Presentation and Approach to Evaluation and Management . . . . . . . . . . . . . 46

Cutting-edge Neuro-rehabilitation . . . . . . . . . . . . . . . . 61 The Global Burden of Neurologic Diseases . . . . . . . . . . . . . 46

C10 Neuroendocrine Update: Nuts and Bolts of What You

Need to Know . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37

C11

Epilepsy and Neuroimmunology . . . . . . . . . . . . . . . . . . 29

7:15 a.m.-7:45 a.m. PT

Ocular, and MuSK Myasthenia . . . . . . . . . . . . . . . . . . . . . . 62

C16

Autoimmune Neurology: Central Nervous System . . . 29 C17 United We Stand: Enhancing Your Practice with APPs . . . 38

C18

C19 N1

Food for Thought: Nutrition and Neurologic Disease. . 38 COVID-19 in Pediatric Neurology . . . . . . . . . . . . . . . . . . 49 Neuroscience in the Clinic: Neurobiology of Learning and Memory in 2022 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27

12:15 p.m.-4:45 p.m. PT

CME

C12 Resident Basic Science: Neuropathology . . . . . . . . . . . . . . 67 C13 Skills Workshop: Interventional HA/Pain Management:

Botulinum Toxin Injections for Headache and Trigger Point Injections . . . . . . . . . . . . . . . . . . . 47

1:00 p.m.-1:30 p.m. PT

The Power of Lifestyle Medicine: How Nutrition, Movement, Sleep, and Connection Can Change Your Life . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38

1:00 p.m.-1:45 p.m. PT

Neuro HeadTalk: Story Slams . . . . . . . . . . . . . . . . . . . . . . . 38

CME

C15 Neuromuscular Junction Disorders: Myasthenia Gravis,

Fireside Chat: Wellness for APPs . . . . . . . . . . . . . . . . . 37 Welcome to the Annual Meeting . . . . . . . . . . . . . . . . . . . . 38

9:15 a.m.-11:15 a.m. PT

CME

C14 Tics/Tourette’s and Paroxysmal Movement Disorders . . . 52

Yoga . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37

8:00 a.m.-8:30 a.m. PT

12:15 p.m.-2:15 p.m. PT

Controversies in Neurology Plenary Session . . . . . . . . . . . . . 38

2:45 p.m.-4:45 p.m. PT

CME

C20 Deep Brain Stimulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52

C21 Controversies in Stroke Treatment and Prevention . . . . . . 30 C22 Rehabilitation in Neurology . . . . . . . . . . . . . . . . . . . . . . . . . 61 C23 Drugs and Toxin-induced Neurologic Emergencies/CNS

Toxicities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38 C24 LGBTQI Health in Neurology . . . . . . . . . . . . . . . . . . . . . . . . 39

C25

Sequelae of COVID-19 . . . . . . . . . . . . . . . . . . . . . . . . . . 50 C26 Basics of Coding: E&M, Procedures, Telehealth, and New Codes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66

C27

Epilepsy/Seizure Semiology . . . . . . . . . . . . . . . . . . . . . . 33

3:00 p.m.-3:30 p.m. PT

Poetry and Neurology Workshop . . . . . . . . . . . . . . . . . 39

2022 AAN Annual Meeting

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

3:00 p.m.-3:45 p.m. PT

LEC

= Additional Fee Required

= Learner Engagement Center

= New in 2022

= Experiential Learning Area

EEG Talk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39

4:00 p.m.-4:45 p.m. PT

AAN Business Meeting. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47 Reflections from Women in Medicine: The Other Side of Doctoring . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39

5:00 p.m.-6:00 p.m. PT

CME

Hot Topics Plenary Session . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39

5:30 p.m.-6:30 p.m. PT Reception CME

SATURDAY, APRIL 2

6:15 p.m.-8:15 p.m. PT

C28 Case Studies: Unusual Movement Disorders . . . . . . . . . . . 52 C29 Case Studies: Diagnosis and Management of Unusual

|Cases in Neuromuscular Disease . . . . . . . . . . . . . . . . . . . . 62 C30 Case Studies: Challenging Acute Ischemic Stroke Cases. . 30 C31 Case Studies: Challenging Headache Cases . . . . . . . . . . . . 47

C32 Case Studies: Test Your Knowledge: A Case-based

Approach to Neuroimaging . . . . . . . . . . . . . . . . . . . . . . . . . 39

7:00 p.m.-10:00 p.m. PT Industry Therapeutic Updates

AAN.com/AM

DAILY SCHEDULE SUN April 3 7:00 a.m.-9:00 a.m. PT

CME

C33 Peripheral Neuropathy: Neuropathies Associated with

Rheumatologic and Hematologic Disorders . . . . . . . . . . . . 62 C34 Update in Movement Disorder: Parkinson’s Disease/Atypical Parkinson’s Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53 C35 Endovascular Management of Ischemic and Hemorrhagic Stroke . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 C36 Multiple Sclerosis in the Trenches . . . . . . . . . . . . . . . . . . . . 55

C37 Neuro-ophthalmology 1: Visual Loss, Optic Neuropathies,

and Papilledema . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59 C38 Critical Care Consultations for Neurohospitalists . . . . . . . 57 C40 Video EEG: Basics and Monitoring . . . . . . . . . . . . . . . . . . . 34

7:15 a.m.-7:45 a.m. PT

SUNDAY, APRIL 3

Yoga . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39

8:00 a.m.-8:30 a.m. PT

Fireside Chat: Self-compassion—Learning to Ignore Your Inner Critic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39

8:00 a.m.-8:45 a.m. PT

What’s That in Your Brain: 50 Essential Instant Pathological Recognition Cases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39

9:15 a.m.-12:00 p.m. PT

CME

2.75

Presidential Plenary Session . . . . . . . . . . . . . . . . . . 30, 32, 40, 48

11:30 a.m.-4:00 p.m. PT Exhibit Hall

Demyelinating Neuropathies . . . . . . . . . . . . . . . . . . . . . . . . 62 C42 Update in Movement Disorder: Essential Tremor/Ataxia/ Hyperkinetic Movement Disorders . . . . . . . . . . . . . . . . . . . 53 C43 Critical Care EEG Monitoring . . . . . . . . . . . . . . . . . . . . . . . . 34

C44 Child Neurology: Autism, Behavioral, and Developmental

Issues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32 C45 Neuro-ophthalmology 2: Optic Neuritis, Visual Fields, and Anisocoria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59 C46 Neuro-rehabilitation Update . . . . . . . . . . . . . . . . . . . . . . . . 61

C47 Clinical Neurology for Advanced Practice Providers . . . . . 40 C48

Blockbuster or Bankrupt: A Debate on When to Use New Drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66 C49 Neurointensive Care: The Essentials . . . . . . . . . . . . . . . . . . 57

IS1 S1

Invited Science: Epilepsy . . . . . . . . . . . . . . . . . . . . . . . . 34 Sleep . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69

Behavioral and Cognitive Neurology . . . . . . . . . . . . . . . . . . 27

Autoimmune Neurology 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . 29

Headache 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47

1:00 p.m.-5:30 p.m. PT C50 Resident Basic Science: Neuroanatomy—All the

CME

Lesions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67

C51

LEC

Neurology Trivia: Localize the Lesion . . . . . . . . . . . . . . . . . 40

CME

C41 Peripheral Neuropathy: Anatomical Basis and Acquired

Skills Workshop: Deep Brain Stimulation . . . . . . . . . . . . . . . . . . . . . . . . . . . 53

1:30 p.m.-4:30 p.m. PT

Exhibit Hall Opening Luncheon 11:30 a.m.-1:00 p.m. PT

12:00 p.m.-12:45 p.m. PT

1:00 p.m.-3:00 p.m. PT

Implementation Science: How to Translate Policy into Real-world Change . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67

3:00 p.m.-3:30 p.m. PT

Enhancing Personal and Professional Well-being Through Appreciative Inquiry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40

3:00 p.m.-3:45 p.m. PT

Is There a Neurologist on This Flight? . . . . . . . . . . . . . . . . . 40

2022 AAN Annual Meeting

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

3:30 p.m.-5:30 p.m. PT C52

CME

IS = Invited Science

= CME Credit

LEC

= Additional Fee Required

= Learner Engagement Center

= New in 2022

= Experiential Learning Area

CME

Brain Death . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57 C53 Child Neurology: Neuromuscular and Movement Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32 C54 Vascular Dementia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27

C55 Comprehensive Migraine Update: Advances in Acute,

Preventive, and Cognitive Behavioral Therapies . . . . . . . . 47 C56 Neuro-ophthalmology 3: Diplopia, Ocular Motility Disorders, and Nystagmus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60 C57 Circadian Rhythm Disorders . . . . . . . . . . . . . . . . . . . . . . . . . 69

C58

Disparities in Care in Practice: The Current State and How to Advocate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48

C59

COVID-19 and Neuromuscular Disorders . . . . . . . . . . . 50

Epilepsy and Clinical Neurophysiology (EEG) 1 . . . . . . . . . . 34

Cerebrovascular Disease and Interventional Neurology 1. . 30

General Neurology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40

5:00 p.m.-5:30 p.m. PT

SUNDAY, APRIL 3

Neuroscience in the Clinic: Applications of Artificial Intelligence and Machine Learning Tools in Neurology . . . 40 MS and CNS Inflammatory Disease 1 . . . . . . . . . . . . . . . . . 55

Guided Meditation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40

5:00 p.m.-5:45 p.m. PT

Standing on the Shoulders of Giants . . . . . . . . . . . . . . . . . . 40

7:00 p.m.-10:00 p.m. PT The Great Neuro Reunion Party. . . . . . . . . . . . . . . . . . . . . . . . . . . 3

AAN.com/AM

DAILY SCHEDULE MON April 4 7:00 a.m.-9:00 a.m. PT

CME

C60 Parkinson’s Disease: Assessment and Management . . . . . 53

C61 Alzheimer’s Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27

MONDAY, APRIL 4

C62

Cutting-edge Concepts and Applications in Technology, Cellular Therapy, Imaging, and Interventions and Rehabilitation of Stroke . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30

C63

COVID and MS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56 C64 Core Principles of Brain Tumors . . . . . . . . . . . . . . . . . . . . . . 58

11:30 a.m.-6:00 p.m. PT Exhibit Hall Exhibit Hall Networking Reception 4:00 p.m.-6:00 p.m. PT

12:00 p.m.-12:45 p.m. PT

1:00 p.m.-1:30 p.m. PT

C65

Specialty Population Sleep Disorders . . . . . . . . . . . . . . 69 Faculty Development: Enhancing Your Role in Student and C66 Resident Training . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67 C67 Women’s Neurology: Beyond Pregnancy . . . . . . . . . . . . . . 40

C68

1:00 p.m.-1:45 p.m. PT

Fireside Chat: Wellness for Residents and Fellows . . . . . . . 41

9:15 a.m.-11:30 a.m. PT

Haiku Cares? Write Creatively, Fight Burnout, and Submit Work to Humanities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

1:00 p.m.-1:50 p.m. PT

Nutrition for Neurologists . . . . . . . . . . . . . . . . . . . . . . . . 41

Create Your Own Byte of Neurology . . . . . . . . . . . . . . . 40

8:00 a.m.-8:30 a.m. PT

Neuro-Jeopardy: Telencephalon Twisters . . . . . . . . . . . . . . 41

CME

0.75

Pain and Palliative Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65

CME

2.25

Contemporary Clinical Issues Plenary Session . . . . . . . . . . . 41

Health Care Equity Symposium Quality Health Care for All

2022 , 4 il r p A , y a Mond . PT m . p 0 3 : 5 – . lity m 1:00 p. access to qua

rtunity will participate in a multi-facacereteddisparities. o p p O ip h s r Schola quity Scholarship recipientsaimed at mitigating health ceive: ent are E will re ip recipients AAN Health C tinue personal developm h rs la o ch S . g n l Meetin program to co e 2022 Annua th t a ff o k ic k will n The program ng registratio ti e e M l a u n n • 2022 A end 022. • $1,000 stip January 14, 2 y b S A E ID / m .co Apply at AAN

that the reality is ding on race, gender, , d rl o w ’s y a In tod depen ctors. Join us aries greatly health care v status, and many other fa e explore ways w ic socioeconom are Equity Symposium as gifted C h -2019) was a eged. 0 6 9 at the Healt te the disparity gap. (1 y Ja r. .D vil a Lecture al Cheryl A. Jay Keynote Lecthucarere and serving the underpri te we can elimin o n y e K S y A a u E J lt Cheryl A. will feature the second ann about social justice in hea AA N . co m / I D session Learn more: assionate This as p logist who w clinical neuro

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

1:00 p.m.-3:00 p.m. PT

CME

IS = Invited Science

= CME Credit

LEC

CME

= Additional Fee Required

= Learner Engagement Center

= New in 2022

= Experiential Learning Area

S13 MS and CNS Inflammatory Disease 2 . . . . . . . . . . . . . . . . . 56

C69 Atypical Parkinsonism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53

S14 Aging and Dementia 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27

C71 Child Neurology: Metabolic Conditions and Genetics . . . . 32

S16 Cerebrovascular Disease and Interventional Neurology 2. . 31

C70 Behavioral Neurology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27

S15 Movement Disorders 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54

C72 Neuro-rheumatology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29

4:00 p.m.-4:45 p.m. PT

C73 Neuro-oncology: Navigating Current Trends . . . . . . . . . . . 58 C74 Neurologic Intensive Care: Vascular Disease . . . . . . . . . . . 57 C75 Parasomnias Including REM Behavior Disorder . . . . . . . . . 69 IS2

6:00 p.m.-8:00 p.m. PT

Invited Science: Headache . . . . . . . . . . . . . . . . . . . . . . 47 Neuromuscular and Clinical Neurophysiology (EMG) 1 . . . 63

Faculty and Trainee Reception

S11 Neuroepidemiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

7:00 p.m.-10:00 p.m. PT

S10

S12 Epilepsy/Clinical Neurophysiology (EEG) 2 . . . . . . . . . . . . . 34

C76

Industry Therapeutic Updates

CME

MONDAY, APRIL 4

1:00 p.m.-5:30 p.m. PT

It Takes a Village: Neurologic Care in Rural Communities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

Resident Basic Science: Neurophysiology . . . . . . . . . . 67 C77 Skills Workshop: EMG Guided Injections: Spasticity and Dystonia . . . . . . . . . . . . . . . . . . . 54 Health Care Equity Symposium . . . . . . . . . . . . . . . . . . . . . . 48

2:00 p.m.-2:45 p.m. PT

Neuro Exam Tricks and Tips . . . . . . . . . . . . . . . . . . . . . . . . . . 41

3:00 p.m.-3:45 p.m. PT

Creating Your Social Media Brand . . . . . . . . . . . . . . . . . 41

3:30 p.m.-5:30 p.m. PT

CME

C78 Epilepsy Therapy Update . . . . . . . . . . . . . . . . . . . . . . . . . . . 34 C79 Motor Neuron Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63 C80

Child Neurology: Neuro-oncology . . . . . . . . . . . . . . . . . 32 Higher Cortical Visual Disorders: Case-based Review . . . . 60 C81 C82 Trigeminal Neuralgia and Facial Pain . . . . . . . . . . . . . . . . . . 47

C83 Neurologic Intensive Care: Brain and Acute Spinal Cord

Injury and Neuromuscular Disease . . . . . . . . . . . . . . . . . . . 57 C84 Functional Neurologic Disorders: Truths, Myths, and Misunderstandings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

C85 N3

Post COVID Clinic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50 Neuroscience in the Clinic: Aducanumab: From Clinical Trials to the Clinic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27

IN CONJUNCTION WITH (ICW) MEETINGS The AAN welcomes affiliated organizations to meet and host functions during AAN-approved dates and times in conjunction with the 2022 Annual Meeting in Seattle. Discounted ICW submission fees are available if you reserve by January 14, 2022. Visit AAN.com/AnnualMeetingICW for rates, guidelines, and to submit your application. Questions? Contact Nafisa Ghazi, Conference Coordinator, at ICW@aan.com.

AAN.com/AM

DAILY SCHEDULE TUE April 5 6:30 a.m.-8:00 a.m. PT

C96 Epilepsy: Surgery, Neuromodulation, and Outcomes . . . . . 34

Run/Walk for Brain Research

Neurologic Complications of Novel Anti-neoplastic Therapies Including Immunotherapy . . . . . . . . . . . . . . . . . . 59 C98 Emerging Neuroinfectious Disease . . . . . . . . . . . . . . . . . . . 63

7:00 a.m.-9:00 a.m. PT

C97 CME

C39 Meeting the Moment: Mastering Difficult Conversations in

Serious Neurological Illness . . . . . . . . . . . . . . . . . . . . . . . . . 42 C86 Spinocerebellar and Spastic Ataxias: Diagnosis and Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54 C87 Multiple Sclerosis Overview . . . . . . . . . . . . . . . . . . . . . . . . 56

C88 Epilepsy: Basics and Considerations Across the Age Span:

Pediatrics, Pregnancy, Elderly, and Special Populations . . 34

C89

TUESDAY, APRIL 5

Autoimmune Neurology: Paraneoplastic . . . . . . . . . . . 29 C90 Global Infectious Diseases . . . . . . . . . . . . . . . . . . . . . . . . . . 50 C91 Diagnosis and Management of Concussions . . . . . . . . . . . 70

C92 Clinical Approach to Sleep Disorders . . . . . . . . . . . . . . . . . 69 C93

Health Care Disparities in the US and Internationally. . 49

8:00 a.m.-8:30 a.m. PT

Fireside Chat: So You’ve Been Sued—Handling Litigation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66

8:00 a.m.-8:45 a.m. PT

New Therapies for Migraine and Other Headache Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47 C100 Sports Neurology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70

C101

Sleep Apnea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69 C102 Continuum® Test Your Knowledge: A Multiple-choice Question Review 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42

N4 S17

S18 MS and CNS Inflammatory Disease 3 . . . . . . . . . . . . . . . . . 56

S19 Aging and Dementia 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 S20 Neurocritical Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57

C104 Skills Workshop: EMG/Nerve Conduction 2:00 p.m.-2:45 p.m. PT

2.25

3:00 p.m.-3:00 p.m. PT

3:30 p.m.-4:10 p.m. PT

Neurology at the Movies . . . . . . . . . . . . . . . . . . . . . . . . . . . 42 CME

Adolescent/Child Neurology for the Adult Neurologist . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32 C95 Evaluation and Management of Autonomic Disorders: Autonomic Testing, Failure, and Peripheral Neuropathies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63

2022 AAN Annual Meeting

Consejos Prácticos para un Buen Examen Neurológico (Neuro Exam Tips and Tricks) . . . . . . . . . . . . . . . . . . . . . . . . 42

Mindful Snacking . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42

C94

”A Molecule Away from Madness: Tales of the Hijacked Brain” . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42

Exhibit Hall

1:00 p.m.-3:00 p.m. PT

. . . . . . . . . . . . . . . . . . . . . . . . . . . 63

11:30 a.m.-4:00 p.m. PT

1:00 p.m.-1:45 p.m. PT

C103 Resident Basic Science: Neuropharmacology . . . . . . . . . . 68

CME

1:00 p.m.-5:30 p.m. PT

Clinical Trials Plenary Session . . . . . . . . . . . . . . . . . . . . . . . . . . 42

1:00 p.m.-1:30 p.m. PT

Neuroscience in the Clinic: Neuroscience of Coma and Consciousness in the Clinic . . . . . . . . . . . . . . . . . . . . . . . . . 57 Infectious Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50

Lost in Translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42

9:15 a.m.-11:30 a.m. PT

C99

CME

S21 History of Neurology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49 3:30 p.m.-5:30 p.m. PT

CME

C105 The Dystonias: Diagnosis, Treatment, and Update on

Etiologies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54 C106 Chronic Traumatic Encephalopathy . . . . . . . . . . . . . . . . . . . 28 C107 Essentials of Acute Treatment and Prevention of Ischemic Stroke . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 C108 Pediatric Neuro-ophthalmology . . . . . . . . . . . . . . . . . . . . . . 32

C109

Diagnosed a Patient with a Neuroinfectious Disease: Now What? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

= Additional Fee Required

= Learner Engagement Center

= New in 2022

= Experiential Learning Area

C110 Cervical Spondylotic Myelopathy, Cervical Radiculopathy,

and the Differential Diagnosis of Myelopathies . . . . . . . . . 42 C111 Continuum® Test Your Knowledge: A Multiple-choice Question Review 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42 C112 How to Run a Practice: Business Strategies for Neurology Private Practices and the Future . . . . . . . . . . . . . . . . . . . . . 66

C113 S22

Theater for Health Care Equity . . . . . . . . . . . . . . . . . . . 49 Neuromuscular and Clinical Neurophysiology (EMG) 2 . . . 63

S23 Epilepsy/Clinical Neurophysiology (EEG) 3 . . . . . . . . . . . . . 35

S24 Autoimmune Neurology 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 4:00 p.m.-4:45 p.m. PT

Courage in Neurology . . . . . . . . . . . . . . . . . . . . . . . . . . 43

5:00 p.m.-5:45 p.m. PT

TUESDAY, APRIL 5

Leading Through Adversity . . . . . . . . . . . . . . . . . . . . . . 43

7:00 p.m.-10:00 p.m. PT Industry Therapeutic Updates

AAN.com/AM

DAILY SCHEDULE WED April 6 7:00 a.m.-9:00 a.m. PT

CME

C114 Emergency Room Neuro-ophthalmology . . . . . . . . . . . . . . . 61 C115 Clinical Approach to Muscle Disease: Role of Antibodies,

Muscle Imaging, and Genetic Testing . . . . . . . . . . . . . . . . . 64 C116 Rapidly Progressive Dementia . . . . . . . . . . . . . . . . . . . . . . . 28 C117 Multiple Sclerosis Disease-modifying Treatment . . . . . . . . 56

C118 Neurologic Consultations in Cancer Patients . . . . . . . . . . . 59

C119 Infections of Nervous System 1 . . . . . . . . . . . . . . . . . . . . . . . 51 C120 Neurologic Case Studies in Pregnancy . . . . . . . . . . . . . . . . 43 C121 Neuroimaging for the General Neurologist: Spine . . . . . . . 43 C122

Neuropsychiatric Considerations in Epilepsy . . . . . . . . 35

WEDNESDAY, DATE APRIL 6

8:00 a.m.-8:30 a.m. PT

Fireside Chat: Thinking of Changing Careers . . . . . . . . 43

9:15 a.m.-11:30 a.m. PT

CME

2.25

CME

1:00 p.m.-3:00 p.m. PT C123 Diagnosis and Treatment of Functional Movement

Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54 C124 Clinical Approach to Muscle Disease: Inflammatory Myopathies and Muscle Pathology . . . . . . . . . . . . . . . . . . . 64 C125 Stroke in Pediatrics, the Young, and Special Populations. . 31

C126 Introduction to Primary Headache Disorders: Trigeminal

Autonomic Cephalalgias and Other Primary Headaches, Including New Daily Persistent Headache, Cough, Exercise, and Thunderclap Headaches . . . . . . . . . . . . . . . . . . . . . . . . 48 C127 Lumbar Radiculopathy, Lumbar Spinal Stenosis, Low Back Pain, and Failed Back Syndrome . . . . . . . . . . . . . . . . . . . . . 65 C128 Infections of the Nervous System 2: Opportunistic Infections, HIV, and Parasitic Infections . . . . . . . . . . . . . . . . 51 C129 Therapy in Neurology 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43

C130 C131

Neurologic Conditions in Transgender Patients . . . . . . 43 Autoimmune Neurology: Peripheral Nervous System. . 29

Frontiers in Neuroscience Plenary Session. . .28, 43, 51, 56, 64

IS3

11:30 a.m.-4:00 p.m. PT

S26 Neuro-oncology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59

S27 Health Care Disparities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49

Exhibit Hall

12:00 p.m.-12:45 p.m. PT

Neurology Pictionary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43

1:00 p.m.-1:55 p.m. PT

S25

Invited Science: Alzheimer’s Disease . . . . . . . . . . . . . . 28 MS and CNS Inflammatory Disease 4 . . . . . . . . . . . . . . . . . 56

The Effects of Brain Damage on Creativity . . . . . . . . . . . . . 44

S28 Neuromuscular and Clinical Neurophysiology (EMG) 3 . . . 64 CME

1:00 p.m.-5:00 p.m. PT

3.5

C132 Research Career Symposium . . . . . . . . . . . . . . . . . . . . . . . . 68 CME

1:00 p.m.-5:30 p.m. PT C133 Skills Workshop: Neuro-ophthalmology

. . . . . . . . . . . . . . . . . . . . . . . . . . . 61

2:00 p.m.-2:45 p.m. PT

The Effects of Loneliness: Connectivity Matters . . . . . . . . 44

3:00 p.m.-3:30 p.m. PT

Visual Thinking Strategies . . . . . . . . . . . . . . . . . . . . . . . 44

2022 AAN Annual Meeting

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

3:30 p.m.-4:00 p.m. PT

CME

IS = Invited Science

= CME Credit

CME

0.5

S29 Autonomic Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64 3:30 p.m.-5:30 p.m. PT

CME

C134 Maximizing Quality of Life in Stroke, ALS, Parkinson’s

Disease, and Dementia: A Palliative Approach . . . . . . . . . 65 C135 MS Across the Lifespan/Pregnancy and Breastfeeding in MS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56 C136 Status Epilepticus Update . . . . . . . . . . . . . . . . . . . . . . . . . . 36

C137

The History of Diversity and Inclusion in Neurology . . 49 Health Equity for Neurologists . . . . . . . . . . . . . . . . . . . . . . . 49 C138 C139 Infections of the Nervous System 3: Encephalitis . . . . . . . . 51

= Learner Engagement Center

= New in 2022

= Experiential Learning Area

S32 Cerebrovascular Disease and Interventional Neurology 3. . 31 5:00 p.m.-5:45 p.m. PT

Standing on the Shoulders of Giants . . . . . . . . . . . . . . . . . . 44

WEDNESDAY, APRIL 6

LEC

= Additional Fee Required

6:00 p.m.-10:00 p.m. PT Commitment to Cures

7:00 p.m.-10:00 p.m. PT Industry Therapeutic Updates

C140 Therapy in Neurology 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44 C141

Cognitive, Behavioral, and Disease-modifying Therapeutics in Dementia . . . . . . . . . . . . . . . . . . . . . . . . . . 28

C142

Writing and Reviewing Multiple Choice Exam Questions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44

Neuroscience in the Clinic: Brain Health and the Neurovascular Unit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 Headache 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48

S30

S31 Movement Disorders 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54

AAN.com/AM

DAILY SCHEDULE THU April 7 7:00 a.m.-9:00 a.m. PT

CME

C143 Neuromyelitis Optica Spectrum Disorders . . . . . . . . . . . . . 57 C144 Essentials of Diagnosis and Management of Hemorrhagic

Stroke . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 C145 Mild Cognitive Impairment/Subjective Cognitive Impairment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 C146 EEG: Normal EEG, Normal Variants, and How to Avoid the Common Pitfall of Overreading . . . . . . . . . . . . . . . . . . . . . . 36 C147 Differential Diagnosis of Neurologic Infections . . . . . . . . . . 51

C148 Core Concepts in Pain Management: Safe and Appropriate

Opioid Prescribing in Neurology . . . . . . . . . . . . . . . . . . . . . . 66 C149 Neurogenetics: Diagnostic Dilemmas and Therapeutic Implications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44

C158 Telecommunication and How to Create Effective Virtual

Teaching Material . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68

C159 N6

S33

THURSDAY, APRIL 7

8:00 a.m.-8:30 a.m. PT

S35 Cerebrovascular Disease and Interventional Neurology 4. . 31 S36 Movement Disorders 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55 1:00 p.m.-5:30 p.m. PT

Death Evaluation, Avoid Pitfalls, and Convey the News to the Family . . . . . . . . . . . . . . . . . . 58

CME

2.25

Neurology Year in Review Plenary Session . . . . . . . . . . . . . . 44

12:00 p.m.-12:45 p.m. PT

The Neurology of Creativity at the Keyboard . . . . . . . . . . . 45

1:00 p.m.-1:45 p.m. PT

CME

3:30 p.m.-4:00 p.m. PT

CME

0.5

3:30 p.m.-5:30 p.m. PT

CME

C161 Phenomenology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55 C162 Clinical EMG 2: Case-based Clinical Applications of Nerve

Conduction Studies and Needle Electromyography . . . . . . 65 C163 EEG: Focal, Diffuse, and Epileptiform Abnormalities in Adults . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 C164 Hot Topics in Headaches and Related Disorders . . . . . . . . 48

C165 Myelopathies: Recognizing and Evaluating Myelopathic

Microaggressions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45

1:00 p.m.-3:00 p.m. PT

3:00 p.m.-3:45 p.m. PT

S37 Global Health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46

C160 Skills Workshop: Brain Death: How to Perform a Brain

Case Studies: Ethical Conundrums in Neurology . . . . . . . . 44

9:15 a.m.-11:30 a.m. PT

CME

Managing Social Media and Navigating Hospital Policies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45

Fireside Chat: Supporting Your Colleagues Through Burnout . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44

8:00 a.m.-8:45 a.m. PT

Neuroscience in the Clinic: Neurological Implications of Long-haul COVID Infection . . . . . . . . . . . . . . . . . . . . . . . . . . . 51 Research Methodology and Education . . . . . . . . . . . . . . . . 68

S34 Infectious Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51

C150

Leveraging Quality Improvement to Help Your Patients and Your Practice, Too . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66 C151 Movement Disorders: Huntington’s Disease . . . . . . . . . . . . 55

Palliative Care in the Neuro ICU . . . . . . . . . . . . . . . . . . 58

C152 Neuro-otology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61 C153 Clinical EMG 1: Principles and Practice of NCS and Needle EMG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65 C154 Frontotemporal Dementia . . . . . . . . . . . . . . . . . . . . . . . . . . 28 C155 EEG: Neonatal and Pediatric . . . . . . . . . . . . . . . . . . . . . . . . 36

C156 Clinical Pearls in Autoimmune Neurology: Real-world Cases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 C157 Neuroimaging for the General Neurologist: Brain . . . . . . . 45

Patients for Inflammatory and Vascular Causes . . . . . . . . . 45 C166 Neurologic Complications of Medical and Surgical Therapies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46

IS4

S38

Invited Science: Neuro-ophthalmology . . . . . . . . . . . . . 61 Child Neurology and Developmental Neurology . . . . . . . . . 33

S39 MS and CNS Inflammatory Disease 5 . . . . . . . . . . . . . . . . . 57

S40 Autoimmune Neurology 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 4:30 p.m.-5:15 p.m. PT

NeuroZone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46

5:00 p.m.-7:00 p.m. PT Closing Party

2022 AAN Annual Meeting

Information is accurate as of November 29, 2021, and is subject to change.

SEATTLE PROGRAMS BY TOPIC 3:30 p.m.–5:30 p.m. PT

AGING, DEMENTIA, COGNITIVE, AND BEHAVIORAL NEUROLOGY

C54: Vascular Dementia

7:00 a.m.–9:00 a.m. PT CME

Director(s): Melissa Armstrong, MD, MSc, FAAN, Gainesville, FL

Learning Objectives: Participants should be able to discuss the diagnostic challenges and current and potential future therapeutic approaches for the management of vascular cognitive impairment and dementia. Lecture/Faculty:

» Vascular Cognitive Impairment and Dementia: Clinical Impact and

» Recognizing Prodromal Lewy Body Dementia and Making the Diagnosis Samantha K. Holden, MD, MS, Aurora, CO » Diagnostic Tests and Biomarkers for Lewy Body Dementia Faculty » Pharmacologic and Non-pharmacologic Strategies for Treating Lewy Body Dementia Melissa Armstrong, MD, MSc, FAAN, Gainesville, FL

Current Challenges Mark R. Etherton, MD, Boston, MA » Diagnosis and Treatment of Vascular Dementia Alessandro Biffi, MD, Boston, MA » Cardiovascular Determinants of Brain Aging and Dementia Faculty

Monday, April 4 7:00 a.m.–9:00 a.m. PT

C61: Alzheimer’s Disease

CME

Director(s): Liana Apostolova, MD, FAAN, Indianapolis, IN

7:00 a.m.–4:00 p.m. PT CME

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

Director(s): Joseph E. Safdieh, MD, FAAN, New York, NY

1:00 p.m.–3:00 p.m. PT

See learning objectives on page 37.

C70: Behavioral Neurology

CME

Director(s): Dylan P. Wint, MD, Las Vegas, NV

7:00 a.m.–4:00 p.m. PT

C3: Neurology Update

CME

Director(s): Adam Quick, MD, Columbus, OH See learning objectives on page 37.

3:30 p.m.–5:30 p.m. PT

12:15 p.m.–2:15 p.m. PT

N1: Neuroscience in the Clinic: Neurobiology of Learning and Memory in 2022

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

CME

Director(s): Joshua M. Shulman, MD, PhD, FAAN, Houston, TX Anna K. Gillespie, PhD, San Francisco, CA

N3: Neuroscience in the Clinic: Aducanumab: From Clinical Trials to the Clinic

CME

Director(s): Amy Brodtmann, PhD, FRACP, MBBS, Melbourne, VIC Vijay K. Ramanan, MD, PhD, Rochester, MN 3:30 p.m.–5:30 p.m. PT

S14: Aging and Dementia 1

Sunday, April 3

CME

1:00 p.m.–3:00 p.m. PT

S2: Behavioral and Cognitive Neurology

CME

AAN.com/AM

AGING, DEMENTIA, COGNITIVE, AND BEHAVIORAL NEUROLOGY

Learning Objectives: Participants should be able to recognize prodromal presentations of Lewy body dementia; be able to review assessments and biomarkers used in the clinical diagnosis of Lewy body dementia, including recent FDA approvals; and be able to identify pharmacologic and non-pharmacologic approaches to treating individuals with Lewy body dementia. Lecture/Faculty:

C2: Neurology Continuing Certification Prep Course

Director(s): Mark R. Etherton, MD, Boston, MA

Saturday, April 2 C5: Lewy Body Dementia

CME

SEATTLE PROGRAMS BY TOPIC Tuesday, April 5 1:00 p.m.–3:00 p.m. PT

S19: Aging and Dementia 2

CME

3:30 p.m.–5:30 p.m. PT

AGING, DEMENTIA, COGNITIVE, AND BEHAVIORAL NEUROLOGY

C106: Chronic Traumatic Encephalopathy

CME

Director(s): Faculty Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

Dementia Lealani Mae Acosta, MD, FAAN, Nashville, TN » Non-pharmacologic Management of Cognitive and Behavioral Symptoms in Dementia Julio C. Rojas -Martinez, MD, PhD, San Francisco, CA » Disease-modifying Treatment in Dementia Meredith Wicklund, MD, FAAN, Scottsdale , AZ

7:00 a.m.–9:00 a.m. PT

C116: Rapidly Progressive Dementia

CME

Director(s): Michael D. Geschwind, MD, PhD, FAAN, San Francisco, CA Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available. 9:15 a.m.–11:30 a.m. PT CME

Frontiers in Neuroscience Plenary Session

Learning Objectives: This plenary session features basic and translational research related to clinical issues of importance. Hear from outstanding speakers as they summarize their recent research finding and dive into the clinical implications of the results. Lecture/Faculty: Adam L. Boxer, MD, PhD, San Francisco, CA

1:00 p.m.–3:00 p.m. PT

IS3 Invited Science: Alzheimer’s Disease

C145: Mild Cognitive Impairment/Subjective Cognitive Impairment

CME

Director(s): Ronald C. Petersen, PhD, MD, FAAN, Rochester, MN Learning Objectives: Participants should understand current practice of diagnosing mild cognitive impairment; apply the diagnosis of mild cognitive impairment to clinical practice; employ reasonable evaluation strategy for persons with MCI; analyze data regarding the typical and atypical etiologies of the syndrome of MCI; and evaluate potential treatments for MCI in the setting of disease modifying therapies for Alzheimer’s disease. Lecture/Faculty:

» Overview of Mild Cognitive Impairment

» Advances in Frontotemporal Degenerations

CME

Ronald C. Petersen, PhD, MD, FAAN, Rochester, MN » Atypical Forms of MCI Oscar L. Lopez, MD, FAAN, Pittsburgh, PA » Treatments for MCI David J. Gill, MD, FAAN, Rochester, NY » Case Studies of MCI Ronald C. Petersen, PhD, MD, FAAN, Rochester, MN Oscar L. Lopez, MD, FAAN, Pittsburgh, PA David J. Gill, MD, FAAN, Rochester, NY 1:00 p.m.–3:00 p.m. PT

3:30 p.m.–5:30 p.m. PT

C134: Maximizing Quality of Life in Stroke, ALS, Parkinson’s Disease, and Dementia: A Palliative Approach

CME

Director(s): Maisha T. Robinson, MD, MS, FAAN, Jacksonville, FL See learning objectives on page 65. 3:30 p.m.–5:30 p.m. PT

C141: Cognitive, Behavioral, and Diseasemodifying Therapeutics in Dementia Director(s): Meredith Wicklund, MD, FAAN, Scottsdale , AZ Learning Objectives: Participants should become familiar with the indication for and clinical utility of pharmacological and nonpharmacological therapeutics for dementia related cognitive and 2022 AAN Annual Meeting

» Pharmacologic Management of Cognitive and Behavioral Symptoms in

Thursday, April 7

Wednesday, April 6

behavioral symptoms. Participants will additionally become familiar with the first ever disease modifying treatment for dementia and its role in clinical practice. Lecture/Faculty:

CME

C154: Frontotemporal Dementia

CME

Director(s): Bradley F. Boeve, MD, FAAN, Rochester, MN Learning Objectives: Participants should become familiar with the key clinical, neuropsychological, and neuroimaging aspects of frontotemporal dementia, as well as the current and future management/treatment considerations for those with frontotemporal dementia. Lecture/Faculty:

» Clinical and Neuropsychological Aspects of FTD Bradley F. Boeve, MD, FAAN, Rochester, MN

» Neuroimaging Aspects of FTD

Faculty » Management/Treatment Aspects of FTD Adam L. Boxer, MD, PhD, San Francisco, CA

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

Amanda Lee Piquet, MD, Aurora, CO

» Central Nervous System Vasculitis

Prashanth S. Ramachandran, Jr., MBBS, San Francisco, CA

7:00 a.m.–9:00 a.m. PT CME

Director(s): Claude Steriade, MD, New York City, NY Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

C89: Autoimmune Neurology: Paraneoplastic CME

» Central Nervous System

Amy Kunchok, MBBS, Cleveland, OH » Central Nervous System Faculty » Central Nervous System Alfonso Sebastian Lopez, MD, Jacksonville, FL

Director(s): Marianna Spatola, MD, PhD, Cambridge, MA Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available. 3:30 p.m.–5:30 p.m. PT

S24 Autoimmune Neurology 2

CME

Wednesday, April 6 1:00 p.m.–3:00 p.m. PT

C131: Autoimmune Neurology: Peripheral Nervous System

Sunday, April 3

CME

Director(s): Divyanshu Dubey, MD, Rochester, MN

1:00 p.m.–3:00 p.m. PT CME

Monday, April 4 1:00 p.m.–3:00 p.m. PT

Learning Objectives: Participants should become familiar with the differential diagnosis of neurological manifestations of rheumatological, systemic inflammatory and other autoimmune diseases; be able to identify common phenotypes associated with neurological organ system involvement of rheumatological syndromes; learn ways of distinguishing neuro-rheumatological diagnoses from other neuroinflammatory disorders; and develop practical approaches to treatment, care coordination, and health maintenance for neuro-rheumatological conditions.

CME

Learning Objectives: Participants should be able identify clinical phenotypes, electrodiagnostic, and histopathological features suggestive of serologically defined autoimmune or paraneoplastic neuromuscular presentations; and be familiar with the current diagnosis and management of neuromuscular immune-related adverse events from immune checkpoint inhibitor therapies. Advances in translational research to further characterize immune related adverse events will also be discussed. Participants should be familiar with current literature regarding parainfectious autoimmune or auto-inflammatory neuromuscular complications of COVID-19. Lecture/Faculty:

» Autoimmune Neuropathies

Divyanshu Dubey, MD, Rochester, MN

» Autoimmune Myopathies

Anthony A. Amato, MD, FAAN, Boston, MA

» Autoimmune Dysautonomia Faculty

AAN.com/AM

AUTOIMMUNE NEUROLOGY

Learning Objectives: Participants should become familiar with the differential diagnosis and management of CNS immune mediated disorders. Lecture/Faculty:

Director(s): Amanda Lee Piquet, MD, Aurora, CO

Rheumatological Diseases: Systemic Lupus Erythematosus, Antiphospholipid Syndrome, Behçet’s Disease Shamik Bhattacharyya, MD, Boston, MA

7:00 a.m.–9:00 a.m. PT

Director(s): Alfonso Sebastian Lopez, MD, Jacksonville, FL

C72: Neuro-rheumatology

» Neurologic Manifestations of Systemic Inflammatory and

Tuesday, April 5

12:15 p.m.–2:15 p.m. PT

S3: Autoimmune Neurology 1

= Experiential Learning Area

» Neurosarcoidosis

Saturday, April 2

C16: Autoimmune Neurology: Central Nervous System

= Learner Engagement Center

= New in 2022

Lecture/Faculty:

AUTOIMMUNE NEUROLOGY

C11: Epilepsy and Neuroimmunology

= Additional Fee Required

SEATTLE PROGRAMS BY TOPIC 6:15 p.m.–8:15 p.m. PT

Thursday, April 7

C30: Case Studies: Challenging Acute Ischemic Stroke Cases

1:00 p.m.–3:00 p.m. PT

C156: Clinical Pearls in Autoimmune Neurology: Real-world Cases

CME

CEREBROVASCULAR DISEASE AND INTERVENTIONAL NEUROLOGY

Director(s): Stacey Clardy, MD, PhD, FAAN, Salt Lake City, UT Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

CME

Director(s): Vivien H. Lee, MD, FAAN, Columbus, OH Learning Objectives: Participants will review challenging acute stroke cases with faculty experts and should learn how to promptly recognize IVtPA eligible cases that require special considerations, be aware of potential rare complications, and be comfortable in delivering IVtPA to acute stroke patients under special circumstances. Lecture/Faculty:

» Case Series 1

3:30 p.m.–5:30 p.m. PT

S40: Autoimmune Neurology 3

CME

Vivien H. Lee, MD, FAAN, Columbus, OH

» Case Series 2 Faculty

» Case Series 3

CEREBROVASCULAR DISEASE AND INTERVENTIONAL NEUROLOGY 7:00 a.m.–4:00 p.m. PT

May A. Kim-Tenser, MD, MHA, FAHA, Los Angeles, CA

Saturday, April 2

7:00 a.m.–9:00 a.m. PT

C2: Neurology Continuing Certification Prep Course

CME

C35: Endovascular Management of Ischemic and Hemorrhagic Stroke

7:00 a.m.–4:00 p.m. PT CME

Director(s): Adam Quick, MD, Columbus, OH

9:15 a.m.–12:00 p.m. PT

Presidential Plenary Session

See learning objectives on page 37. 2:45 p.m.–4:45 p.m. PT CME

Director(s): Pierre Fayad, MD, FAAN, FAHA, Omaha, NE Learning Objectives: Participants should become familiar with areas in stroke treatment and prevention where evidence is lacking or insufficient to formulate clear recommendations, or where new evidence has emerged that challenges the current consensus. This course is devised to address thoroughly a selected group of such controversial areas and provide the attendees with practical approaches to help them sort through such situations. Lecture/Faculty:

CME

Learning Objectives: This session features the AAN’s premier lecture awards for clinically relevant research and a presentation by a leading lecturer. Top researchers speak on some of the most significant findings in neurology in 2022. Lecture/Faculty:

» Robert Wartenberg Lecture: Leaving No One Behind: Charting the Course to Cerebrovascular Health Equity Bruce I. Ovbiagele, MD, MSc, FAAN, San Francisco, CA

3:30 p.m.–5:30 p.m. PT

S6: Cerebrovascular Disease and Interventional Neurology 1

CME

Monday, April 4

» Controversies in Acute and Endovascular Management of Stroke Faculty » Controversies in Infectious Diseases and Stroke Avindra Nath, MD, MBBS, FAAN, Bethesda, MD » Controversies in Stroke Prevention Pierre Fayad, MD, FAAN, FAHA, Omaha, NE

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

See learning objectives on page 37.

C21: Controversies in Stroke Treatment and Prevention

CME

Director(s): Johanna Therese Fifi, MD, FAAN, New York, NY

Director(s): Joseph E. Safdieh, MD, FAAN, New York, NY

C3: Neurology Update

Sunday, April 3

7:00 a.m.–9:00 a.m. PT

C62: Cutting-edge Concepts and Applications in Technology, Cellular Therapy, Imaging, and Interventions and Rehabilitation of Stroke

CME

Director(s): Pierre Fayad, MD, FAAN, FAHA, Omaha, NE Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

2022 AAN Annual Meeting

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

= Additional Fee Required

= Learner Engagement Center

CME

7:00 a.m.–9:00 a.m. PT

C144: Essentials of Diagnosis and Management of Hemorrhagic Stroke

Tuesday, April 5

CME

Director(s): Ashutosh P. Jadhav, MD, Phoenix, AZ

3:30 p.m.–5:30 p.m. PT

C107: Essentials of Acute Treatment and Prevention of Ischemic Stroke

= Experiential Learning Area

Thursday, April 7

3:30 p.m.–5:30 p.m. PT

S16: Cerebrovascular Disease and Interventional Neurology 2

= New in 2022

CME

Director(s): Joshua Z. Willey, MD, New York, NY

» New Treatment Options with Thrombolytics

» Diagnostic Approach to Hemorrhagic Stroke

Faculty » Acute Management of Hemorrhagic Stroke Faculty » Outpatient Management of the Post-Hemorrhage Stroke Patient Faculty

Joshua Z. Willey, MD, New York, NY

» Evaluation & Selection of Patients for Neuro-endovascular Treatment

1:00 p.m.–3:00 p.m. PT

Setareh Salehi Omran, MD, Aurora, CO » Anti-platelet Agents & Secondary Prevention Strategies Erika Tatiana Marulanda-Londono, MD, Miami, FL

S35: Cerebrovascular Disease and Interventional Neurology 4

Wednesday, April 6 CME

Saturday, April 2

Director(s): Lori L. Billinghurst, MD, Hamilton, ON, Canada

7:00 a.m.–9:00 a.m. PT

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

C6: Treatment of Pediatric MS In the Current Era

See learning objectives on page 55. CME

Director(s): Fernando Testai, MD, PhD, Chicago, IL Andy Shih, PhD, Seattle, WA

7:00 a.m.–4:00 p.m. PT

C2: Neurology Continuing Certification Prep Course

CME

Director(s): Joseph E. Safdieh, MD, FAAN, New York, NY See learning objectives on page 37.

3:30 p.m.–5:30 p.m. PT

C134: Maximizing Quality of Life in Stroke, ALS, Parkinson’s Disease, and Dementia: A Palliative Approach

CME

Director(s): Brenda Banwell, MD, FAAN, Philadelphia, PA

3:30 p.m.–5:30 p.m. PT

N5: Neuroscience in the Clinic: Brain Health and the Neurovascular Unit

CHILD NEUROLOGY AND DEVELOPMENTAL NEUROLOGY

1:00 p.m.–3:00 p.m. PT

C125: Stroke in Pediatrics, the Young, and Special Populations

CME

12:15 p.m.–2:15 p.m. PT

C19: COVID-19 in Pediatric Neurology

CME

Director(s): Grace Gombolay, MD, Atlanta, GA

Director(s): Maisha T. Robinson, MD, MS, FAAN, Jacksonville, FL

See learning objectives on page 49.

See learning objectives on page 65. 3:30 p.m.–5:30 p.m. PT

S32: Cerebrovascular Disease and Interventional Neurology 3

CME

AAN.com/AM

CHILD NEUROLOGY AND DEVELOPMENTAL NEUROLOGY

Learning Objectives: Participants should gain knowledge in the clinical and imaging based criteria for thrombolysis within four and a half hours and beyond; become familiar with the diagnostic testing and patient selection criteria used to identify patients who are eligible for thrombolysis; and understand the indications for antiplatelet agents in the acute and chronic stages of stroke care, as well as the use of anticoagulants and best medical therapy. Lecture/Faculty:

Learning Objectives: Participants should learn to describe common causes of hemorrhagic stroke and the role of neuroimaging; recognize factors that lead to hematoma expansion and treat them; prevent rebleeding from cerebral, vascular, and systemic complications; and manage the post-hemorrhage patient in the outpatient setting. Lecture/Faculty:

SEATTLE PROGRAMS BY TOPIC Sunday, April 3

3:30 p.m.–5:30 p.m. PT

C80: Child Neurology: Neuro-oncology

9:15 a.m.–12:00 p.m. PT CME

Presidential Plenary Session

CHILD NEUROLOGY AND DEVELOPMENTAL NEUROLOGY

» George C. Cotzias Lecture: Autism and Genetics

CME

Director(s): Sonia Partap, MD, Palo Alto, CA Learning Objectives: Participants should be able to understand the current treatment strategies of pediatric CNS tumors, become familiar with the acute neurologic sequelae related to tumor and or cancer therapies, and anticipate late neurologic effects in survivors of these cancers. Lecture/Faculty:

» Epidemiology and Review of Current Pediatric CNS Treatments

Daniel H. Geschwind, MD, PhD, Los Angeles, CA » Sidney Carter Award in Child Neurology: Vascular Pediatrics Catherine M. Amlie-Lefond, MD, FAAN, Seattle, WA

Sonia Partap, MD, Palo Alto, CA

» CAR-T Toxicities in Pediatric Cancer Patients Faculty

» Neurologic Sequelae in Adult Survivors of Pediatric CNS Tumors Faculty

1:00 p.m.–3:00 p.m. PT

C44: Child Neurology: Autism, Behavioral, and Developmental Issues

CME

1:00 p.m.–3:00 p.m. PT

Director(s): Shafali Jeste, MD, FAAN, Los Angeles, CA

C94: Adolescent/Child Neurology for the Adult Neurologist

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

CME

Director(s): Anne M. Connolly, MD, FAAN, Columbus, OH Learning Objectives: This pediatric neuromuscular and movement disorder course is case based and will introduce six children’s stories to answer the question: Where are we now? and Where might we be in 2-3 years? Each child’s story will demonstrate the known and emerging understanding of the pathogenesis of the disorder and speakers will examine current and future management options. For appropriate patients, updates on the potential role of gene therapy will also be reviewed. Participants should be able to understand the pathogenesis of common and uncommon pediatric neuromuscular and movement disorders and understand the role and status of gene therapy in pediatric neuromuscular and movement disorders.

Monday, April 4 1:00 p.m.–3:00 p.m. PT

C71: Child Neurology: Metabolic Conditions and Genetics Director(s): Kara Stuart Lewis, MD, FAAN, Phoenix, AZ

CME

Director(s): Madeline A. Chadehumbe, MD, Plainsboro Township, NJ

3:30 p.m.–5:30 p.m. PT

C53: Child Neurology: Neuromuscular and Movement Disorders

Tuesday, April 5

CME

Learning Objectives: Participants should become familiar with common and uncommon conditions that require a transition from childhood to adulthood, and become familiar with the approach and workup of conditions that are not part of the routine adult practices. Lecture/Faculty:

» Pediatric Epilepsy - Overview and Future

Rana R. Said, MD, FAAN, Dallas, TX » Community Pediatric Neurology - Potpourri Feature Cases Madeline A. Chadehumbe, MD, Plainsboro Township, NJ » Neurodevelopment Disabilities and Disorders and Transition of Care - A Growing Adult Enigma Lawrence W. Brown, MD, Merion Station, PA 3:30 p.m.–5:30 p.m. PT

C108: Pediatric Neuro-ophthalmology

CME

Director(s): Christopher Glisson, DO, FAAN, Grand Rapids, MI Learning Objectives: Management of pediatric neuro-ophthalmic disorders is challenging. Participants will learn to indentify clinically meaningful findings on the pediatric neuro-ophthalmology examination, and apply anatomic and evidence-based knowlege to the evaluation of patients with common and complex afferent and efferent disorders including vision loss, diplopia/abnormal eye movements and neuro-visual manifestations of systemic disease.

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

2022 AAN Annual Meeting

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

Wednesday, April 6

= Learner Engagement Center

= New in 2022

= Experiential Learning Area

7:00 a.m.–4:00 p.m. PT

C3: Neurology Update

1:00 p.m.–3:00 p.m. PT

C125: Stroke in Pediatrics, the Young, and Special Populations

= Additional Fee Required

CME

Director(s): Lori L. Billinghurst, MD, Hamilton, ON, Canada

CME

Director(s): Adam Quick, MD, Columbus, OH See learning objectives on page 37. 7:00 a.m.–9:00 a.m. PT

See learning objectives on page 31.

C11: Epilepsy and Neuroimmunology

Thursday, April 7

CME

Director(s): Claude Steriade, MD, New York City, NY See learning objectives on page 29.

3:30 p.m.–5:30 p.m. PT

S38: Child Neurology and Developmental Neurology

CME

2:45 p.m.–4:45 p.m. PT

C27: Epilepsy/Seizure Semiology EPILEPSY/CLINICAL NEUROPHYSIOLOGY (EEG)

CME

Director(s): Asim Shahid, MD, Cleveland, OH Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

Saturday, April 2 7:00 a.m.–4:00 p.m. PT

C2: Neurology Continuing Certification Prep Course

CME

Director(s): Joseph E. Safdieh, MD, FAAN, New York, NY See learning objectives on page 37.

EXPERIENTIAL LEARNING AREAS MIND, BODY, AND SPIRIT Visit two areas for interactive learning that engages you intellectually, emotionally, and socially.

HEADTALKS

Health E dutainment Amusement Discussion We’re back! Watch as HeadTalks reclaims the stage for a collection of unique and lively panels, games, and more.

LIVE WELL

Taking care of patients starts with taking care of you Achieving balance, well-being, and wholeness in all aspects of your life extends to the quality of care you provide your patients. Explore new ways to achieve success in your career and your AAN.com/AM personal life.

SEATTLE PROGRAMS BY TOPIC Sunday, April 3

3:30 p.m.–5:30 p.m. PT

C78: Epilepsy Therapy Update

7:00 a.m.–9:00 a.m. PT

C40: Video EEG: Basics and Monitoring

CME

Director(s): Susan T. Herman, MD, FAAN, Phoenix, AZ Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available. 1:00 p.m.–3:00 p.m. PT

C43: Critical Care EEG Monitoring

CME

EPILEPSY/CLINICAL NEUROPHYSIOLOGY (EEG)

Director(s): Suzette M. LaRoche, MD, FAAN, Chapel Hill , NC Learning Objectives: Participants should apply standardized critical care EEG terminology to appropriately recognize and categorize seizures, periodic and rhythmic patterns and the ictal interictal continuum; learn to apply the 2HELPS2B seizure risk score and understand the potential clinical impact on duration of EEG monitoring; understand how implementation of QEEG technology can assist in rapid detection of electrographic seizures in addition to other clinically significant EEG changes; and become familiar with management approaches to complex patterns that fall along the ictal interictal continuum. Lecture/Faculty:

» What Do I Call This and What Does it Mean? Importance of

Director(s): Joseph I. Sirven, MD, FAAN, Jacksonville, FL Learning Objectives: Participants should become familiar with all currently approved antiseizure drugs in the US and how to tailor each drug to the correct patient with seizures; be aware of all surgical modalities inclusive of resective surgery and devices; and become familiar with the presentation of autoimmune epilepsy and how to confirm diagnosis and current therapeutic choices. Lecture/Faculty:

» Antiseizure Medications

Joseph I. Sirven, MD, FAAN, Jacksonville, FL

» Surgery & Devices

Michael R. Sperling, MD, FAAN, Philadelphia, PA

» Autoimmune Epilepsy Faculty

7:00 a.m.–9:00 a.m. PT

Tuesday, April 5

C88: Epilepsy: Basics and Considerations Across the Age Span: Pediatrics, Pregnancy, Elderly, and Special Populations

CME

Director(s): Amy Z. Crepeau, MD, Phoenix, AZ Learning Objectives: Participants should be able to identify the heterogenous nature of all patients with epilepsy; outline specific considerations in the treatment of epilepsy across special populations, specifically in regards to pediatric populations, hormonal influences on epilepsy, and elderly patients; and construct treatment approaches to patients with epilepsy across the lifespan. This program complements Epilepsy: Surgery, Neuromodulation, and Outcomes but covers independent topics Lecture/Faculty:

Standardized Critical Care EEG Terminology Suzette M. LaRoche, MD, FAAN, Chapel Hill , NC » QEEG Analysis: Seizure Detection and Beyond Hiba Arif Haider, MD, Chicago, IL » Controversial Patterns: Recognition and Approach to Management Monica B. Dhakar, MBBS, Providence, RI 1:00 p.m.–3:00 p.m. PT

IS1: Invited Science: Epilepsy

CME

» Pediatric Epilepsy Basics

Courtney Wusthoff, MD, Palo Alto, CA

» Epilepsy and Hormones Faculty

3:30 p.m.–5:30 p.m. PT

S7: Epilepsy and Clinical Neurophysiology (EEG) 1

CME

Monday, April 4

» Epilepsy in the Elderly and Consideration of Co-Morbid Conditions Amy Z. Crepeau, MD, Phoenix, AZ

1:00 p.m.–3:00 p.m. PT

S12: Epilepsy/Clinical Neurophysiology (EEG) 2

CME

C96: Epilepsy: Surgery, Neuromodulation, and Outcomes

CME

Director(s): Carol M. Ulloa, MD, FAES, FAAN, Kansas City, KS Learning Objectives: Participants should better understand the current measures of epilepsy surgery outcome classification and should identify surgical outcomes beyond seizure freedom. This will highlight outcome research areas in need of exploration. Additionally, participants should recognize how epilepsy surgery risk is overestimated, evaluate how minimally invasive epilepsy surgery options may mitigate patient surgical risk perception, and identify

2022 AAN Annual Meeting

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

the surgery evaluation as a collaborative process where patients and physicians make choices based on individual risk tolerance. Participants will also have a better understanding of patient selection for neuromodulation therapies. This program complements Epilepsy: Basics and Considerations Across the Age Span: Pediatrics, Pregnancy, Elderly, and Special Populations but covers independent topics. Lecture/Faculty:

» Using Minimally Invasive Epilepsy Procedures to Reframe Epilepsy Surgery Consideration Patrick Landazuri, MD, Kansas City, KS » Neuromodulation in Epilepsy Vikram Rao, MD, San Francisco, CA » What Defines a Successful Epilepsy Surgery? Lara Jehi, MD, Cleveland, OH

3:30 p.m.–5:30 p.m. PT

S23: Epilepsy/Clinical Neurophysiology (EEG) 3

CME

= Additional Fee Required

= Learner Engagement Center

= New in 2022

= Experiential Learning Area

Wednesday, April 6 7:00 a.m.–9:00 a.m. PT

C122: Neuropsychiatric Considerations in Epilepsy

CME

Director(s): David L. Perez, MD, FAAN, Boston, MA Learning Objectives: Attendees should have learned an overview of the components of the neuropsychiatric perspective that can be leveraged to provide patient-centered care to patients with seizures; how to use the biopsychosocial framework to guide treatment planning for patients with seizures; a practical approach to pharmacotherapy, including anti-seizure medications, and psychotherapy recommendations in patients with epilepsy experiencing co-morbid psychiatric symptoms; evidence-based approach to differentiating epileptic vs. functional seizures, and available management strategies for functional seizures. Lecture/Faculty:

» Neuropsychiatry: Bridging Brain, Mind and Body David L. Perez, MD, FAAN, Boston, MA

» Epilepsy and Major Psychiatric Comorbidities: A Patient-centered

Approach Faculty » Comorbid Functional and Epileptic Seizures: Dual Diagnosis Challenges Faculty

Experiential Learning Areas Are Back!

HEADTALKS

LIVE WELL

HeadTalks is back to bring you Taking care of patients starts with the best lineup of presentations taking care of you. and discussions on health care and Achieving balance, well-being, and wholeness in all aspects of your life extends to the quality of care you navigating the complicated field provide your patients. of neurology. Explore new ways to achieve success in your career and your Watch as HeadTalks reclaims the stage for a collection of unique and lively experiences, including: • • • •

Games—from trivia to Pictionary Panels and networking opportunities with giants in the field Tips and tricks for practicing neurology and reaching your community And more!

personal life in a variety of topics and formats, including: • • • • •

Guided meditation Interactive fireside chats on wellness, selfcompassion, changing careers, handling litigation, and supporting your colleagues through burnout Nutrition and mindful snacking Workshop on poetry and neurology And more!

AAN.com/AM

SEATTLE PROGRAMS BY TOPIC 3:30 p.m.–5:30 p.m. PT

1:00 p.m.–3:00 p.m. PT

C136: Status Epilepticus Update

CME

Director(s): Lawrence J. Hirsch, MD, FAAN, New Haven, CT

Director(s): Nicholas Scott Abend, MD, Philadelphia, PA

Learning Objectives: Participants should be able to describe which patients are at highest risk for nonconvulsive seizures and therefore warrant continuous EEG monitoring; manage equivocal EEG findings, such as periodic discharges and the ictal-interictal continuum; rapidly diagnose and treat status epilepticus of all types; and better manage patients with postanoxic status epilepticus (including myoclonic SE) and NORSE. Lecture/Faculty:

Learning Objectives: Participants should be able to distinguish normal pattern form abnormalities and describe key EEG findings that impact patient management. This program complements EEG: Focal, Diffuse, and Epileptiform Abnormalities in Adults & EEG: Normal EEG, Normal Variants, and How to Avoid the Common Pitfall of Overreading but covers independent topics. Lecture/Faculty:

» Critical Care EEG Monitoring

EPILEPSY/CLINICAL NEUROPHYSIOLOGY (EEG)

C155: EEG: Neonatal and Pediatric

Nicholas Scott Abend, MD, Philadelphia, PA

Lawrence J. Hirsch, MD, FAAN, New Haven, CT » Status Epilepticus: Treatment and Controversies, Including the Ictalinterictal Continuum Faculty » When We Have to Think Outside the Box: Special Considerations in Post-anoxic SE and NORSE Carolina B. Maciel, MD, MSCR, Gainesville, FL » Interactive Game: What is the Status of Your Knowledge of Status? With Panel Commentary Lawrence J. Hirsch, MD, FAAN, New Haven, CT Carolina B. Maciel, MD, MSCR, Gainesville, FL

Thursday, April 7 7:00 a.m.–9:00 a.m. PT

C146: EEG: Normal EEG, Normal Variants, and How to Avoid the Common Pitfall of Overreading Director(s): Aatif M. Husain, MD, Durham, NC Learning Objectives: Participants should appreciate the basic normal EEG patterns; recognize common normal variants; and understand how to minimize the chance of misinterpretation of normal EEG. This program complements EEG: Focal, Diffuse, and Epileptiform Abnormalities in Adults & EEG: Neonatal and Pediatric but covers independent topics. Lecture/Faculty:

» Normal EEG Patterns

» Neonatal EEG

CME

» EEG for Key Management Decisions

Sudha Kessler, MD, Philadelphia, PA

» Epileptic Encephalopathy

Ernesto Gonzalez-Giraldo, MD, San Francisco, CA

3:30 p.m.–5:30 p.m. PT

C163: EEG: Focal, Diffuse, and Epileptiform Abnormalities in Adults

CME

Director(s): Katherine H. Noe, MD, PhD, FAAN, Phoenix, AZ Learning Objectives: Participant should be able to recognize common abnormal EEG findings including focal and generalized slowing, epileptiform discharges, and electrographic seizures while avoiding commone pitfalls such as misinterpretation of artifacts and normal variants. This program complements EEG: Neonatal and Pediatric & EEG: Normal EEG, Normal Variants, and How to Avoid the Common Pitfall of Overreading but covers independent topics. Lecture/Faculty:

» Focal and Diffuse Abnormalities in Adult EEG David C. Spencer, MD, FAAN, Portland, OR

» Interictal and Ictal Abnormalities in Adult EEG

Katherine H. Noe, MD, PhD, FAAN, Phoenix, AZ

» EEG Quiz 1

David C. Spencer, MD, FAAN, Portland, OR » EEG Quiz 2 Katherine H. Noe, MD, PhD, FAAN, Phoenix, AZ

Faculty

» Normal EEG Variants

Aatif M. Husain, MD, Durham, NC » Avoiding EEG Reading Pitfalls Faculty

2022 AAN Annual Meeting

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

CME

Director(s): Alison M. Pack, MD, FAAN, New York, NY Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

SA-CME

» Update in Neurological Infectious Disease Faculty

» Update in Neuro-oncology

Roy E. Strowd, III, MD, FAAN, Winston Salem, NC » Update in Neuromuscular Disease Adam Quick, MD, Columbus, OH » Update in Multiple Sclerosis Faculty » Update in Sleep Rachel Marie E. Salas, MD, MEd, FAAN, Baltimore, MD » Update in Epilepsy Faculty » Update in Movement Disorders Faculty » Update in Stroke Faculty » Update in Headache Faculty

GENERAL NEUROLOGY

Learning Objectives: Participants should feel more comfortable with the format and structure of the Continuing Certification examination; know the scope of topics covered; and acquire updated knowledge about the core clinical features, diagnosis, and therapeutic modalities for many of the neurologic disorders covered on the exam. Additionally, participants will identify both areas of strength as well as areas where they should focus their studying efforts for the upcoming examination. Lecture/Faculty:

Eric M. McDade, DO, Saint Louis, MO » Vascular Neurology Alexander Merkler, MD, New York, NY » Movement Disorders Harini Sarva, MD, New York, NY » Neuromuscular Disorders Nuri Jacoby, MD, New York, NY » Genetic and Developmental Disorders Belinda Oyinkan Marquis, MD, New York, NY » Neuroimmunologic & Paraneoplastic Disorders of CNS Faculty » Neuro-oncologic Disorders/Neuroinfectious Diseases Amy A. Pruitt, MD, FAAN, Philadelphia, PA » Neuro-ophthalmologic & Neuro-otologic Disorders Faculty » Headache Joseph E. Safdieh, MD, FAAN, New York, NY

Learning Objectives: Neurology is a rapidly evolving field of medicine that has differentiated into numerous subspecialties. It can be an enormous challenge for many neurologists to stay current on recent diagnostic and therapeutic advancements. Participants in the course should learn about the most important developments in each subspecialty of neurology from the past year or two and become familiar with how to apply these changes to clinical practice. Lecture/Faculty: Faculty

Director(s): Joseph E. Safdieh, MD, FAAN, New York, NY

Carl W. Bazil, MD, PhD, FAAN, New York, NY

» Update in Dementia

7:00 a.m.–4:00 p.m. PT

» Behavioral Neurology and Cognitive Disorders

CME

Director(s): Adam Quick, MD, Columbus, OH

7:00 a.m.–9:00 a.m. PT

» Epilepsy and Sleep Disorders

= Experiential Learning Area

C3: Neurology Update

Saturday, April 2

C2: Neurology Continuing Certification Prep Course

= Learner Engagement Center

= New in 2022

7:00 a.m.–4:00 p.m. PT

GENERAL NEUROLOGY

C10: Neuroendocrine Update: Nuts and Bolts of What You Need to Know

= Additional Fee Required

7:15 a.m.–7:45 a.m. PT

Live Well: Yoga Speaker(s): Megan Weigel, DNP, ARNP-c, Jacksonville , FL Learning Objectives: Participate in vinyasa style yoga class with modifications. 8:00 a.m.–8:30 a.m. PT

Live Well: Fireside Chat: Wellness for APPs Speaker(s): Courtney Bloss, PA, Allentown, PA Megan Weigel, DNP, ARNP-c, Jacksonville , FL Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-todate information.

AAN.com/AM

SEATTLE PROGRAMS BY TOPIC 8:00 a.m.–8:30 a.m. PT

1:00 p.m.–1:30 p.m. PT

HeadTalks: Welcome to the Annual Meeting Speaker(s): Hope O’Brien, MD, FAAN, MBA, Cincinnati, OH

Live Well: The Power of Lifestyle Medicine: How Nutrition, Movement, Sleep, and Connection Can Change Your Life

Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-todate information. 9:15 a.m.–11:15 a.m. PT CME

Controversies in Neurology Plenary Session

Learning Objectives: This session features experts discussing the most current and controversial issues in neuroscience. Tune in for a scholarly debate between two expert speakers, each advocating for one side of a single topic, followed by a rebuttal.

GENERAL NEUROLOGY

12:15 p.m.–2:15 p.m. PT

C17: United We Stand: Enhancing Your Practice with APPs

CME

Director(s): Bryan D. Walker, PA, Durham, NC

Learning Objectives: Participants should understand and describe the impact of nutrition, physical activity, sleep, stress management, and social connection to individual well-being; evaluate their lifestyle habits and identify individual strengths and areas for improvement; and learn how to use practical tools to integrate lifestyle changes into their daily activities. 1:00 p.m.–1:45 p.m. PT

HeadTalks: Neuro HeadTalk: Story Slams Speaker(s): Joseph I. Sirven, MD, FAAN, Jacksonville, FL Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-todate information. 2:45 p.m.–4:45 p.m. PT

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

C23: Drugs and Toxin-induced Neurologic Emergencies/CNS Toxicities

CME

Director(s): Neeraj Kumar, MD, Rochester, MN

12:15 p.m.–2:15 p.m. PT

C18: Food for Thought: Nutrition and Neurologic Disease

CME

Director(s): Barbara S. Giesser, MD, FAAN, Santa Monica, CA Learning Objectives: Participants should be able to describe the role of nutrition in management of persons with neurologic disease; counsel patients on the basic parameters of a healthy diet and recommend any evidence-based dietary strategies, as may be available; describe the impact of diet in persons with MS; discuss current “best practice” dietary interventions for prevention of cerebrovascular disease; and discuss the role of diet in management and possible prevention of neurodegenerative diseases such as Alzheimer’s. Lecture/Faculty:

» Principles of Nutrition and Cerebrovascular Disease

Speaker(s): Andrea C. Wasilewski, MD, Rochester, NY

Learning Objectives: Participants should develop an understanding of how to diagnose neurological disorders that may accompany illicit drug use and heavy metal toxicity. They should recognize the neurotoxicity associated with newer therapies like chimeric antigen T-cell therapy and therapy with immune checkpoint inhibitors; and be familiar with toxidromes like serotonin syndrome, neuroleptic malignant syndrome, posterior reversible encephalopathy syndrome, and reversible cerebral vasoconstriction syndrome. Lecture/Faculty:

» Neuro-toxidromes and Newer Therapies-related Neurotoxicity Neeraj Kumar, MD, Rochester, MN

» Drugs of Abuse and Neurology

Derek William Stitt, MD, Rochester, MN » Neurotoxicity of Heavy Metals Neeraj Kumar, MD, Rochester, MN

Karima Benameur, MD, Peachtree City, GA

» The Role of Diet in Management of MS

Barbara S. Giesser, MD, FAAN, Santa Monica, CA » Nutrition and Neurodegenerative Disease Verna R. Porter, MD, Santa Monica, CA

2022 AAN Annual Meeting

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

2:45 p.m.–4:45 p.m. PT

C24: LGBTQI Health in Neurology

= Learner Engagement Center

= New in 2022

= Experiential Learning Area

6:15 p.m.–8:15 p.m. PT CME

Director(s): Holly E. Hinson, MD, MCR, FAAN, Portland, OR Learning Objectives: Participants should be able to describe LGBTQI terminology and health disparities, list strategies to collect data on sexual orientation and gender identity in clinical settings, discuss the role of LGBTQI identity specific to neurologic illness, and describe how to create a welcoming and inclusive clinic environment for LGBTQI individuals. Lecture/Faculty:

» LGBTQI Health in Neurology

Starane Anthony Shepherd, MD, Atlanta, GA

C32: Case Studies: Test Your Knowledge: A Casebased Approach to Neuroimaging

CME

Director(s): Joshua P. Klein, MD, PhD, FANA, FAAN, Boston, MA Learning Objectives: Participants will be presented with a series of diagnostically challenging neuroimaging cases and, for each case, have the opportunity to vote on a correct answer using an audience response system. This will be followed by a detailed explanation of the correct answer and additional high-yield teaching points related to the imaging findings. Participants should increase their familiarity with common and less common imaging abnormalities. Lecture/Faculty:

» Cases I

» Interventions to Make Neurologic Care More Inclusive

Joseph C. Masdeu, MD, PhD, FAAN, Houston, TX

Nicole Rosendale, MD, San Francisco, CA » Cases Holly E. Hinson, MD, MCR, FAAN, Portland, OR

» Cases II

Dara G. Jamieson, MD, New York, NY

» Cases III

Joshua P. Klein, MD, PhD, FANA, FAAN, Boston, MA

3:00 p.m.–3:30 p.m. PT

7:15 a.m.–7:45 a.m. PT

Live Well: Yoga Speaker(s): Megan Weigel, DNP, ARNP-c, Jacksonville , FL Learning Objectives: Participate in vinyasa style yoga class with modifications. 8:00 a.m.–8:30 a.m. PT

HeadTalks: EEG Talk Speaker(s): Michael Brandon Westover, MD, PhD, Belmont, MA Fabio Augusto Nascimento E Silva, MD, Boston, MA

Live Well: Fireside Chat: Self-compassion—Learning

to Ignore Your Inner Critic

HeadTalks: Reflections from Women in Medicine: The Other Side of Doctoring

Speaker(s): Aimee Aoi Sato, MD, Seattle, WA Andrea C. Wasilewski, MD, Rochester, NY Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-todate information. 8:00 a.m.–8:45 a.m. PT

Speaker(s): Amtul Farheen, MD, FAAN, Lebanon, PA Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-todate information. 5:00 p.m.–6:00 p.m. PT

HeadTalks: What’s That in Your Brain: 50 Essential Instant Pathological Recognition Cases Speaker(s): J. Clay Goodman, MD, FAAN, Houston, TX Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-todate information.

CME

Learning Objectives: This session features the latest, cutting-edge translational research related to clinical issues of importance. Three outstanding speakers provide summaries of their recent research findings and describe the clinical implications of the results. AAN.com/AM

GENERAL NEUROLOGY

Sunday, April 3

Live Well: Poetry and Neurology Workshop Speaker(s): Michael L. Wynn, DO, FAAN, Corvallis, OR

Hot Topics Plenary Session

= Additional Fee Required

SEATTLE PROGRAMS BY TOPIC 3:00 p.m.–3:45 p.m. PT

9:15 a.m.–12:00 p.m. PT CME

Presidential Plenary Session

» Presidential Lecture: Post-COVID Challenges to Scientific Research

3:30 p.m.–5:30 p.m. PT

Brenda Banwell, MD, FAAN, Philadelphia, PA Merit E. Cudkowicz, MD, MSc, Boston, MA Nina F. Schor, MD, PhD, FAAN, Bethesda, MD

N2: Neuroscience in the Clinic: Applications of Artificial Intelligence and Machine Learning Tools in Neurology

HeadTalks: Neurology Trivia: Localize the Lesion Speaker(s): Luis F. Torres, MD, Houston, TX Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-todate information. 1:00 p.m.–3:00 p.m. PT

C47: Clinical Neurology for Advanced Practice Providers

CME

Director(s): Antonio M. P. Omuro, MD, New Haven, CT Sunil Sheth, MD, Houston, TX

12:00 p.m.–12:45 p.m. PT

GENERAL NEUROLOGY

HeadTalks: Is There a Neurologist on This Flight? Speaker(s): Joseph I. Sirven, MD, FAAN, Jacksonville, FL Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-todate information.

CME

Director(s): Shannon Donovan Anderson, PA, Portland, OR Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available. Lecture/Faculty:

» APP Guide to Dementia

Allison Lindauer, PhD, APRN, Portland, OR » Case-based Neuroimaging for APPs Ryan Hakimi, DO, Greenville, SC 3:00 p.m.–3:30 p.m. PT

3:30 p.m.–5:30 p.m. PT

S8: General Neurology

5:00 p.m.–5:30 p.m. PT

Live Well: Guided Meditation Speaker(s): Barbara Anne Pickut, MD, Grand Rapids, MI Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-todate information. 5:00 p.m.–5:45 p.m. PT

HeadTalks: Standing on the Shoulders of Giants Speaker(s): Robert C. Griggs, MD, FAAN, Rochester, NY Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-todate information.

Monday, April 4

Live Well: Enhancing Personal and Professional Well-

being Through Appreciative Inquiry

CME

7:00 a.m.–9:00 a.m. PT

Speaker(s): Jeffrey Dewey, MD, New Haven, CT Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-todate information.

C67: Women’s Neurology: Beyond Pregnancy

CME

Director(s): Naymee J. Velez-Ruiz, MD, Miami, FL Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available. 7:00 a.m.–9:00 a.m. PT

C68: Create Your Own Byte of Neurology

CME

Director(s): Roy E. Strowd, III, MD, FAAN, Winston Salem, NC Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available. 40

2022 AAN Annual Meeting

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

= Experiential Learning Area

= Learner Engagement Center

HeadTalks: Neuro Exam Tricks and Tips Speaker(s): Nancy J. Newman, MD, FAAN, Atlanta, GA Amy A. Pruitt, MD, FAAN, Philadelphia, PA

Live Well: Fireside Chat: Wellness for Residents and

Fellows

Speaker(s): Jennifer Rose Molano, MD, FAAN, Cincinnati, OH Jeffrey Dewey, MD, New Haven, CT Rebecca Kate Miller-Kuhlmann, MD, Stanford, CA Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-todate information. 9:15 a.m.–11:30 a.m. PT CME

Learning Objectives: This session highlights issues most critical to practicing neurologists, including abstracts related to new therapeutic developments, clinical applications of basic and translational research, and innovative technical developments. The first half of the session will consist of abstract presentations followed by a commentary from the discussant. The second half of the session will feature standalone talks on various topics.

HeadTalks: Creating Your Social Media Brand Speaker(s): Catherine S.W. Albin, MD, Atlanta, GA Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-todate information. 3:30 p.m.–5:30 p.m. PT CME

Director(s): Selim R. Benbadis, MD, FAAN, Tampa, FL

HeadTalks: Neuro-Jeopardy: Telencephalon Twisters Speaker(s): Veronica E. Santini, MD, MA, El Granada, CA Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-todate information. 1:00 p.m.–3:00 p.m. PT CME

1:00 p.m.–1:30 p.m. PT

Live Well: Nutrition for Neurologists Speaker(s): Tamika M. Burrus, MD, FAAN, Los Angeles, CA Learning Objectives: Participants should be able to describe the current data around a healthy diet and how it impacts mental and physical health. 1:00 p.m.–1:45 p.m. PT

HeadTalks: Haiku Cares? Write Creatively, Fight Burnout, and Submit Work to Humanities Speaker(s): Lealani Mae Acosta, MD, FAAN, Nashville, TN Michael L. Wynn, DO, FAAN, Corvallis, OR

Learning Objectives: Participants should become familiar with functional (psychogenic) symptoms encountered in neurology practice, how they are diagnosed and treated, and the key pertinent psychiatric diagnoses. Lecture/Faculty:

» Introduction and Functional Seizures as the Prototype of Functional

Disorders Selim R. Benbadis, MD, FAAN, Tampa, FL » Functional Neurologic Disorders Other Than Seizures Mark Hallett, MD, FAAN, Bethesda, MD » Functional Disorders Outside of Neurology Selim R. Benbadis, MD, FAAN, Tampa, FL » Psychiatric Aspects of Functional Disorders (Diagnostic and Therapeutic) W. Curt LaFrance, Jr., MD, MPH, FAAN, Providence, RI 4:00 p.m.–4:45 p.m. PT

HeadTalks: It Takes a Village: Neurologic Care in Rural Communities Speaker(s): Muhib Khan, MD, Grand Rapids, MI Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-todate information. \

GENERAL NEUROLOGY

C84: Functional Neurologic Disorders: Truths, Myths, and Misunderstandings

12:00 p.m.–12:45 p.m. PT

S11: Neuroepidemiology

= New in 2022

2:00 p.m.–2:45 p.m. PT

8:00 a.m.–8:30 a.m. PT

Contemporary Clinical Issues Plenary Session

= Additional Fee Required

SEATTLE PROGRAMS BY TOPIC 7:00 a.m.–9:00 a.m. PT

Tuesday, April 5

1:00 p.m.–1:45 p.m. PT

C39: Meeting the Moment: Mastering Difficult Conversations in Serious Neurological Illness

CME

Director(s): Jessica Michelle Sedley Besbris, MD, Los Angeles, CA Learning Objectives: Participants should be able to implement the SPIKES framework for disclosing serious news; demonstrate communication strategies for responding to patient emotion; and analyze an observed simulated clinical interaction for key elements of successful and suboptimal communication strategies. 8:00 a.m.–8:45 a.m. PT

HeadTalks: Lost in Translation Speaker(s): Joseph I. Sirven, MD, FAAN, Jacksonville, FL Jose G. Merino, MD, MPhil, FAAN, Washington, DC Learning Objectives: Programming full of fresh ideas is still being finalized, so check back online.

GENERAL NEUROLOGY

2:00 p.m.–2:45 p.m. PT

HeadTalks: “A Molecule Away from Madness: Tales of the Hijacked Brain” Speaker(s): Sara Manning, MD, Philadelphia, PA Orly Avitzur, MD, MBA, FAAN, Tarrytown, NY Learning Objectives: Programming full of fresh ideas is still being finalized, so check back online.. 3:00 p.m.–3:00 p.m. PT

HeadTalks: Consejos Prácticos para un Buen Examen Neurológico (Neuro Exam Tips and Tricks)

9:15 a.m.–11:30 a.m. PT CME

Clinical Trials Plenary Session

HeadTalks: Neurology at the Movies Speaker(s): Joseph F. Drazkowski, MD, FAAN, Phoenix, AZ Learning Objectives: Programming full of fresh ideas is still being finalized, so check back online.

Speaker(s): Jose Biller, MD, FAAN, FACP, FAHA, Maywood, IL Vladimir Hachinski, MD, DSc, FAAN, London, ON, Canada Learning Objectives: Programming full of fresh ideas is still being finalized, so check back online.

Learning Objectives: This session covers important clinical topics identified from other society meetings that affect patient care. The latest 3:30 p.m.–5:30 p.m. PT updates within several clinical trials conducted over the course of the last year will be presented. C110: Cervical Spondylotic Myelopathy, Cervical

Radiculopathy, and the Differential Diagnosis of Myelopathies

1:00 p.m.–3:00 p.m. PT

C102: Continuum® Test Your Knowledge: A Multiplechoice Question Review 1

CME

Director(s): J. D. Bartleson, MD, FAAN, The Villages, FL Learning Objectives: Participants will know how to recognize clinically important neck and upper limb pain and neurologic symptoms Director(s): Ralph F. Jozefowicz, MD, FAAN, Rochester, NY and signs indicating significant cervical spine disease. Attendees Learning Objectives: Participants should be able to increase will learn when to order diagnostic tests and which tests to order and refresh their knowledge of core topics in neurology through for patients with cervical spinal cord and/or cervical spinal nerve presentation of common and not-so-common clinical problems. The two core topics include: spinal cord disorders, and peripheral nerve and impingement. The managemental of these patients will be discussed. motor neuron disorders. Participants should also learn to work through Non-operative treatment will be emphasized. Indications for surgery and surgical treatment options be presented. difficult clinical presentations both logically and successfully. This Lecture/Faculty: ® program complements Continuum Test Your Knowledge: A Multiple» Cervical Spondylotic Myelopathy choice Question Review 2 but covers independent topics. Neeraj Kumar, MD, Rochester, MN Lecture/Faculty: SA-CME

» Cervical Radiculopathy

» Spinal Cord Disorders

Ligia Viorela Onofrei, MD, Salt Lake City, UT

Eoin P. Flanagan, MBBCh, FAAN, Rochester, MN » Peripheral Nerve and Motor Neuron Disorders A. Gordon Smith, MD, FAAN, Richmond, VA

» Differential Diagnosis of Myelopathies Neeraj Kumar, MD, Rochester, MN

1:00 p.m.–1:30 p.m. PT

3:30 p.m.–5:30 p.m. PT

Live Well: Mindful Snacking Speaker(s): Belinda A. Savage-Edwards, MD, FAAN, Huntsville, AL Learning Objectives: Programming full of fresh ideas is still being finalized, so check back online.

C111: Continuum® Test Your Knowledge: A Multiplechoice Question Review 2

2022 AAN Annual Meeting

SA-CME

Director(s): Ralph F. Jozefowicz, MD, FAAN, Rochester, NY Learning Objectives: Participants should be able to increase and refresh their knowledge of core topics in neurology through presentation of common and not-so-common clinical problems.

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

The two core topics include neuro-otology and neuro-infectious diseases. Participants should also learn to work through difficult clinical presentations both logically and successfully. This program complements Continuum® Test Your Knowledge: A Multiple-choice Question Review 1 but covers independent topics. Lecture/Faculty:

= Additional Fee Required

= Learner Engagement Center

= New in 2022

= Experiential Learning Area

9:15 a.m.–11:30 a.m. PT

Frontiers in Neuroscience Plenary Session

CME

» Neuro-otology

Terry D. Fife, MD, FAAN, Phoenix, AZ

» Neuro-infectious Diseases

» Mapping the Connectivity of Consciousness

Aaron L. Berkowitz, MD, PhD, FAAN, Altadena, CA

Brian Edlow, MD, Boston, MA » mRNA Vaccines for Therapeutic Applications in Neuroscience Michael Lim, MD, Palo Alto, CA

4:00 p.m.–4:45 p.m. PT

HeadTalks: Courage in Neurology Speaker(s): Joyce K. Lee-Iannotti, MD, Phoenix, AZ David S. Knopman, MD, FAAN, Rochester, MN David Y. Hwang, MD, FAAN, New Haven, CT

12:00 p.m.–12:45 p.m. PT

HeadTalks: Neurology Pictionary Speaker(s): Mark Milstein, MD, FAAN, Bronx, NY Learning Objectives: Programming full of fresh ideas is still being finalized, so check back online.

5:00 p.m.–5:45 p.m. PT

1:00 p.m.–3:00 p.m. PT

HeadTalks: Leading Through Adversity Speaker(s): James C. Stevens, MD, FAAN, Fort Wayne, IN

C129: Therapy in Neurology 1

Learning Objectives: Programming full of fresh ideas is still being finalized, so check back online.

Learning Objectives: Participants should be able to describe the most recent advances in the treatment of amyotrophic lateral sclerosis and epilepsy. This program complements Therapy in Neurology 2 but covers independent topics. Lecture/Faculty:

7:00 a.m.–9:00 a.m. PT CME

Director(s): Janet F. Waters, MD, FAAN, Pittsburgh, PA

» Therapy in ALS Faculty

» Therapy in Epilepsy Faculty

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

1:00 p.m.–3:00 p.m. PT

C130: Neurologic Conditions in Transgender Patients

7:00 a.m.–9:00 a.m. PT

C121: Neuroimaging for the General Neurologist: Spine

Director(s): Madhu Soni, MD, FAAN, Chicago, IL

Wednesday, April 6 C120: Neurologic Case Studies in Pregnancy

CME

Director(s): Asim Zia Mian, MD, Boston, MA Learning Objectives: Participants should be able to conduct a review of normal spine anatomy; conduct a review of various spine pathology (demyelinating disease, degenerative spine, trauma, infection etc.); and identify mimics of spine pathology. 8:00 a.m.–8:30 a.m. PT

Live Well: Fireside Chat: Thinking of Changing Careers Speaker(s): Jennifer Bickel, MD, FAAN, Tampa, FL Learning Objectives: Programming full of fresh ideas is still being finalized, so check back online.

CME

Director(s): Nicole Rosendale, MD, San Francisco, CA Learning Objectives: Participations should be able to define terminology and concepts relevant to the care of transgender individuals; describe current best practices in the neurologic care of transgender individuals; and identify interventions to promote an inclusive workplace and clinical practice. Lecture/Faculty:

» How to Create an Inclusive and Affirming Environment Nicole Rosendale, MD, San Francisco, CA

» Gender Minority Health Disparities in Neurology Mackenzie Paige Lerario, MD, Tarrytown, NY » Case Discussion Eric Kaiser, MD, PhD, Philadelphia, PA

AAN.com/AM

GENERAL NEUROLOGY

Learning Objectives: Programming full of fresh ideas is still being finalized, so check back online.

SEATTLE PROGRAMS BY TOPIC Lecture/Faculty:

1:00 p.m.–1:55 p.m. PT

» What’s a Good Question to Ask? Selecting Content for Multiple Choice

HeadTalks: The Effects of Brain Damage on Creativity Speaker(s): Kenneth M. Heilman, MD, FAAN, Gainesville, FL Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-todate information. 2:00 p.m.–2:45 p.m. PT

HeadTalks: The Effects of Loneliness: Connectivity

Matters

Speaker(s): Stephanie Cacioppo, PhD, Chicago, IL Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-to-date information.

GENERAL NEUROLOGY

3:00 p.m.–3:30 p.m. PT

Live Well: Visual Thinking Strategies Speaker(s): Jennifer Rose Molano, MD, FAAN, Cincinnati, OH Aileen Antonio, MD, Grand Rapids, MI Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-to-date information.

Questions Jeremy Moeller, MD, FAAN, New Haven, CT » Writing Effective Questions: Principles and Pitfalls Zachary N. London, MD, FAAN, Ann Arbor, MI » Interactive Item-Writing Workshop Zachary N. London, MD, FAAN, Ann Arbor, MI Jeremy Moeller, MD, FAAN, New Haven, CT » Review of Example Questions and Wrap-Up Zachary N. London, MD, FAAN, Ann Arbor, MI Jeremy Moeller, MD, FAAN, New Haven, CT 5:00 p.m.–5:45 p.m. PT

HeadTalks: Standing on the Shoulders of Giants Speaker(s): Josep O. Dalmau, MD, PhD, FAAN, Barcelona, Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-to-date information.

Thursday, April 7 7:00 a.m.–9:00 a.m. PT

C149: Neurogenetics: Diagnostic Dilemmas and Therapeutic Implications

CME

Director(s): Jacinda B. Sampson, MD, PhD, Palo Alto, CA

3:30 p.m.–5:30 p.m. PT

C140: Therapy in Neurology 2

CME

Director(s): Madhu Soni, MD, FAAN, Chicago, IL Learning Objectives: Participants should be able to describe the most recent advances in the treatment of neuro-opthalmologic disorders and conditions encountered by neurohospitalists, and offer these treatments to their patients. This program complements Therapy in Neurology 1 but covers independent topics. Lecture/Faculty:

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available. 8:00 a.m.–8:30 a.m. PT

Live Well: Fireside Chat: Supporting Your Colleagues Through Burnout Speaker(s): Rebecca Kate Miller-Kuhlmann, MD, Stanford, CA Ara Schlaman Hall, MD, Kansas City, MO Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-to-date information.

» Therapy in Neuro-ophthalmology

Nancy J. Newman, MD, FAAN, Atlanta, GA » Therapy in Neurology: Neurohospitalist Perspective Russell E. Bartt, MD, FAAN, Englewood, CO

8:00 a.m.–8:45 a.m. PT 3:30 p.m.–5:30 p.m. PT

C142: Writing and Reviewing Multiple Choice Exam Questions

HeadTalks: Case Studies: Ethical Conundrums in

CME

Director(s): Jeremy Moeller, MD, FAAN, New Haven, CT Learning Objectives: At the end of this session, participants should be able to: (1) identify a good concept for testing, depending on the learner, purpose of the assessment and relevant assessment standards; (2) describe best practices for multiple choice question (MCQ) item writing and recognize common pitfalls; (3) recognize sources of bias in MCQ item development; and (4) develop and evaluate new MCQ items. We aim to identify and educate future contributors to assessment tools from the AAN and other sources. 44

2022 AAN Annual Meeting

Neurology

Neurology Year in Review Plenary Session

CME

Learning Objectives: This session looks back at the past year of research, highlighting some of the most relevant strides made in neurology subspecialties.

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

= Additional Fee Required

= Learner Engagement Center

= New in 2022

= Experiential Learning Area

12:00 p.m.–12:45 p.m. PT

3:00 p.m.–3:45 p.m. PT

HeadTalks: The Neurology of Creativity at the Keyboard Speaker(s): Phillip L. Pearl, MD, FAAN, Boston, MA Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-to-date information.

HeadTalks: Managing Social Media and Navigating Hospital Policies

1:00 p.m.–3:00 p.m. PT

C157: Neuroimaging for the General Neurologist: Brain

Speaker(s): Eseosa Ighodaro, MD, PhD, Rochester, MN Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized, so check back online for the most up-to-date information. 3:30 p.m.–5:30 p.m. PT

CME

C165: Myelopathies: Recognizing and Evaluating Myelopathic Patients for Inflammatory and Vascular Causes

Director(s): John Leever, MD, Kansas City, KS Learning Objectives: The primary learning objective of this course is to identify and comprehend the key imaging features and clinical implications of acute stroke imaging (primarily utilizing noncontrast head CT and CT perfusion imaging) as well as various epileptogenic pathologies (primarily utilizing MR imaging). Lecture/Faculty:

CME

Director(s): Benjamin M. Greenberg, MD, FAAN, Dallas, TX Learning Objectives: Participants should be familiar with the differential diagnosis of acute and subacute myelopathy; the testing and management of patients with suspected myelitis; and recognize the red flags for vascular myelopathies and understand the indications for obtaining spinal angiograms. Lecture/Faculty:

» Acute Stroke: CT Perfusion Imaging Faculty » Epilepsy Imaging John Leever, MD, Kansas City, KS

» Introduction to Myelopathies and Myelitis

Benjamin M. Greenberg, MD, FAAN, Dallas, TX

» Vascular Myelopathies

1:00 p.m.–1:45 p.m. PT

HeadTalks: Microaggressions Speaker(s): Audrey R. Nath, MD, Houston, TX Learning Objectives: This talk is designed to engage you intellectually, emotionally, and socially. Programming full of fresh ideas is still being finalized,Name) so check back Page onlineHorizontal> for the most information. DEP: YY(Project Ad—Half AMup-to-date custom

Faculty

Placed in AM Publication 8.25 x 4.4375 +0.125 bleed, 4C

Community Education

Professional Growth

Advocacy

Practice Management

Wellness Research

AAN.com/Membership

YOUR SOURCE FOR

SUCCESS Only AAN membership offers access to the highest quality resources from the world’s largest and most trusted community of neurology professionals.

Join or renew today. 45 AAN.com/AM

SEATTLE PROGRAMS BY TOPIC 3:30 p.m.–5:30 p.m. PT

C166: Neurologic Complications of Medical and Surgical Therapies

HEADACHE

CME

Director(s): Christopher Lawrence Kramer, MD, Chicago, IL

Saturday, April 2

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

7:00 a.m.–9:00 a.m. PT

C7: Low and High Pressure Headache: Clinical Presentation and Approach to Evaluation and Management

4:30 p.m.–5:15 p.m. PT

HeadTalks: NeuroZone Speaker(s): Jennifer Bickel, MD, FAAN, Tampa, FL Mark Milstein, MD, FAAN, Bronx, NY

Director(s): Kathleen B. Digre, MD, FAAN, Salt Lake City, UT

Learning Objectives: Participants should be able to list symptoms and signs of high and low pressure headache; evaluate key imaging findings of both low and high pressure; and enumerate treatment options for high and low pressure headaches. Lecture/Faculty:

» Understanding Pressure and Headache Relationships Deborah I. Friedman, MD, MPH, FAAN, Dallas, TX

» Basic Recognition of Low Pressure Headache Syndromes

GLOBAL HEALTH GLOBAL HEALTH

CME

Deborah I. Friedman, MD, MPH, FAAN, Dallas, TX » Basic Recognition of High Pressure Headache Syndromes Kathleen B. Digre, MD, FAAN, Salt Lake City, UT

Saturday, April 2 7:00 a.m.–9:00 a.m. PT

C9: The Global Burden of Neurologic Diseases

7:00 a.m.–4:00 p.m. PT CME

Director(s): Mehari Gebreyohanns, MD, FAAN, Dallas, TX

C2: Neurology Continuing Certification Prep Course

CME

Director(s): Joseph E. Safdieh, MD, FAAN, New York, NY

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

See learning objectives on page 37. 7:00 a.m.–4:00 p.m. PT

Tuesday, April 5

C3: Neurology Update

7:00 a.m.–9:00 a.m. PT

CME

Director(s): Adam Quick, MD, Columbus, OH

C90: Global Infectious Diseases

CME

See learning objectives on page 37.

Director(s): Farrah J. Mateen, MD, PhD, FAAN, Boston, MA See learning objectives on page 50.

Thursday, April 7 3:30 p.m.–4:00 p.m. PT

S37: Global Health

2022 AAN Annual Meeting

CME

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

= Additional Fee Required

= Learner Engagement Center

12:15 p.m.–4:45 p.m. PT

C13: Skills Workshop: Interventional HA/ Pain Management: Botulinum Toxin Injections for Headache and Trigger Point Injections

= Experiential Learning Area

Monday, April 4

CME

1:00 p.m.–3:00 p.m. PT

IS2: Invited Science: Headache

CME

Director(s): Rashmi B. Halker Singh, MD, FAAN, Scottsdale, AZ

3:30 p.m.–5:30 p.m. PT

Learning Objectives: Participants should gain familiarity with the different procedures available in headache medicine, including onabotulinumtoxinA, as well as cranial nerve blocks, and trigger point injections; be able to explain their indications and rationale for use; and gain confidence and proficiency in the techniques of doing these procedures. Lecture/Faculty:

C82: Trigeminal Neuralgia and Facial Pain

Hope O’Brien, MD, FAAN, MBA, Cincinnati, OH » Cranial Nerve Blocks Cynthia Emilie Armand, MD, Bronx, NY » Trigger Point Injections Meredith J. Barad, MD, Redwood City, CA » Headache Procedures in Children and Adolescents Christina Lynch Szperka, MD, Philadelphia, PA

Tuesday, April 5 C99: New Therapies for Migraine and Other Headache Disorders

CME

Director(s): Jessica Ailani, MD, FAAN, McLean, VA

Learning Objectives: Participants should identify benefits of new treatments for migraine and cluster headache; formulate a sequence of headache treatments integrating new therapies; and construct a multi-modal toolkit for complex headache cases. Lecture/Faculty:

» State of Affairs in Headache Treatment

Rashmi B. Halker Singh, MD, FAAN, Scottsdale, AZ

» The Future of Headache Treatment

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

Matthew S. Robbins, MD, FAAN, New York, NY

Sunday, April 3

AAN Business Meeting

1:00 p.m.–3:00 p.m. PT CME

3:30 p.m.–5:30 p.m. PT CME

Saturday, April 2, 4:00 p.m.–4:45 p.m. PT All Academy members are invited and encouraged to attend to hear about the Academy’s strategic priorities, recent accomplishments on behalf of members, and current fiscal performance.

Director(s): Rashmi B. Halker Singh, MD, FAAN, Scottsdale, AZ Learning Objectives: Participants should be able to discuss pearls to taking a good headache history, list contraindications to migraine acute therapies, discuss key considerations to new migraine therapies, and become familiar with non-pharmacologic options for migraine. Lecture/Faculty:

» Case-based Presentations

Rashmi B. Halker Singh, MD, FAAN, Scottsdale, AZ Carrie Dougherty, MD, McLean, VA Niushen Zhang, MD, Palo Alto, CA

AAN.com/AM

HEADACHE

CME

Director(s): Peter Goadsby, MD, PhD, Los Angeles, CA

C55: Comprehensive Migraine Update: Advances in Acute, Preventive, and Cognitive Behavioral Therapies

1:00 p.m.–3:00 p.m. PT

6:15 p.m.–8:15 p.m. PT

S4: Headache 1

CME

Director(s): Faculty Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

» OnabotulinumtoxinA

C31: Case Studies: Challenging Headache Cases

= New in 2022

SEATTLE PROGRAMS BY TOPIC Wednesday, April 6

HEALTH CARE DISPARITIES

1:00 p.m.–3:00 p.m. PT

C126: Introduction to Primary Headache Disorders: Trigeminal Autonomic Cephalalgias and Other Primary Headaches, Including New Daily Persistent Headache, Cough, Exercise, and Thunderclap Headaches

CME

9:15 a.m.–12:00 p.m. PT

Presidential Plenary Session

Director(s): Teshamae Monteith, MD, FAAN, Miami, FL Learning Objectives: Participants should become familiar with the numerous lesser known primary headache disorders and understand the differential diagnoses and work-up; recognize key diagnostic clues to distinguish cluster headache from other trigeminal autonomic cephalalgias and identify syndrome-based and pathophysiologybased treatments for non-migraine primary headache disorders such as exercise, sex, cough, and primary thunderclap headache; and become familiar with recent advances in the field. Lecture/Faculty:

HEALTH CARE DISPARITIES

» Other Primary Headache Disorders

Teshamae Monteith, MD, FAAN, Miami, FL » Lesser Known Headache Syndromes: NDPH, Cough Headache, and Primary Exercise Headache Teshamae Monteith, MD, FAAN, Miami, FL » Primary Thunderclap Headache? Stephanie J. Nahas, MD, FAAN, Philadelphia, PA » Trigeminal Autonomic Cephalalgias: What Every Neurologist Must Know Peter Goadsby, MD, PhD, Los Angeles, CA 3:30 p.m.–5:30 p.m. PT

CME

» Robert Wartenberg Lecture: Leaving No One Behind: Charting the Course to Cerebrovascular Health Equity Bruce I. Ovbiagele, MD, MSc, FAAN, San Francisco, CA

3:30 p.m.–5:30 p.m. PT

C58: Disparities in Care in Practice: The Current State and How to Advocate

CME

Director(s): Alejandro Vargas, MD, Chicago, IL Sharon Lewis, MD, Philadelphia, PA Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

Monday, April 4 1:00 p.m.–5:30 p.m. PT

S30: Headache 2

CME

3:30 p.m.–5:30 p.m. PT

C164: Hot Topics in Headaches and Related Disorders

CME

Director(s): David W. Dodick, MD, FAAN, Scottsdale, AZ Learning Objectives: Participants should be able to describe the evidence to support new therapeutics for migraine and chronic migraine; discuss the clinical practice and treatment implications of new migraine therapeutics based on real world experience; identify the diagnostic advances in the evaluation of patients suspected of intracranial hypotension secondary to CSF leaks; and describe advances in the understanding of the biology and treatment of medication-overuse headache, post-traumatic headache, and idiopathic intracranial hypertension. Lecture/Faculty:

» New Therapeutics For Migraine

David W. Dodick, MD, FAAN, Scottsdale, AZ

» IIH, SIH, and PTH - Novel Insights in Biology and Therapy Faculty

2022 AAN Annual Meeting

Health Care Equity Symposium

CME

Speaker(s): Jeffrey C. McClean, II, MD, FAAN, San Antonio, TX

Thursday, April 7

Sunday, April 3

Learning Objectives: Attendees should be able to recognize disparities in care for specific neurologic conditions, and how to modify practice to promote neurologic health equity. Lecture/Faculty:

» Cheryl A. Jay Keynote Lecture Faculty

» Disparities in Stroke Care

Olajide Abiodun Williams, MD, New York, NY

» Poster Blitz

Faculty » Clinical Disease Disparities Presentation Faculty 4:00 p.m.–4:45 p.m. PT

HeadTalks: It Takes a Village: Neurologic Care in Rural Communities Speaker(s): Muhib Khan, MD, Grand Rapids, MI See learning objectives on page 41.

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

= Additional Fee Required

= Learner Engagement Center

Tuesday, April 5

= New in 2022

= Experiential Learning Area

Wednesday, April 6

7:00 a.m.–9:00 a.m. PT

3:30 p.m.–5:30 p.m. PT

C93: Health Care Disparities in the US and Internationally

CME

C137: The History of Diversity and Inclusion in Neurology

CME

Director(s): Lilyana M. Amezcua, MD, FAAN, Los Angeles, CA

Director(s): Alison L. Christy, MD, PhD, Portland, OR

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

Learning Objectives: Participants should become familiar with the societal limitations that have historically obstructed participation in neurologic societies by women and people of color; recognize achievements of women and people of color in neurology; and recognize the importance of studying the history of neurology as a way to better understand our current models of practice. Lecture/Faculty:

3:30 p.m.–5:30 p.m. PT

C113: Theater for Health Care Equity

CME

Director(s): Nimish A. Mohile, MD, FAAN, Rochester, NY

» Women in Neurology

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

» Black and African American Neurology

Alison L. Christy, MD, PhD, Portland, OR Alexis N. Simpkins, MD, Gainesville, FL

» Women in Neurology in Latin America

Sasha Alick-Lindstrom, MD, Dallas, TX » History of Neurology in Asia Faculty

1:00 p.m.–3:00 p.m. PT

S27: Health Care Disparities

CME

3:30 p.m.–5:30 p.m. PT

C138: Health Equity for Neurologists

CME

INFECTIOUS DISEASE

Saturday, April 2

Director(s): Bruce I. Ovbiagele, MD, MSc, FAAN, San Francisco, CA 7:00 a.m.–4:00 p.m. PT

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

C2: Neurology Continuing Certification Prep Course

Director(s): Joseph E. Safdieh, MD, FAAN, New York, NY See learning objectives on page 37.

HISTORY OF NEUROLOGY

7:00 a.m.–4:00 p.m. PT

Tuesday, April 5

C3: Neurology Update

CME

Director(s): Adam Quick, MD, Columbus, OH

3:30 p.m.–4:10 p.m. PT

S21: History of Neurology

CME

See learning objectives on page 37. 12:15 p.m.–2:15 p.m. PT

C19: COVID-19 in Pediatric Neurology

CME

Director(s): Grace Gombolay, MD, Atlanta, GA Learning Objectives: Participants should be able to describe neurological and psychiatric manifestations and neuroimaging findings in children with COVID-19, including in the acute inpatient and outpatient settings, along with post-acute sequelae of COVID-19 in children. Participants also should be able to summarize recent studies on potential underlying mechanisms for neurological symptoms in children with COVID-19. AAN.com/AM

HISTORY OF NEUROLOGY

Wednesday, April 6

SEATTLE PROGRAMS BY TOPIC Lecture/Faculty:

2:45 p.m.–4:45 p.m. PT

C25: Sequelae of COVID-19

CME

» Introduction to Post COVID Clinic

Sarah M. Benish, MD, FAAN, Minneapolis, MN

» Rehabilitation Needs of Post COVID Patients

Director(s): Kenneth L. Tyler, MD, FAAN, Aurora, CO

Faculty

Learning Objectives: Participants should understand the nature and frequency of neurologic sequelae of COVID-19, their diagnosis, and potential mechanisms and treatment options. Lecture/Faculty:

» Cognitive Effects of COVID Faculty

Tuesday, April 5

» Pathogenetic Mechanisms of Neurological Complications and Sequelae

INFECTIOUS DISEASE

of COVID-19 Avindra Nath, MD, MBBS, FAAN, Bethesda, MD » Neurological Sequelae and Follow-up of Hospitalized and Nonhospitalized COVID-19 Patients: The Northwestern Experience Faculty » Neurological Sequelae and Follow-up of Hospitalized and Nonhospitalized COVID19 Patients: The NYU Langone Experience Jennifer A. Frontera, MD, Brooklyn, NY » Health Care Disparities in COVID-19 Kiran Thakur, MD, New York, NY

7:00 a.m.–9:00 a.m. PT

C90: Global Infectious Diseases

CME

Director(s): Farrah J. Mateen, MD, PhD, FAAN, Boston, MA Learning Objectives: Participants will get an overview of neurologic infections from the global perspective; neurological infections seen in US neurology practices, including emerging techniques to identify pathogen; and review clinical updates, scientific advances, and best practices for diagnosing and treating selected neurologic infections. Lecture/Faculty:

Sunday, April 3

» No Time to Die: Around the World in Nine Neurological Infections

3:30 p.m.–5:30 p.m. PT

C59: COVID-19 and Neuromuscular Disorders

CME

Director(s): Pushpa Narayanaswami, MBBS, MD, FAAN, Boston, MA Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

Farrah J. Mateen, MD, PhD, FAAN, Boston, MA » Casino Royale: International Mysteries in Emerging Infections Michael R. Wilson, MD, FAAN, San Francisco, CA » You Only Live Twice: Advances in Neurological Infectious Disease Care Monica M. Diaz, MD, Chapel Hill, NC 1:00 p.m.–3:00 p.m. PT

S17: Infectious Disease

Monday, April 4

CME

7:00 a.m.–9:00 a.m. PT

C63: COVID and MS

CME

Director(s): Jeffrey Alan Cohen, MD, Cleveland, OH See learning objectives on page 56.

3:30 p.m.–5:30 p.m. PT

C109: Diagnosed a Patient with a Neuroinfectious Disease: Now What?

CME

Director(s): Michel Toledano, MD, Rochester, MN

3:30 p.m.–5:30 p.m. PT

C85: Post COVID Clinic

CME

Director(s): Sarah M. Benish, MD, FAAN, Minneapolis, MN Learning Objectives: Participants should learn to describe common neurological symptoms of acute COVID infection and symptoms of Post COVID “long haulers” Case-based discussion of appropriate testing and management strategies should help participant to learn and recognize findings to apply in a clinical setting. Multidisciplinary care will be discussed teaching participants how to appraise needs and work with other health care providers to help these patients.

Learning Objectives: Participants will become familiar with the management of patients diagnosed with infections of the nervous system. Beyond selection of antimicrobials, participants will learn about handling potential false positive results, monitoring and managing complications, assessing for response, and using adjunctive immunotherapies. Lecture/Faculty:

» Fungal and Mycobacterial Infections

Prashanth S. Ramachandran, Jr., MBBS, San Francisco, CA

» HIV and PML Faculty

» Bacterial and Viral Meningoencephalomyelitis Michel Toledano, MD, Rochester, MN

2022 AAN Annual Meeting

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

3:30 p.m.–5:30 p.m. PT

= Additional Fee Required

= Learner Engagement Center

= New in 2022

= Experiential Learning Area

3:30 p.m.–5:30 p.m. PT

C111: Continuum® Test Your Knowledge: A Multiplechoice Question Review 2

SA-CME

C139: Infections of the Nervous System 3: Encephalitis

CME

Director(s): Ralph F. Jozefowicz, MD, FAAN, Rochester, NY

Director(s): Payal B. Patel, MD, Bellevue, WA

See learning objectives on page 42.

Learning Objectives: Participants should be able identify clinical phenotypes, diagnostic, and histopathological features of rare cause of infectious and autoimmune encephalitis, and be familiar with the current management of treatable rare causes of encephalitis. Advances in translational research to further characterize and diagnose rare causes of encephalitis will be discussed. Participants should be familiar with current literature regarding infectious and parainfectious encephalitis. This program complements Infections of Nervous System 1 & Infections of the Nervous System 2: Opportunistic Infections, HIV, and Parasitic Infections but covers independent topics. Lecture/Faculty:

7:00 a.m.–9:00 a.m. PT

Wednesday, April 6

C119: Infections of Nervous System 1

CME

Director(s): Kiran Thakur, MD, New York, NY Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available. This program complements Infections of the Nervous System 2: Opportunistic Infections, HIV, and Parasitic Infections & Infections of the Nervous System 3: Encephalitis but covers independent topics.

Ariane Soldatos, MD, FAAN, Bethesda, MD

» Parainfectious and Autoimmune Causes of Encephalitis

9:15 a.m.–11:30 a.m. PT CME

Lecture/Faculty:

Michel Toledano, MD, Rochester, MN

» Case-based Learning

Payal B. Patel, MD, Bellevue, WA

» Neurobiology of COVID-19

Thursday, April 7

Robyn S. Klein, MD, PhD, Saint Louis, MO 7:00 a.m.–9:00 a.m. PT

C147: Differential Diagnosis of Neurologic Infections

Director(s): Shruti Prabodh Agnihotri, MD, Birmingham, AL Learning Objectives: Participants should be able to recognize scenarios where opportunistic infections are encountered, become familiar with neurologic complications of HIV, and review the common presentations of parasitic infections. This program complements Infections of Nervous System 1 & Infections of the Nervous System 3: Encephalitis but covers independent topics. Lecture/Faculty:

» CNS Opportunistic Infections

Shruti Prabodh Agnihotri, MD, Birmingham, AL » Neurologic Complications of HIV Shibani Sharon Mukerji, MD, Boston, MA » Parasitic Infections of the Nervous system Faculty

Director(s): Michael R. Wilson, MD, FAAN, San Francisco, CA

1:00 p.m.–3:00 p.m. PT

C128: Infections of the Nervous System 2: Opportunistic Infections, HIV, and Parasitic Infections

CME

Learning Objectives: Participants should be able to improve their ability to form a more precise differential diagnosis of possible neurologic infections, and to recognize specific laboratory tests and imaging findings that can guide the differential diagnosis accordingly. Lecture/Faculty:

» Acute Encephalitis

Kiran Thakur, MD, New York, NY

» Chronic Meningitis

Prashanth S. Ramachandran, Jr., MBBS, San Francisco, CA » Myelitis Faculty 1:00 p.m.–3:00 p.m. PT

N6: Neuroscience in the Clinic: Neurological Implications of Long-haul COVID Infection

CME

Director(s): Riley Bove, MD, San Francisco, CA Kiran Thakur, MD, New York, NY 1:00 p.m.–3:00 p.m. PT

S34: Infectious Disease

CME

AAN.com/AM

INFECTIOUS DISEASE

Frontiers in Neuroscience Plenary Session

» Rare Infectious Causes of Encephalitis

SEATTLE PROGRAMS BY TOPIC 2:45 p.m.–4:45 p.m. PT

MOVEMENT DISORDERS

C20: Deep Brain Stimulation

Director(s): Joohi Jimenez Shahed, MD, New York City, NY

Saturday, April 2 7:00 a.m.–9:00 a.m. PT

C4: Non-motor Parkinson’s Disease Symptoms

CME

Director(s): Holly A. Shill, MD, FAAN, Phoenix, AZ Learning Objectives: Participants should be able to discuss the evaluation and management of prodromal symptoms of Parkinson’s disease; evaluate and treat the spectrum of autonomic dysfunction in Parkinson’s disease; and become more comfortable assessing and treating neuropsychiatric manifestations of Parkinson’s disease. Lecture/Faculty:

» Prodromal Non-motor Symptoms in Parkinson’s Disease

MOVEMENT DISORDERS

CME

Learning Objectives: Participants should be able to identify which movement disorders will benefit from deep brain stimulation (DBS) and understand DBS in the context of other advanced disease treatments; describe DBS mechanisms and differentiate the expected clinical outcomes and effects from stimulation in various targets; understand evolving DBS technology and how it can be used to optimize DBS programming. Lecture/Faculty:

» DBS in Context: Selecting the Right Patient and the Right Time Neepa J. Patel, MD, Chicago, IL

» DBS Mechanisms and Target-based Outcomes Aristide Merola, MD, PhD, Columbus, OH

Shyamal Mehta, MD, PhD, Phoenix, AZ » The Spectrum of Autonomic Dysfunction in PD Faculty » Neuropsychiatric Manifestations in PD Holly A. Shill, MD, FAAN, Phoenix, AZ

» DBS Technology: Applying New Approaches to Basic Principles Joohi Jimenez Shahed, MD, New York City, NY

6:15 p.m.–8:15 p.m. PT

C28: Case Studies: Unusual Movement Disorders

7:00 a.m.–4:00 p.m. PT

C2: Neurology Continuing Certification Prep Course

CME

Director(s): Caroline M. Tanner, MD, PhD, FAAN, San Francisco, CA CME

Director(s): Joseph E. Safdieh, MD, FAAN, New York, NY See learning objectives on page 37.

Learning Objectives: Participants should be able to use recognition of phenomenology to develop differential diagnoses, diagnostic investigations, and management. Lecture/Faculty:

» Phenomenology Overview

7:00 a.m.–4:00 p.m. PT

C3: Neurology Update

CME

Director(s): Adam Quick, MD, Columbus, OH See learning objectives on page 37.

Caroline M. Tanner, MD, PhD, FAAN, San Francisco, CA Cynthia L. Comella, MD, FAAN, New Philadelphia, OH » Case-based Discussions Caroline M. Tanner, MD, PhD, FAAN, San Francisco, CA Cynthia L. Comella, MD, FAAN, New Philadelphia, OH

12:15 p.m.–2:15 p.m. PT

C14: Tics/Tourette’s and Paroxysmal Movement Disorders

CME

Director(s): Tamara M. Pringsheim, MD, FAAN, Calgary, AB, Canada Learning Objectives: Participants will get a large video-based overview of the clinical aspects of tics, functional tic-like behaviors, motor stereotypies, and primary (genetic) and secondary forms of paroxysmal movement disorders, particularly paroxysmal dyskinesia, episodic ataxia, benign developmental movement disorders, and paroxysmal functional movement disorders. Participants should learn to recognize and identify these movement disorders and develop an approach to diagnosis and treatment. Lecture/Faculty:

» Tourette Syndrome, Functional Tic-Like Behaviors, and Stereotypies Tamara M. Pringsheim, MD, FAAN, Calgary, AB, Canada

» Paroxysmal Movement Disorders

Emmanuel Roze, MD, PhD, Paris, AE, France

2022 AAN Annual Meeting

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

Sunday, April 3 CME

Director(s): Claire Henchcliffe, MD, PhD, FAAN, Orange, CA

= Experiential Learning Area

C53: Child Neurology: Neuromuscular and Movement Disorders

CME

Director(s): Anne M. Connolly, MD, FAAN, Columbus, OH See learning objectives on page 32.

Learning Objectives: Participants should become familiar with current best practices in diagnosis and treatment of Parkinson’s disease and atypical Parkinson’s disease, and should receive an update on new research, clinical trials, and breakthroughs in these fields. Lecture/Faculty:

Monday, April 4 7:00 a.m.–9:00 a.m. PT

C60: Parkinson’s Disease: Assessment and Management

CME

Director(s): Blanca Yvette Valdovinos, MD, Rochester, NY

» Update on Parkinson’s Disease

Learning Objectives: Participants should understand how to assess for Parkinson’s disease, including knowing the core clinical features, the physical exam findings, and when imaging studies (DaT scans) are helpful; and understand the management of Parkinson’s disease, including medications and advanced therapies. Lecture/Faculty:

Pinky Agarwal, MD, FAAN, Kirkland, WA » Update on Surgical and Device Assisted Therapies in PD Joohi Jimenez Shahed, MD, New York City, NY » Update in Atypical Parkinson’s Disease Claire Henchcliffe, MD, PhD, FAAN, Orange, CA

» Parkinson’s Disease: Assessment

1:00 p.m.–3:00 p.m. PT CME

Blanca Yvette Valdovinos, MD, Rochester, NY » Parkinson’s Disease: Management Faculty

Director(s): Deborah Hall, MD, PhD, FAAN, Chicago, IL 1:00 p.m.–3:00 p.m. PT

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

C69: Atypical Parkinsonism

CME

Director(s): Joan Miravite, FNP, New York, NY Learning Objectives: Participants should be able to demonstrate how to utilize each DBS programmer to make DBS setting changes; explain bipolar mode, monopolar mode, and fractionalization; and apply knowledge to troubleshoot during DBS programming sessions. Lecture/Faculty:

» Principles of Programming

Joan Miravite, FNP, New York, NY

» Using Abbott Programmer, PD Case

Director(s): Irene Litvan, MD, FAAN, La Jolla, CA

1:00 p.m.–5:30 p.m. PT

C51: Skills Workshop: Deep Brain Stimulation

CME

Learning Objectives: Participants should become familiar with the features to suspect the diagnosis of atypical Parkinsonian disorders; the features and clinical diagnostic criteria of the primary tauopathies progressive supranuclear palsy and corticobasal degeneration; and the features and clinical diagnostic to diagnose multiple system atrophy and its differentiation with dementia with Lewy Bodies and Parkinson disease. Lecture/Faculty:

» What is New in the Primary Tauopathies PSP and CBD? Irene Litvan, MD, FAAN, La Jolla, CA

» What is New in the Atypical Synucleonopathies: MSA and DLB? Faculty

Joan Miravite, FNP, New York, NY » Using Boston Scientific Programmer, ET Case Kelvin L. Chou, MD, FAAN, Ann Arbor, MI » Using Medtronic Programmer, Dystonia Case Alfonso Fasano, MD, PhD, Toronto, ON, Canada, Canada » Troubleshooting Alfonso Fasano, MD, PhD, Toronto, ON, Canada, Canada » Practical Considerations Kelvin L. Chou, MD, FAAN, Ann Arbor, MI

AAN.com/AM

MOVEMENT DISORDERS

C42: Update in Movement Disorder: Essential Tremor/Ataxia/Hyperkinetic Movement Disorders

= Learner Engagement Center

= New in 2022

3:30 p.m.–5:30 p.m. PT

7:00 a.m.–9:00 a.m. PT

C34: Update in Movement Disorder: Parkinson’s Disease/Atypical Parkinson’s Disease

= Additional Fee Required

SEATTLE PROGRAMS BY TOPIC 1:00 p.m.–5:30 p.m. PT

3:30 p.m.–5:30 p.m. PT

C77: Skills Workshop: EMG Guided Injections: Spasticity and Dystonia

CME

Director(s): Veronica E. Santini, MD, MA, El Granada, CA

Director(s): Marta San Luciano, MD, FAAN, San Francisco, CA

Learning Objectives: Participants should be able to analyze a patient examination with cervical and limb dystonia and limb spasticity to identify patients that may be treated with EMG guided chemodenervation; construct an appropriate treatment plan for a patient (including muscle selection, dosage determination, injection localization); and recognize important safety concerns and measures to mitigate these safety issues during injections. Lecture/Faculty:

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

» The Toxins and the Evidence (Toxins, Their Indications, and Their Dosage) Cynthia L. Comella, MD, FAAN, New Philadelphia, OH

» The Stepwise Approach to Chemodenervation for the Patient with

MOVEMENT DISORDERS

C105: The Dystonias: Diagnosis, Treatment, and Update on Etiologies

Cervical Dystonia, Limb Dystonia, or Limb Spasticity Veronica E. Santini, MD, MA, El Granada, CA Laurice T. Yang, MD, MHA, Palo Alto, CA Cynthia L. Comella, MD, FAAN, New Philadelphia, OH » Rotating Breakout Sessions: Cervical Dystonia Practicum, Limb Dystonia Practicum, Limb Spasticity Practicum Veronica E. Santini, MD, MA, El Granada, CA Laurice T. Yang, MD, MHA, Palo Alto, CA Cynthia L. Comella, MD, FAAN, New Philadelphia, OH 3:30 p.m.–5:30 p.m. PT

S15: Movement Disorders 1

CME

Tuesday, April 5 7:00 a.m.–9:00 a.m. PT

C86: Spinocerebellar and Spastic Ataxias: Diagnosis and Management

CME

Learning Objectives: Participants should become familiar with the differential diagnoses, work-up, and management of patients with spinocerebellar and spastic ataxias with particular attention to genetic testing, update on pathophysiology, and potential for new and genetic therapies. Lecture/Faculty: Oksana Suchowersky, MD, FAAN, Edmonton, AB, Canada » Pathogenetics and Potential Treatments Faculty

2022 AAN Annual Meeting

Wednesday, April 6 1:00 p.m.–3:00 p.m. PT

C123: Diagnosis and Treatment of Functional Movement Disorders

CME

Director(s): Alberto J. Espay, MD, FAAN, Cincinnati, OH Learning Objectives: Participants should be able to understand the principles underlying the diagnosis of functional movement disorders; formulate a rational utilization of electrophysiologic measures to support a laboratory-supported diagnosis of functional tremor and functional myoclonus; appraise the different evidencebased treatment strategies tailored for patients with functional movement disorders; be able to make a positive diagnosis of functional movement disorders; formulate a rational utilization of electrophysiologic measures to support the diagnosis in cases of functional tremor and functional myoclonus; and know how to organize a multidisciplinary approach to therapy. Lecture/Faculty:

» Diagnosis of Functional Movement Disorders Alberto J. Espay, MD, FAAN, Cincinnati, OH

» Laboratory-supported Diagnosis

Mark Hallett, MD, FAAN, Bethesda, MD » Treatment of Functional Movement Disorders Sarah C. Lidstone, MD, PhD, Toronto, ON, Canada, Canada

Director(s): Oksana Suchowersky, MD, FAAN, Edmonton, AB, Canada

» Clinical and Genetic Aspects of the SCAs and Spastic Ataxias

CME

3:30 p.m.–5:30 p.m. PT

C134: Maximizing Quality of Life in Stroke, ALS, Parkinson’s Disease, and Dementia: A Palliative Approach

CME

Director(s): Maisha T. Robinson, MD, MS, FAAN, Jacksonville, FL See learning objectives on page 65. 3:30 p.m.–5:30 p.m. PT

S31: Movement Disorders 2

CME

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

Thursday, April 7 2

Learning Objectives: Participants should understand new evidence explaining variable age at onset in Huntington’s and implications for genetic testing, apply a multidisciplinary approach to treatment for motor, cognitive, and psychiatric impairments across the lifespan, and critically evaluate pharmacological and nonpharmacological current and future clinical trials in HD. Lecture/Faculty:

» What’s New in Huntington’s Disease

Saturday, April 2 7:00 a.m.–9:00 a.m. PT

C6: Treatment of Pediatric MS In the Current Era Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

CME

See learning objectives on page 37. 7:00 a.m.–4:00 p.m. PT

C3: Neurology Update CME

CME

Director(s): Adam Quick, MD, Columbus, OH See learning objectives on page 37.

Sunday, April 3 CME

Director(s): Andres Felipe Deik Acosta Madiedo, MD, Philadelphia, PA Learning Objectives: Participants should become familiar with the most common movements affecting the craniocervical region, as well as with the clinical features that allow distinction amongst them; be able to elicit the testing maneuvers that allow the differentiation among the different types of hand tremor, as well as to distinguish tremor from its mimics; and be able to distinguish among the different gait patters present in patients with movements disorders. Lecture/Faculty:

7:00 a.m.–9:00 a.m. PT

C36: Multiple Sclerosis in the Trenches

CME

Director(s): Aaron E. Miller, MD, FAAN, New York, NY Learning Objectives: Participants should better understand and select DMTs in various circumstances; better understand the use of the McDonald Criteria and their limitations, as well as the new phenotypic descriptions used for MS; and better understand a variety of social and other medical situations that impact the management of people with MS. Lecture/Faculty:

» Case-based Discussion

Aaron E. Miller, MD, FAAN, New York, NY Stephen Krieger, MD, FAAN, New York, NY

3:30 p.m.–5:30 p.m. PT

S5: MS and CNS Inflammatory Disease 1

AAN.com/AM

CME

MS AND CNS INFLAMMATORY DISEASE

Director(s): Joseph E. Safdieh, MD, FAAN, New York, NY

3:30 p.m.–5:30 p.m. PT

Harini Sarva, MD, New York, NY » Abnormal Movements of the Upper Extremities Andres Felipe Deik Acosta Madiedo, MD, Philadelphia, PA » Gait Abnormalities and Abnormal Movements Affecting the Lower Extremities Claire Henchcliffe, MD, PhD, FAAN, Orange, CA

Director(s): Brenda Banwell, MD, FAAN, Philadelphia, PA

C2: Neurology Continuing Certification Prep Course

1:00 p.m.–3:00 p.m. PT

» Abnormal Movements of the Craniocervical Region

CME

7:00 a.m.–4:00 p.m. PT

Faculty » Genetic Modifiers of Age at Onset in HD: A Paradigm Shift Faculty » Multidisciplinary Approach to HD Care Across the Lifespan Faculty » Update on Clinical Trials in Huntington’s Disease Faculty

C161: Phenomenology

= Experiential Learning Area

CME

Director(s): Karen S. Marder, MD, MPH, FAAN, New York, NY

S36: Movement Disorders 3

= Learner Engagement Center

= New in 2022

MS AND CNS INFLAMMATORY DISEASE

7:00 a.m.–9:00 a.m. PT

C151: Movement Disorders: Huntington’s Disease

= Additional Fee Required

SEATTLE PROGRAMS BY TOPIC Monday, April 4

Wednesday, April 6

7:00 a.m.–9:00 a.m. PT

C63: COVID and MS

CME

Director(s): Jeffrey Alan Cohen, MD, Cleveland, OH Learning Objectives: Participants should become familiar with the effects of MS and disease-modifying therapies on the risk and severity of COVID-19, effects of MS disease-modifying therapies on humoral and cellular immune responses to SARS-CoV-2 vaccination, acute CNS inflammatory complications of COVID-19 and SARS-CoV-2 vaccination, and the long-term neurologic complications of COVID-19 focusing on those which overlap MS manifestations. Lecture/Faculty:

MS AND CNS INFLAMMATORY DISEASE

» Overview of the Interaction of COVID-19 and MS

CME

Director(s): Jacqueline Bernard, MD, FAAN, Portland, OR Learning Objectives: Participants should be comfortable with selecting DMTs based on risk stratification, including pregnancy and family planning for RRMS, SPMS, and PPMS; understand complications associated with approved DMTs in RRMS, SPMS, and PPMS; creating an algorithm for patients who break through therapies and no longer meet “NEDA” criteria; and the impact of COVID-19 disease and vaccination on DMT doses. Lecture/Faculty:

» Multiple Sclerosis Disease-modifying Treatment

Jeffrey Alan Cohen, MD, Cleveland, OH » Effects of MS DMTs on SARS-CoV-2 Vaccine Response Amit Bar-Or, MD, FRCPC, Philadelphia, PA » Long-term Neurologic Symptoms of COVID-19 Lara Jehi, MD, Cleveland, OH

Jacqueline Bernard, MD, FAAN, Portland, OR

9:15 a.m.–11:30 a.m. PT

Frontiers in Neuroscience Plenary Session

3:30 p.m.–5:30 p.m. PT

S13: MS and CNS Inflammatory Disease 2

CME

Tuesday, April 5

CME

» Roles of Astrocytes in CNS Inflammation Francisco J. Quintana, PhD, Boston, MA

7:00 a.m.–9:00 a.m. PT

C87: Multiple Sclerosis Overview

CME

Director(s): Augusto A. Miravalle, MD, FAAN, Fort Collins, CO

1:00 p.m.–3:00 p.m. PT

S25: MS and CNS Inflammatory Disease 4

Learning Objectives: Participants will review current criteria for the diagnosis of multiple sclerosis; discuss common differential diagnoses of relapsing demyelinating CNS disorders; understand basic principles behind the selection process of disease-modifying therapies in MS; understand how the use of disease-modifying therapies influences response to COVID-19 vaccination; and review non-pharmacological approaches to maximize brain health in MS. Lecture/Faculty:

CME

3:30 p.m.–5:30 p.m. PT

C135: MS Across the Lifespan/Pregnancy and Breastfeeding in MS

CME

Director(s): Le Hua, MD, FAAN, Las Vegas, NV

» Diagnosing MS: Current Guidelines and Clinical Pitfalls Amanda Lee Piquet, MD, Aurora, CO

» Selecting Disease Modifying Therapies: Navigating a Crowded Market Augusto A. Miravalle, MD, FAAN, Fort Collins, CO

» COVID-19 and MS: Practical Considerations

Joseph R. Berger, MD, FAAN, Philadelphia, PA

Learning Objectives: Participants should be able to recognize the various treatment considerations for patients at different ages; identify the changes in biological processes that contribute to MS inflammation and neurodegeneration throughout the lifespan; and become familiar with pregnancy and breastfeeding counseling for patients with MS. Lecture/Faculty:

» MS Treatment and Management Considerations Across the Lifespan Le Hua, MD, FAAN, Las Vegas, NV

1:00 p.m.–3:00 p.m. PT

S18: MS and CNS Inflammatory Disease 3

C117: Multiple Sclerosis Disease-modifying Treatment

CME

» Biological Changes in MS Across the Lifespan Jennifer Graves, MD, PhD, San Diego, CA

» Pregnancy and Breastfeeding in MS

Kristen M. Krysko, MD, Toronto, ON, Canada

2022 AAN Annual Meeting

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

Thursday, April 7 CME

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available. 3:30 p.m.–5:30 p.m. PT CME

Director(s): Panayiotis N. Varelas, MD, PhD, FAAN, Albany, NY Learning Objectives: Participants should become familiar with the process of conducting a complete BD evaluation, be able to address difficult cases and avoid pitfalls leading to false declarations, and be aware of state laws and hospital policies when discussing with families of the deceased, especially in cases of denial or accommodation. Lecture/Faculty:

» Brain Death: How to Perform an Exam

David M. Greer, MD, FAAN, Boston, MA

» Brain Death: Special Situations (Hypothermia, ECMO, Post Fossa

Monday, April 4

7:00 a.m.–9:00 a.m. PT CME

Director(s): Jana Wold, MD, Salt Lake City, UT

C74: Neurologic Intensive Care: Vascular Disease

CME

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

» The Dark Side of Emerging Cancer Therapies

Faculty » Delirium Management for the Neurohospitalist Faculty

3:30 p.m.–5:30 p.m. PT

C83: Neurologic Intensive Care: Brain and Acute Spinal Cord Injury and Neuromuscular Disease

CME

Director(s): Kristine H. O’Phelan, MD, Miami, FL

1:00 p.m.–3:00 p.m. PT CME

Director(s): Katharina M. Busl, MD, MS, FAAN, Gainesville, FL Learning Objectives: Participants should get a review of essential diseases and syndromes encountered in neurocritical care; classify syndromes, recognize emergencies, apply treatment algorithms, and choose work-up. The course will utilize a combination of brief topic reviews and case-based scenarios to allow participants to organize scientific basis of various neurocritical disease processes and formulate management plans. Lecture/Faculty: Carolina B. Maciel, MD, MSCR, Gainesville, FL » Critical Care Essentials Faculty » Critical Care Essentials Katharina M. Busl, MD, MS, FAAN, Gainesville, FL

1:00 p.m.–3:00 p.m. PT

Director(s): Lori A. Shutter, MD, FCCM, FNCS, Pittsburgh, PA

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available. Lecture/Faculty:

» Critical Care Essentials

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

Tuesday, April 5 1:00 p.m.–3:00 p.m. PT

N4: Neuroscience in the Clinic: Neuroscience of Coma and Consciousness in the Clinic

CME

Director(s): Holly E. Hinson, MD, MCR, FAAN, Portland, OR Shraddha Mainali, MD, Richmond, VA 1:00 p.m.–3:00 p.m. PT

S20: Neurocritical Care

CME

AAN.com/AM

NEURO TRAUMA AND CRITICAL CARE

Sunday, April 3

C49: Neurointensive Care: The Essentials

CME

Lesions, Alternative Apnea Tests etc) Panayiotis N. Varelas, MD, PhD, FAAN, Albany, NY » Brain Death and the Law Ariane Lewis, MD, New York, NY

NEURO TRAUMA AND CRITICAL CARE

C38: Critical Care Consultations for Neurohospitalists

= Experiential Learning Area

C52: Brain Death

Director(s): Dean M. Wingerchuk, MD, FAAN, Scottsdale, AZ

S39: MS and CNS Inflammatory Disease 5

= Learner Engagement Center

= New in 2022

3:30 p.m.–5:30 p.m. PT

7:00 a.m.–9:00 a.m. PT

C143: Neuromyelitis Optica Spectrum Disorders

= Additional Fee Required

SEATTLE PROGRAMS BY TOPIC Thursday, April 7

Monday, April 4

1:00 p.m.–5:30 p.m. PT

7:00 a.m.–9:00 a.m. PT

C160: Skills Workshop: Brain Death: How to Perform a Brain Death Evaluation, Avoid Pitfalls, and Convey the News to the Family

CME

Learning Objectives: Participants should learn the proper methods of determining death by neurological criteria, as well as become familiar with the areas of controversy, strict methods of clinical testing including apnea testing, as well as when to get an ancillary test and how to interpret it. Lecture/Faculty:

» Brain Death Evaluation Lecture with Video Demonstrations

NEURO-ONCOLOGY

CME

Director(s): Nimish A. Mohile, MD, FAAN, Rochester, NY

Director(s): David M. Greer, MD, FAAN, Boston, MA

David M. Greer, MD, FAAN, Boston, MA » Difficult Cases - Vignettes Ariane Lewis, MD, New York, NY » Manikin Simulation Panayiotis N. Varelas, MD, PhD, FAAN, Albany, NY David M. Greer, MD, FAAN, Boston, MA Matthew Kirschen, MD, PhD, Philadelphia, PA » How to Approach Families and What to Tell Them - Accommodation and Difficult Discussions Ariane Lewis, MD, New York, NY 1:00 p.m.–3:00 p.m. PT

C159: Palliative Care in the Neuro ICU

C64: Core Principles of Brain Tumors

CME

Director(s): Mara Lugassy, MD, Valhalla, NY Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

Learning Objectives: Participants should receive a primer on the classification, oncologic multi-disciplinary treatment, neurologic care, supportive and palliative care for patients with adult gliomas. Faculty will provide an update on tumor classification, an overview of principles of oncologic treatment, and updates regarding recent clinical trials. Management of neurologic and medical complications will be discussed in addition to principles of palliative care. Lecture/Faculty:

» Classification of Adult Brain Tumors: WHO 2021 Nimish A. Mohile, MD, FAAN, Rochester, NY

» Treatment of Adult-type Gliomas

Jennie W. Taylor, MD, San Francisco, CA

» Medical and Neurologic Care of Patients with Brain Tumors

Nimish A. Mohile, MD, FAAN, Rochester, NY » Palliative and Supportive Care for Patients with Brain Tumors Faculty 1:00 p.m.–3:00 p.m. PT

C73: Neuro-oncology: Navigating Current Trends

CME

Director(s): Maciej M. Mrugala, MD, PhD, MPH, FAAN, Scottsdale, AZ Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available. 3:30 p.m.–5:30 p.m. PT

C80: Child Neurology: Neuro-oncology

NEURO-ONCOLOGY

CME

Director(s): Sonia Partap, MD, Palo Alto, CA See learning objectives on page 32.

Saturday, April 2 7:00 a.m.–4:00 p.m. PT

C2: Neurology Continuing Certification Prep Course

CME

Director(s): Joseph E. Safdieh, MD, FAAN, New York, NY See learning objectives on page 37. 7:00 a.m.–4:00 p.m. PT

C3: Neurology Update

CME

Director(s): Adam Quick, MD, Columbus, OH See learning objectives on page 37.

2022 AAN Annual Meeting

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

= Additional Fee Required

= Learner Engagement Center

Tuesday, April 5

= New in 2022

= Experiential Learning Area

Sunday, April 3

1:00 p.m.–3:00 p.m. PT

7:00 a.m.–9:00 a.m. PT

C97: Neurologic Complications of Novel Antineoplastic Therapies Including Immunotherapy

CME

C37: Neuro-ophthalmology 1: Visual Loss, Optic Neuropathies, and Papilledema

Director(s): Yazmin Odia, MD, FAAN, MS, Miami, FL

Director(s): Nancy J. Newman, MD, FAAN, Atlanta, GA

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available Lecture/Faculty:

Learning Objectives: Participants should become familiar with the diagnosis, evaluation, and treatment of common afferent neuro-ophthalmic problems. This program complements Neuroophthalmology 2: Optic Neuritis, Visual Fields, and Anisocoria & Neuro-ophthalmology 3: Diplopia, Ocular Motility Disorders, and Nystagmus but covers independent topics. Lecture/Faculty:

» Complications of Cytotoxic, Biologic, and Hormone Therapies Na Tosha N. Gatson, MD, PhD, FAAN, Phoenix, AZ

» Complications of Immunotherapies

Nancy J. Newman, MD, FAAN, Atlanta, GA Nancy J. Newman, MD, FAAN, Atlanta, GA

» Papilledema

Valerie Biousse, MD, Atlanta, GA

7:00 a.m.–9:00 a.m. PT CME

C45: Neuro-ophthalmology 2: Optic Neuritis, Visual Fields, and Anisocoria

CME

NEURO-OPHTHALMOLOGY/ NEURO-OTOLOGY

Learning Objectives: Participants should become familiar with the diagnosis, evaluation, and treatment of common afferent and efferent neuro-ophthalmic problems. This program complements Neuroophthalmology 1: Visual Loss, Optic Neuropathies, and Papilledema & Neuro-ophthalmology 3: Diplopia, Ocular Motility Disorders, and Nystagmus but covers independent topics. Lecture/Faculty: Nancy J. Newman, MD, FAAN, Atlanta, GA

» Management of Optic Neuritis

Steven Galetta, MD, FAAN, New York, NY

» Case 2

7:00 a.m.–4:00 p.m. PT

See learning objectives on page 37.

» Case 1

Saturday, April 2

Director(s): Joseph E. Safdieh, MD, FAAN, New York, NY

CME

Director(s): Valerie Biousse, MD, Atlanta, GA

1:00 p.m.–3:00 p.m. PT

C2: Neurology Continuing Certification Prep Course

1:00 p.m.–3:00 p.m. PT

CME

Nancy J. Newman, MD, FAAN, Atlanta, GA » Visual Fields Nancy J. Newman, MD, FAAN, Atlanta, GA » Case 3 and Discussion Valerie Biousse, MD, Atlanta, GA » Case 4 Valerie Biousse, MD, Atlanta, GA » Anisocoria Steven Galetta, MD, FAAN, New York, NY » Case 5 Valerie Biousse, MD, Atlanta, GA » Case 6 Nancy J. Newman, MD, FAAN, Atlanta, GA

AAN.com/AM

NEURO-OPHTHALMOLOGY/NEURO-OTOLOGY

» Optic Neuropathies

Wednesday, April 6

S26: Neuro-oncology

» Visual Loss

Reena Parada Thomas, MD, Palo Alto, CA » Complications of Radiation and Multimodal Therapies Yazmin Odia, MD, FAAN, MS, Miami, FL

C118: Neurologic Consultations in Cancer Patients

CME

SEATTLE PROGRAMS BY TOPIC Monday, April 4

3:30 p.m.–5:30 p.m. PT

C56: Neuro-ophthalmology 3: Diplopia, Ocular Motility Disorders, and Nystagmus

CME

Director(s): Steven Galetta, MD, FAAN, New York, NY Learning Objectives: Participants should become familiar with the diagnosis, evaluation, and treatment of common efferent neuro-ophthalmic problems. This program complements Neuroophthalmology 1: Visual Loss, Optic Neuropathies, and Papilledema & Neuro-ophthalmology 2: Optic Neuritis, Visual Fields, and Anisocoria but covers independent topics. Lecture/Faculty:

» Case 1

Valerie Biousse, MD, Atlanta, GA

NEURO-OPHTHALMOLOGY/NEURO-OTOLOGY

» Those Other Causes of Diplopia

Nancy J. Newman, MD, FAAN, Atlanta, GA

» Case 2

Valerie Biousse, MD, Atlanta, GA » Supranuclear and Internuclear Ocular Motility Disorders Steven Galetta, MD, FAAN, New York, NY » Case 3 Valerie Biousse, MD, Atlanta, GA » Nystagmus Steven Galetta, MD, FAAN, New York, NY » Case 4 Nancy J. Newman, MD, FAAN, Atlanta, GA » Assorted Cases Valerie Biousse, MD, Atlanta, GA Nancy J. Newman, MD, FAAN, Atlanta, GA

3:30 p.m.–5:30 p.m. PT

C81: Higher Cortical Visual Disorders: Case-based Review

CME

Director(s): Marc Dinkin, MD, New York, NY Learning Objectives: Participants should become familiar with the diagnosis, localization, management, and neuroscientific understanding of disorders of visual processing. Lecture/Faculty:

» Central Hemiachromatopsia

Marc Dinkin, MD, New York, NY » Visual Agnosia Sashank Prasad, MD, Boston, MA » Alexia without Agraphia Marc Dinkin, MD, New York, NY » Riddoch Phenomenon Sashank Prasad, MD, Boston, MA » Prosopagnosia Marc Dinkin, MD, New York, NY » Capgras Syndrome Sashank Prasad, MD, Boston, MA » Balint Syndrome Marc Dinkin, MD, New York, NY » Peduncular Hallucinosis Sashank Prasad, MD, Boston, MA » Charles Bonnet Syndrome Marc Dinkin, MD, New York, NY

Tuesday, April 5 3:30 p.m.–5:30 p.m. PT

C108: Pediatric Neuro-ophthalmology

CME

Director(s): Christopher Glisson, DO, FAAN, Grand Rapids, MI See learning objectives on page 32. 3:30 p.m.–5:30 p.m. PT

C111: Continuum® Test Your Knowledge: A Multiplechoice Question Review 2

SA-CME

Director(s): Ralph F. Jozefowicz, MD, FAAN, Rochester, NY See learning objectives on page 42.

2022 AAN Annual Meeting

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

Wednesday, April 6

= Learner Engagement Center

= New in 2022

= Experiential Learning Area

NEURO-REHABILITATION

7:00 a.m.–9:00 a.m. PT

C114: Emergency Room Neuro-ophthalmology

= Additional Fee Required

CME

Saturday, April 2

Director(s): Heather Moss, MD, PhD, FAAN, Palo Alto, CA Learning Objectives: Participants should be familiar with the clinical presentation, evaluation, and management of common neuro-ophthalmic symptoms, signs, and conditions that present in the emergency department, including loss of vision, double vision, optic nerve swelling, ocular misalignment, anisocoria, nystagmus, fulminant pseudotumor cerebri, giant cell arteritis, third nerve palsy secondary to aneurysm, cerebral venous thrombosis, and pituitary apoplexy. Lecture/Faculty:

» What Am I Looking For? Navigating the Ocular Fundus Exam

7:00 a.m.–9:00 a.m. PT

C8: Cutting-edge Neuro-rehabilitation

Director(s): A. M. Barrett, MD, FAAN, Atlanta, GA Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available. 2:45 p.m.–4:45 p.m. PT

C22: Rehabilitation in Neurology

Devin Dean Mackay, MD, Indianapolis, IN » OMG, I Can’t See! Approach to Acute Vision Loss Heather Moss, MD, PhD, FAAN, Palo Alto, CA » How Do I Describe This? Abnormal Eye Movements Devin Dean Mackay, MD, Indianapolis, IN » Double Trouble. Approach to Diplopia Heather Moss, MD, PhD, FAAN, Palo Alto, CA

CME

Director(s): Neeta Garg, MD, Miami, FL

» Symptom Management and Neuromodulation for Motor Functional

1:00 p.m.–5:30 p.m. PT

C133: Skills Workshop: Neuro-ophthalmology

CME

Director(s): Faculty Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

Thursday, April 7

1:00 p.m.–3:00 p.m. PT

C152: Neuro-otology

Restoration Faculty » Overview of Spasticity and Bladder Management Neeta Garg, MD, Miami, FL » Neural Repair: Biological Strategies for Spinal Cord Repair and Advances in Neuroplasticity Neeta Garg, MD, Miami, FL

CME

Director(s): Terry D. Fife, MD, FAAN, Phoenix, AZ Learning Objectives: Participants should be able to recognize and distinguish vestibular migraine, PPPD, acute vestibular syndrome, and BPPV, and to be familiar with orthostatic dizziness, superior canal dehiscence syndrome, persistent mal de debarquement syndrome, and vestibular paroxysmia. Lecture/Faculty:

Sunday, April 3

C46: Neuro-rehabilitation Update

CME

Director(s): Faculty Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

Tuesday, April 5 1:00 p.m.–3:00 p.m. PT

» Acute Vestibular Syndrome, Benign Paroxysmal Positional Vertigo (BPPV) Faculty

C102: Continuum® Test Your Knowledge: A Multiplechoice Question Review 1

» Vestibular Migraine, Persistent Postural-perceptual Dizziness

Director(s): Ralph F. Jozefowicz, MD, FAAN, Rochester, NY

Kristen K. Steenerson, MD, Stanford, CA

See learning objectives on page 42.

» Orthostatic Hypotension & Other Causes of Dizziness

SA-CME

Terry D. Fife, MD, FAAN, Phoenix, AZ

3:30 p.m.–5:30 p.m. PT

IS4: Invited Science: Neuro-ophthalmology

CME

AAN.com/AM

NEURO-REHABILITATION

Learning Objectives: Participants should become familiar with the advances in clinical management of patients with spinal cord disorders including advances in rehabilitation technologies and neural repair strategies. Lecture/Faculty:

SEATTLE PROGRAMS BY TOPIC Sunday, April 3

NEUROMUSCULAR AND CLINICAL NEUROPHYSIOLOGY (EMG)

7:00 a.m.–9:00 a.m. PT

C33: Peripheral Neuropathy: Neuropathies Associated with Rheumatologic and Hematologic Disorders

Saturday, April 2 7:00 a.m.–4:00 p.m. PT

C2: Neurology Continuing Certification Prep Course

CME

Director(s): Joseph E. Safdieh, MD, FAAN, New York, NY

NEUROMUSCULAR AND CLINICAL NEUROPHYSIOLOGY (EMG)

See learning objectives on page 37. 7:00 a.m.–4:00 p.m. PT

C3: Neurology Update

CME

Director(s): Adam Quick, MD, Columbus, OH

12:15 p.m.–2:15 p.m. PT

C15: Neuromuscular Junction Disorders: Myasthenia Gravis, Ocular, and MuSK Myasthenia

CME

Director(s): Srikanth Muppidi, MD, FAAN, Stanford, CA Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

Director(s): A. Gordon Smith, MD, FAAN, Richmond, VA Learning Objectives: Participants should be able to accurately diagnose and manage patients with peripheral neuropathies related to monoclonal gammopathies and myeloma, vasculitis and rheumatologic disease, and diabetic and non-diabetic radiculoplexus neuropathies. This program complements Peripheral Neuropathy: Anatomical Basis and Acquired Demyelinating Neuropathies but covers independent topics. Lecture/Faculty:

C29: Case Studies: Diagnosis and Management of Unusual Cases in Neuromuscular Disease

Faculty » Vasculitic Neuropathies Faculty » Peripheral Neuropathy due to Rheumatologic Disease Faculty » Diabetic and Non-diabetic Radiculopexus Neuropathy A. Gordon Smith, MD, FAAN, Richmond, VA 1:00 p.m.–3:00 p.m. PT

6:15 p.m.–8:15 p.m. PT CME

Director(s): Robert M. Pascuzzi, MD, FAAN, Indianapolis, IN Learning Objectives: Participants should become familiar with a broad range of uncommon or unusual neuromuscular care presentations, and become familiar with a variety of approaches to management of the difficult patient. Key summary points will be supplemented by insights, pearls, and tips from the faculty panel as well as novel opinions from audience members. Participants should expect the session to enhance and enrich their diagnostic skills and management armamentarium. Lecture/Faculty: Robert M. Pascuzzi, MD, FAAN, Indianapolis, IN

» Neuropathies Associated with MGUS and Myeloma

See learning objectives on page 37.

» Neuromuscular Case Presentations

CME

C41: Peripheral Neuropathy: Anatomical Basis and Acquired Demyelinating Neuropathies

CME

Director(s): Mamatha Pasnoor, MD, FAAN, Kansas City, KS Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available. This program complements Peripheral Neuropathy: Neuropathies Associated with Rheumatologic and Hematologic Disorders but covers independent topics. 3:30 p.m.–5:30 p.m. PT

C53: Child Neurology: Neuromuscular and Movement Disorders

CME

Director(s): Anne M. Connolly, MD, FAAN, Columbus, OH See learning objectives on page 32. 3:30 p.m.–5:30 p.m. PT

C59: COVID-19 and Neuromuscular Disorders

CME

Director(s): Pushpa Narayanaswami, MBBS, MD, FAAN, Boston, MA See learning objectives on page 50.

2022 AAN Annual Meeting

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

Monday, April 4 CME

CME

Director(s): Eva Feldman, MD, PhD, FAAN, Ann Arbor, MI

» The Diagnosis and Management of ALS in 2022

Director(s): Daniel Pastula, MD, MHS, Aurora, CO Learning Objectives: Participants should understand the concept of emerging infections; various emerging viruses, bacteria, fungi, and parasites that can infect the human nervous system; and the importance of preventing and responding to such potential emerging threats. Lecture/Faculty:

» Introduction and Emerging Viruses

Daniel Pastula, MD, MHS, Aurora, CO

» Emerging Bacteria, Fungi, and Parasites Felicia Chow, MD, San Francisco, CA

» Preventing and Responding to the Next Emerging Threat Faculty

Faculty » Telehealth and ALS: A Look Toward the Future Zachary Simmons, MD, FAAN, Hershey, PA » Current and Emerging Clinical Trials in ALS Eva Feldman, MD, PhD, FAAN, Ann Arbor, MI

1:00 p.m.–5:30 p.m. PT

C104: Skills Workshop: EMG/Nerve Conduction

CME

Director(s): Holli Ann Horak, MD, FAAN, Tucson, AZ

Tuesday, April 5 1:00 p.m.–3:00 p.m. PT CME

Director(s): Paola Sandroni, MD, PhD, FAAN, Rochester, MN Learning Objectives: Participant should be more comfortable in recognizing autonomic disorders, differentiating them from other conditions, identifying at least the most common peripheral and central autonomic disorders, and be able to identify how to best evaluate the patient and manage their symptoms. Lecture/Faculty:

Learning Objectives: Participants should have a greater understanding of normal NCS/EMG; improved techniques for obtaining accurate data; an improved ability to recognize and eliminate artifacts; obtain accurate nerve conduction and electromyography results; identify technical factors that affect obtaining data; and read and interpret data—differentiating normal from abnormal findings. Lecture/Faculty:

» Sensory Nerve Conduction Studies

Holli Ann Horak, MD, FAAN, Tucson, AZ

» Motor Nerve Conduction Studies

Jun Kimura, MD, FAAN, Iowa City, IA

» Late Responses and Repetitive Stimulation

» Autonomic Testing: Overview and Case Presentation

Divya Singhal, MD, FAAN, San Antonio, TX » Needle Electromyography Devon I. Rubin, MD, FAAN, Jacksonville, FL

Paola Sandroni, MD, PhD, FAAN, Rochester, MN » Autonomic Neuropathies: Overview and Case Discussion Guillaume Lamotte, MD, Salt Lake City, UT » Central Autonomic Disorders Elizabeth A. Coon, MD, Rochester, MN

3:30 p.m.–5:30 p.m. PT

S22: Neuromuscular and Clinical Neurophysiology (EMG) 2

1:00 p.m.–3:00 p.m. PT

C102: Continuum® Test Your Knowledge: A Multiplechoice Question Review 1

CME

SA-CME

Director(s): Ralph F. Jozefowicz, MD, FAAN, Rochester, NY See learning objectives on page 42.

AAN.com/AM

NEUROMUSCULAR AND CLINICAL NEUROPHYSIOLOGY (EMG)

Learning Objectives: Participants should become familiar with ALS diagnostics, management in the telehealth era, and the latest clinical trials. Lecture/Faculty:

C95: Evaluation and Management of Autonomic Disorders: Autonomic Testing, Failure, and Peripheral Neuropathies

= Experiential Learning Area

C98: Emerging Neuroinfectious Disease

3:30 p.m.–5:30 p.m. PT

C79: Motor Neuron Disease

= Learner Engagement Center

= New in 2022

1:00 p.m.–3:00 p.m. PT

S10: Neuromuscular and Clinical Neurophysiology (EMG) 1

= Additional Fee Required

SEATTLE PROGRAMS BY TOPIC Wednesday, April 6

1:00 p.m.–3:00 p.m. PT

7:00 a.m.–9:00 a.m. PT

C115: Clinical Approach to Muscle Disease: Role of Antibodies, Muscle Imaging, and Genetic Testing

CME

NEUROMUSCULAR AND CLINICAL NEUROPHYSIOLOGY (EMG)

Director(s): Margherita Milone, MD, FAAN, Rochester, MN Learning Objectives: Participants should appropriately utilize myositis-specific antibodies in clinical practice for both diagnostic and therapeutic purposes. Participants should become familiar with imaging studies that are commonly used in the diagnostic evaluation of muscle diseases. Participants should recognize imaging features that characterize acquired and inherited myopathies. Participants should become familiar with the spectrum of genetic tests and their limitations in the diagnosis of muscle diseases. Participants should recognize implications of genetic findings in patient care. This program complements Clinical Approach to Muscle Disease: Inflammatory Myopathies and Muscle Pathology but covers independent topics. Lecture/Faculty:

» Role of Antibodies in Muscle Diseases Faculty

» Role of Muscle Imaging in Muscle Diseases

Learning Objectives: Participants should better understand the clinical, laboratory, and histopathology of the idiopathic inflammatory myopathies (IIMs): PM, IBM, IMNM, DM, and overlap syndrome; better understand updated advances in the pathogenesis of the IIM; and better understand updated treatment strategies and clinical research studies in the IIMs. This program complements Clinical Approach to Muscle Disease: Role of Antibodies, Muscle Imaging, and Genetic Testing but covers independent topics. Lecture/Faculty:

» Inclusion Body Myositis and Polymyositis

Anthony A. Amato, MD, FAAN, Boston, MA

» Dermatomyostis and Overlap Syndrome

Mazen M. Dimachkie, MD, FAAN, Kansas City, KS

» Immune-Mediated Necrotizing Myopathy

Andrew Mammen, MD, PhD, Bethesda, MD

CME

3:30 p.m.–5:30 p.m. PT CME

Frontiers in Neuroscience Plenary Session

» Mapping the ALS Exposome: A Step Towards Prevention

2022 AAN Annual Meeting

Director(s): Mazen M. Dimachkie, MD, FAAN, Kansas City, KS

S28: Neuromuscular and Clinical Neurophysiology (EMG) 3

9:15 a.m.–11:30 a.m. PT

CME

1:00 p.m.–3:00 p.m. PT

Faculty » Role of Genetic Testing in Muscle Diseases Margherita Milone, MD, FAAN, Rochester, MN

Eva Feldman, MD, PhD, FAAN, Ann Arbor, MI

C124: Clinical Approach to Muscle Disease: Inflammatory Myopathies and Muscle Pathology

C134: Maximizing Quality of Life in Stroke, ALS, Parkinson’s Disease, and Dementia: A Palliative Approach

CME

Director(s): Maisha T. Robinson, MD, MS, FAAN, Jacksonville, FL See learning objectives on page 65. 3:30 p.m.–4:00 p.m. PT

S29: Autonomic Disorders

CME

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

Thursday, April 7

= Learner Engagement Center

CME

1:00 p.m.–1:50 p.m. PT

Learning Objectives: Participants should understand the utility of nerve conduction studies (NCS) in the evaluation of neuromuscular diseases; recognize the different patterns of NCS findings and how they correlate with various neuromuscular pathologies; recognize and improve technical issues that may impact the interpretation of NCS; learn the skills necessary to recognize different needle EMG waveforms; and recognize the significant and interpretation of various spontaneous and voluntary EMG waveforms. This program complements Clinical EMG 2: Case-based Clinical Applications of Nerve Conduction Studies and Needle Electromyography but covers independent topics. Lecture/Faculty:

S9: Pain and Palliative Care

» Nerve Conduction Studies – Utility, Pitfalls, and Practical Findings Devon I. Rubin, MD, FAAN, Jacksonville, FL

3:30 p.m.–5:30 p.m. PT CME

Director(s): Ruple S. Laughlin, MD, FAAN, Rochester, MN Learning Objectives: Participants should be able to demonstrate how to approach a neuromuscular patient electrodiagnostically and utilize nerve conduction studies and needle examination to evaluate suspected peripheral neuropathy, myopathy, radiculopathies, and neuromuscular junction disorders. This program complements Clinical EMG 1: Principles and Practice of NCS and Needle EMG but covers independent topics. Lecture/Faculty:

CME

.75

Wednesday, April 6 1:00 p.m.–3:00 p.m. PT

C127: Lumbar Radiculopathy, Lumbar Spinal Stenosis, Low Back Pain, and Failed Back Syndrome

CME

Director(s): Ligia Viorela Onofrei, MD, Salt Lake City, UT Learning Objectives: Participants should become familiar with evidence-based recommendations for diagnostic testing and treatment of common lumbar spine disorders, including when to obtain advanced imaging, when and what kind of spine injections to order, the appropriate use of opioid analgesics for acute and chronic low back and radicular lower limb pain, and when to recommend lumbar spine surgery. Participants should also become familiar with the evidence behind novel interventions, including spinal cord stimulation and basivertebral nerve ablation. Lecture/Faculty:

» Presentation and Cases

Ligia Viorela Onofrei, MD, Salt Lake City, UT

3:30 p.m.–5:30 p.m. PT

C134: Maximizing Quality of Life in Stroke, ALS, Parkinson’s Disease, and Dementia: A Palliative Approach

CME

Director(s): Maisha T. Robinson, MD, MS, FAAN, Jacksonville, FL Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

Ruple S. Laughlin, MD, FAAN, Rochester, MN

» Case-Based EDX Applications: Radiculopathy and Plexopathy Devon I. Rubin, MD, FAAN, Jacksonville, FL

» Case-Based EDX Application: NMJ and Myopathy Kelly G. Gwathmey, MD, Henrico, VA

AAN.com/AM

PAIN AND PALLIATIVE CARE

Ruple S. Laughlin, MD, FAAN, Rochester, MN

» Needle EMG Findings in Neuromuscular Diseases

» Case-Based EDX Applications in Neuropathy

= Experiential Learning Area

Monday, April 4

Director(s): Devon I. Rubin, MD, FAAN, Jacksonville, FL

C162: Clinical EMG 2: Case-based Clinical Applications of Nerve Conduction Studies and Needle Electromyography

= New in 2022

PAIN AND PALLIATIVE CARE

1:00 p.m.–3:00 p.m. PT

C153: Clinical EMG 1: Principles and Practice of NCS and Needle EMG

= Additional Fee Required

SEATTLE PROGRAMS BY TOPIC Sunday, April 3

Thursday, April 7 7:00 a.m.–9:00 a.m. PT

1:00 p.m.–3:00 p.m. PT

C148: Core Concepts in Pain Management: Safe and Appropriate Opioid Prescribing in Neurology

CME

Director(s): Gil I. Wolfe, MD, FAAN, Buffalo, NY

Director(s): Kavita Nair, PhD, Aurora, CO

Learning Objectives: Participants should understand the principles and challenges behind the management of neuropathic pain related to peripheral nervous system disorders. A summary of neuropathic pain mechanisms, the rationality of combination therapy to address different mechanisms of action, and costs related to opiate use and painful diabetic neuropathy will be presented. Participants should be made aware of pharmacological and alternative approaches in managing these challenging patient issues. Lecture/Faculty:

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

» Core Concepts in Pain Management

CME

Tuesday, April 5 8:00 a.m.–8:30 a.m. PT

Live Well: Fireside Chat: So You’ve Been Sued— Handling Litigation Speaker(s): Jennifer Bickel, MD, FAAN, Tampa, FL

Gil I. Wolfe, MD, FAAN, Buffalo, NY Nicholas Joseph Silvestri, MD, FAAN, Buffalo, NY

PRACTICE, POLICY, AND ETHICS

C48: Blockbuster or Bankrupt: A Debate on When to Use New Drugs

1:00 p.m.–3:00 p.m. PT

C159: Palliative Care in the Neuro ICU

CME

Director(s): Mara Lugassy, MD, Valhalla, NY

C112: How to Run a Practice: Business Strategies for Neurology Private Practices and the Future

See learning objectives on page 58.

CME

Director(s): David A. Evans, MBA, Dallas, TX

PRACTICE, POLICY, AND ETHICS

Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

Saturday, April 2 2:45 p.m.–4:45 p.m. PT

C26: Basics of Coding: E&M, Procedures, Telehealth, and New Codes

CME

Director(s): Korwyn Williams, MD, PhD, FAAN, Phoenix, AZ Learning Objectives: Participants should be confident in billing appropriately for in-person evaluation and management (E/M) services, digital E/M, audio-visual services, e-consults, and remote patient monitoring. Lecture/Faculty:

» What You Don’t Want to Hear about (But Will Thank Us for Afterwards) Korwyn Williams, MD, PhD, FAAN, Phoenix, AZ » E&M Coding/Billing Pearls Meghan Ashley Ward, MD, Norwich, CT » Procedures and Telehealth Codes You’re Not Using Brian T. Cabaniss, MD, Atlanta, GA » Low-Hanging Fruit You Should Consider Billing Korwyn Williams, MD, PhD, FAAN, Phoenix, AZ

2022 AAN Annual Meeting

7:00 a.m.–9:00 a.m. PT

Thursday, April 7

C150: Leveraging Quality Improvement to Help Your Patients and Your Practice, Too

CME

Director(s): Anup D. Patel, MD, FAAN, Columbus, OH Learning Objectives: Participants should understand the basics of quality improvement (QI); be able to describe how quality measures are created, updated, and retired; and provide examples of how QI methodology can be used to improve baselines using existing AAN quality measures. Lecture/Faculty:

» Overview of Quality Improvement

Lidia Maria Veras Rocha Moura, MD, FAAN, Boston, MA

» How AAN Quality Measures are Developed and Used in QI Laurice T. Yang, MD, MHA, Palo Alto, CA

» Examples of How to Implement AAN QM Using QI Methodology Anup D. Patel, MD, FAAN, Columbus, OH Lidia Maria Veras Rocha Moura, MD, FAAN, Boston, MA Laurice T. Yang, MD, MHA, Palo Alto, CA

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

RESEARCH METHODOLOGY AND EDUCATION 7:00 a.m.–12:15 p.m. PT

= New in 2022

= Experiential Learning Area

= Learner Engagement Center 1:30 p.m.–4:30 p.m. PT

LEC

Research Connections: Implementation Science: How to Translate Policy into Real-world Change

Saturday, April 2

C1: Clerkship and Program Directors Conference

= Additional Fee Required

CME

Speaker(s): Holly E. Hinson, MD, MCR, FAAN, Portland, OR Carolina B. Maciel, MD, MSCR, Gainesville, FL Marisela E. Dy-Hollins, MD, MSCR, Boston, MA

Learning Objectives: Implementation science is the study of practice change in the “real-world”, including developing strategies Learning Objectives: Faculty are in the process of developing this for overcoming barriers to the adoption, adaptation, integration, program. Please continue to check AAN.com as details will be updated scale-up, and sustainability of evidence-based interventions, tools, as they become available. policies, and guidelines. Implementation can be used to study nearly any topic, but a special focus will be placed on addressing health 12:15 p.m.–4:45 p.m. PT care disparities. This half-day course is aimed at junior investigators, CME as well as experienced investigators who are looking to adopt new C12: Resident Basic Science: Neuropathology 4 methods. The program will overview what implementation science is, Director(s): Suzanne Powell, MD, Houston, TX the use of implementation models and frameworks, mixed methods, and community engagement in research, especially vulnerable Learning Objectives: Participants should be able to recognize common gross, histological, and molecular features of central nervous communities. system disorders, and be able to understand cellular and gross Monday, April 4 neuropathology in relationship to neurologic disease mechanisms, diagnosis, laboratory studies, imaging, and progression of disease. This 7:00 a.m.–9:00 a.m. PT program complements Resident Basic Science: Neuroanatomy—All the CME Lesions, Resident Basic Science: Neuropharmacology, & Resident Basic C66: Faculty Development: Enhancing Your Role in 2 Student and Resident Training Science: Neurophysiology but covers independent topics. \ Director(s): Vicki Shanker, MD, FAAN, New York, NY Director(s): Emily Poole Pharr, MD, Winston Salem, NC

C50: Resident Basic Science: Neuroanatomy—All the Lesions Director(s): Zachary N. London, MD, FAAN, Ann Arbor, MI Learning Objectives: Participants should be able to name and recognize clinically relevant structures in the brain, brainstem, cerebellum, spinal cord, and peripheral nervous system, and understand the classic clinical features of a lesion in each of these structures. This program complements Resident Basic Science: Neuropathology, Resident Basic Science: Neuropharmacology, & Resident Basic Science: Neurophysiology but covers independent topics. Lecture/Faculty:

» The Brain

Sashank Prasad, MD, Boston, MA » The Brainstem Raymond Price, MD, FAAN, Philadelphia, PA » The Cerebellum Praveen Dayalu, MD, Ann Arbor, MI » The Spinal Cord Kara J. Wyant, MD, Ann Arbor, MI » The Peripheral Nervous System Zachary N. London, MD, FAAN, Ann Arbor, MI

CME

Learning Objectives: Participants should learn skills that clinicians are frequently asked to perform when working with trainees: writing letters of recommendation, providing feedback, and completing evaluations. Attendees will have the opportunity to apply these skills through guided activities and role play. In addition, the course will highlight inequities in medical education and provide a roadmap to combat inequity that can occur in teaching and assessment. Lecture/Faculty:

» Improving Your Letters of Recommendation Faculty

» Improving Feedback and Evaluations

Vicki Shanker, MD, FAAN, New York, NY

» Recognizing and Addressing Inequity in Medical Education Faculty

1:00 p.m.–5:30 p.m. PT

C76: Resident Basic Science: Neurophysiology

CME

Director(s): Raymond Price, MD, FAAN, Philadelphia, PA Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available. This program complements Resident Basic Science: Neuroanatomy—All the Lesions, Resident Basic Science: Neuropathology, & Resident Basic Science: Neuropharmacology but covers independent topics. `

AAN.com/AM

RESEARCH METHODOLOGY AND EDUCATION

Sunday, April 3

1:00 p.m.–5:30 p.m. PT

SEATTLE PROGRAMS BY TOPIC Tuesday, April 5

Thursday, April 7

1:00 p.m.–5:30 p.m. PT

1:00 p.m.–3:00 p.m. PT

C103: Resident Basic Science: Neuropharmacology

CME

Director(s): Hernan Nicolas Lemus Esquivel, MD, Brookline, MA Learning Objectives: The primary objective of this program is to understand the basic pharmacological concepts relevant to the clinical practice of neurology as well as an approach to medication selection for patients with epilepsy, neuroimmunology, headache, and movement disorders. This program complements Resident Basic Science: Neuroanatomy, Resident Basic Science: Neurophysiology, and Resident Basic Science: Neuropathology but covers independent topics. Lecture/Faculty:

» How to Study Effectively

Hernan Nicolas Lemus Esquivel, MD, Brookline, MA

CME

Director(s): Tamara B. Kaplan, MD, Boston, MA Learning Objectives: Participants should better comprehend how course logistics and specific faculty behaviors can promote a supportive online learning environment; how to identify resources and teaching methods for replacing traditional cadaveric neuroanatomy teaching; devise curricular modifications to favor flipped-classroom formats that minimize on-camera fatigue and maximize interactivity; practice teaching strategies that maximize student engagement and participation; how to create effective student assessment in that age of virtual learning. Lecture/Faculty:

» Telecommunication and How to Create Effective Virtual Teaching

» Headache Neuropharmacology

SLEEP

C158: Telecommunication and How to Create Effective Virtual Teaching Material

Material Tamara B. Kaplan, MD, Boston, MA Christopher T. Doughty, MD, Boston, MA

Faculty » Epilepsy Neuropharmacology Hernan Nicolas Lemus Esquivel, MD, Brookline, MA » MOV Disorders Neuropharmacology Faculty » MS Neuropharmacology Hernan Nicolas Lemus Esquivel, MD, Brookline, MA » Neuropharmacology Trivia: Test Your Knowledge! Hernan Nicolas Lemus Esquivel, MD, Brookline, MA

1:00 p.m.–3:00 p.m. PT

S33: Research Methodology and Education

CME

SLEEP

Wednesday, April 6

Saturday, April 2

1:00 p.m.–5:00 p.m. PT

C132: Research Career Symposium

CME

Director(s): Peter K. Todd, MD, PhD, FAAN, Ann Arbor, MI Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available.

7:00 a.m.–4:00 p.m. PT

C2: Neurology Continuing Certification Prep Course

CME

Director(s): Joseph E. Safdieh, MD, FAAN, New York, NY See learning objectives on page 37. 7:00 a.m.–4:00 p.m. PT

C3: Neurology Update

CME

Director(s): Adam Quick, MD, Columbus, OH See learning objectives on page 37.

2022 AAN Annual Meeting

Information is accurate as of November 29, 2021, and is subject to change.

C = Course

S = Scientific Session

P = Poster Session

N = Neuroscience in the Clinic Session

CME

IS = Invited Science

= CME Credit

LEC

= Additional Fee Required

= Learner Engagement Center

Sunday, April 3

= New in 2022

= Experiential Learning Area

Tuesday, April 5

1:00 p.m.–3:00 p.m. PT

7:00 a.m.–9:00 a.m. PT

S1: Sleep

CME

C92: Clinical Approach to Sleep Disorders

CME

Director(s): Logan D. Schneider, MD, Palo Alto, CA 3:30 p.m.–5:30 p.m. PT

C57: Circadian Rhythm Disorders

CME

Director(s): Sabra M. Abbott, MD, PhD, Chicago, IL Learning Objectives: Participants should be able to identify and manage circadian rhythm sleep-wake disorders; understand current recommendations for the management of shift work disorder; and recognize the benefits and pitfalls of consumer wearable electronics in the clinical management of sleep and circadian patients. Lecture/Faculty:

» Circadian Rhythm Sleep-Wake Disorders

Sabra M. Abbott, MD, PhD, Chicago, IL » Shift Work Disorder Liza Ashbrook, MD, San Francisco, CA » The Use of Consumer Wearable Devices in the Sleep/Circadian Clinic Benefits and Pitfalls Faculty

Faculty » The Compulsive Use of Dopamine Agonists for Restless Legs Syndrome: 21st-century RLS Management Faculty 1:00 p.m.–3:00 p.m. PT CME

Director(s): Yasemin Tashman, MD, Phoenix, AZ CME

Director(s): Joyce K. Lee-Iannotti, MD, Phoenix, AZ Learning Objectives: Participants should be aware of common sleep disorders within different patient populations and understand best practices to screen, diagnose and manage these patients effectively, in order to improve neurologic outcomes. 1:00 p.m.–3:00 p.m. PT

C75: Parasomnias Including REM Behavior Disorder

Logan D. Schneider, MD, Palo Alto, CA

» Sleepless in Silico—Cognitive and Behavioral Aspects of Insomnia

C101: Sleep Apnea

Monday, April 4

C65: Specialty Population Sleep Disorders

» How to Think About Your Sleepy Patient

CME

Learning Objectives: Sleep apnea is highly prevalent in patients with neurological disorders and often underdiagnosed in this population. This course will begin with the classification, diagnosis and treatments for sleep disordered breathing. We will delve deeper into the literature showing obstructive sleep apnea as an independent risk factor for stroke and the importance of timely diagnosis and treatment as crucial primary and secondary stroke prevention tools. We will also discuss the nuances of sleep apnea in the aging population, focusing on evidence from basic science and clinical studies supporting a relationship between OSA and dementia.

Director(s): Alberto Ramos, MD, FAAN, Miami, FL Learning Objectives: Participants will: Review the diagnostic criteria and treatment options of parasomnias in adults, including REM behavior disorder; Describe the normal variants of sleep, the theories of REM sleep and the influence of the pandemic on sleep patterns; Identify the risk factors and the patients at risk for parasomnias and its consequences. Lecture/Faculty:

» Introductions. Theories, Neuroanatomy and Physiology of Sleep Alberto Ramos, MD, FAAN, Miami, FL » Evaluation, Treatment and Non-common Causes of Non-REM Parasomnias in Adults Faculty » Evaluation and Treatment of REM Parasomnia Faculty

AAN.com/AM

SLEEP

7:00 a.m.–9:00 a.m. PT

Learning Objectives: Participants should become familiar with historical elements suggestive of hypersomnolence (vs hypersomnia and fatigue), insomnia, and restless legs syndrome; be able to educate their patients on healthy sleep-wake scheduling and behaviors; and be able to choose appropriate diagnostics, referrals, and first-line treatments for common sleep-wake disorders recognized in their patients. Lecture/Faculty:

SEATTLE PROGRAMS BY TOPIC SPORTS NEUROLOGY Tuesday, April 5 7:00 a.m.–9:00 a.m. PT

C91: Diagnosis and Management of Concussions

CME

Director(s): Vernon B. Williams, MD, FAAN, Los Angeles, CA Learning Objectives: Faculty are in the process of developing this program. Please continue to check AAN.com as details will be updated as they become available. 1:00 p.m.–3:00 p.m. PT

C100: Sports Neurology

CME

SPORTS NEUROLOGY

Director(s): Nicole Dorothy Reams, MD, FAAN, Glenview, IL Learning Objectives: Participants should understand the scope of sports neurology; discuss the unique ways to manage neurologic conditions in an athlete and how this may differ from a non-athlete; and outline various ways in which the brain responds to exercise and how it may be altered in the acute phase and may benefit long-term. Lecture/Faculty:

» The Non-concussion Side of Sports Neurology Stephanie Alessi-LaRosa, MD, Hartford, CT

» Exercise as Brain Medicine: The Neurobiology of Exercise Faculty

2022 AAN Annual Meeting

Information is accurate as of November 29, 2021, and is subject to change.

CONFERENCE GUIDELINES The following are a selection of guidelines for AAN conferences. Complete conference guidelines are available at AAN.com/events/conference-guidelines. Annual Meeting registrants must agree to conference guidelines during the registration process. Unless specified, these guidelines apply to all AAN conference formats. In addition to the below guidelines, participation in a live or virtual AAN meeting is subject to AAN’s Privacy Policy (AAN.com/PrivacyPolicy). All individuals engaged in any live or virtual meeting are subject to the Code of Conduct at AAN.com/Conduct, unless otherwise specifically noted. Use of the website and virtual program site(s) is subject to AAN’s Terms of Use (AAN.com/TermsofUse). These conference policies are subject to change without notice, at AAN’s discretion. Any changes will be reflected on AAN.com.

Accreditation ACCME Accreditation The American Academy of Neurology Institute (AANI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AANI holds Accreditation with Commendation, the ACCME highest level of recognition for a CME provider. View the CME Mission Statement at AAN.com/CMEstatement. AMA Credit Designation The AANI designates this live/enduring activity for a maximum of (*) AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. *See individual program descriptions on AAN.com/AM for the maximum number of credits per program. ABPN Statement The American Board of Psychiatry and Neurology has reviewed the relevant AAN conference and has approved the program as a part of a comprehensive lifelong learning program, which is mandated by the ABMS as a necessary component of continuing certification.

Select Meeting Policies Commitment to Inclusion, Diversity, Equity, Anti-racism, and Social Justice (IDEAS) The AAN is committed to intentional actions to be a fully inclusive, deliberately diverse, and anti-racist organization that respects and values our membership, our staff, and the communities we serve. We actively promote equity and social justice in neurology and the neurosciences. As part of this commitment, the AAN is working to ensure we provide a conference environment and educational programming that is fully inclusive, deliberately diverse, and anti-racist. If you have questions about these efforts, identify areas for improvement, or have concerns regarding attendee or staff behavior, please contact Member Services at (800) 879-1960, memberservices@aan.com, or conference staff at registration@aan.com. Professional Conduct & Anti-harassment The AAN expects all meeting participants, including attendees, members, speakers, staff, contractors, vendors, and exhibitors, to behave respectfully, responsibly, and professionally towards each other, and to abide by the AAN’s Meetings Anti-harassment Policy (AAN.com/Anti-harassment), during the conference. The AAN is committed to providing a conference environment that is free from all forms of discrimination and harassment. Violations of this policy may be reported to Member Services at (800) 879-1960, memberservices@aan.com, or to Academy staff at registration@aan.com. AAN.com/AM

Accessibility The AAN strives to make our conferences accessible. The AAN is committed to building and sustaining an inclusive organization that respects and values the diversity of our membership and the communities we serve. We are continually improving our on-site offerings and digital assets to comply with current best practices and accessibility guidelines. If you have questions regarding accessibility of the site and content, please contact registration@aan.com.

COVID-19 Policies The American Academy of Neurology is committed to creating a safe and healthy environment for all our attendees, exhibitors, and staff. Specific health and safety measures will be described and disseminated on AAN.com/AMCOVID19. Vaccination Required All attendees must be “fully vaccinated” (as defined by the CDC at the time of the meeting) and must provide verification of full COVID-19 vaccination status to attend the 2022 Annual Meeting in Seattle. Unvaccinated individuals may register for the Annual Meeting Virtual Experience.

Cancellation Policies Annual Meeting cancellation policies have been updated to be more flexible, as attendees’ safety is our number one concern. We have implemented a no-risk registration for the Annual Meeting in Seattle through the early registration deadline, February 17, 2022. Annual Meeting Seattle and Annual Meeting Gold Registration Cancellation You may cancel your registration for a full refund if requested prior to or on Thursday, February 17. Requests received after February 17 may switch to a Virtual or Virtual Gold registration, but will not receive a refund of the difference in the registration fees. Additional Programs Additional programs purchased with the Annual Meeting registration can be cancelled by February 17 for no penalty and receive a full refund. Requests received on February 18 and after will be refunded minus a $100 cancellation fee. Annual Meeting Virtual Experience and Annual Meeting Virtual Experience Gold Registration Cancellation You may change from a Virtual or Virtual Gold registration to any other registration type for no fee prior to February 17. After February 17, you may change from a virtual registration to a more expensive registration type for the difference in pricing, but no refunds will be given if switching to a less expensive registration type. Full cancellation of Virtual or Virtual Gold registrations are not allowed. All sales for online programs including virtual conferences are final, nonrefundable, and nontransferable to another individual. Virtual registration includes access to recordings and materials through May 14, 2022, or March 31, 2023, with Gold upgrade. Platinum Registration Cancellation You may change from a Platinum registration to any other registration type by Thursday, February 17, and receive a full refund of the difference in registration fees. Requests received after February 17 may switch to any other registration type but will not receive a refund of the difference in the registration fees. Annual Meeting in Seattle Cancellation If the Seattle portion of the Annual Meeting is cancelled and only the Virtual Experience is offered, all Platinum and Annual Meeting Gold registrations will automatically be converted to Virtual Gold registrations, and Annual Meeting registrations will be converted to Virtual registrations. Skills Workshop fees and other tickets for programs taking place at the Annual Meeting will be refunded in full. Donations to the American Brain Foundation will not be refunded. Tickets purchased for the Commitment to Cures event will automatically be converted into a virtual Commitment to Cures ticket. Sign-ups for the Run/Walk for Brain Research will be donated to the AAN Research Program and will not be refunded.

2022 AAN Annual Meeting

Visit AAN.com/AMCOVID19 to learn more.

Health & Safety Come First HELPFUL TIPS

Our next Annual Meeting in Seattle will be both our best and our safest event to date. A dedicated physician work group will determine specific protocols for Seattle so we can take every measure to ensure attendee health and safety throughout the meeting.

Preliminary Health & Safety Measures Proof of vaccination required for all attendees Sanitization stations throughout the convention center Safe food distribution protocols

The AAN will follow CDC, state, and local mandates and guidance to expand or modify our safety protocols as appropriate.

201 Chicago Avenue Minneapolis, MN 55415

Get Ready for the Great Neuro Reunion! The AAN Annual Meeting is back in person in Seattle, in addition to offering a distinct virtual experience. Get ready to reunite with your neurology community from around the globe for the most comprehensive educational offerings and largest scientific program in the field.

AAN.com/AM

Future AAN Annual Meeting Dates and Locations 75th AAN Annual Meeting

76th AAN Annual Meeting

77th AAN Annual Meeting

Boston, MA April 22–April 28, 2023

Denver, CO April 13–April 19, 2024

San Diego, CA April 5–April 11, 2025

AAN Member Services: (800) 879-1960

Use #AANAM and follow the AAN